Polypeptides with mannanase activity and polynucleotides encoding them
By providing peptides and polynucleotides with mannanase activity, the problem of insufficient endo-1,4-β-mannanase activity in the prior art is solved, achieving efficient mannan degradation in detergents, liquid compositions and a variety of applications.
Patent Information
- Application Number
- CN201880063979.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Priority Date
- 2017-10-02
- Filing Date
- 2018-10-02
- Publication Date
- 2026-11-10
- Estimated Expiration
- 2038-10-02
AI Technical Summary
In the prior art, endo-1,4-β-mannanase has limited activity in degrading mannan, which is insufficient to meet the needs of applications such as detergents, bioethanol production, and coffee extract hydrolysis.
Provides polypeptides and polynucleotides with mannanase activity, including polypeptides and variants thereof having at least 91% sequence identity with SEQ ID NO:4, bearing a His-tag or HQ-tag, and containing amino acid extensions or deletions, or fragments thereof, for use in the preparation of detergent compositions and liquid compositions for applications in laundry washing, cleaning, animal feed, food, coffee extraction, and other fields.
These peptides exhibit high activity in degrading mannan and can be effectively applied in detergents, liquid compositions, and various other applications, improving detergency and bioethanol production efficiency.
Smart Images

Figure SMS_21 
Figure SMS_23 
Figure SMS_25
Abstract
Description
[0001] References to sequence lists
[0002] This application contains a sequence list in computer-readable form, which is incorporated herein by reference. Background of the Invention Technical Field
[0004] This invention relates to polypeptides with mannanase activity and polynucleotides encoding these polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising these polynucleotides, as well as methods for producing and using these polypeptides. Background Technology
[0006] Mannan is a polysaccharide with a backbone of D-mannopyranosyl residues linked by β-1,4-linked groups. It can contain galactose or acetyl substitutions and may have glucose residues in the backbone. The main enzyme involved in the degradation of mannan is endo-1,4-β-mannanase (EC 3.2.1.78), which hydrolyzes the internal glycosidic bonds in the mannan backbone.
[0007] Mannans are a type of hemicellulose that makes up up to 25% of the dry weight of cork, but they are also found in other plant materials, especially various seeds. Guar gum, which contains mannans, is used as a stabilizer in many foods.
[0008] Therefore, the use of endomannanases may be advantageous in applications where mannan degradation is required. Examples of where mannanases can be used include in detergents to remove stains containing mannan; in the case of cork (Várnai et al., (2011) "Synergistic action of xylanase and mannanase improves the total hydrolysis of softwood", Bioresource tech., 102(19), pp. 9096–104) and palm kernel filter cake (… Cai et al., (2010) "Production of ethanol and feed by high dry matter hydrolysis and fermentation of palm kernel press cake", Applied Biochem. Biotech., 161(1-8), pp. 318–32. Bioethanol has been used in the production of bioethanol for improving animal feed (Cai et al., (2011), "Acidic β-mannanase from Penicillium pinophilum C1: Cloning, characterization and assessment of its potential for animal feed application", J. Biosci. Bioeng., 112(6), pp. 551–557); and in the hydrolysis of coffee extract (Nunes et al., (2006), "Characterization of Galactomannan..."). Characterization of galactomannan derivatives in roasted coffee beverages, J. Agricultural Food Chem., 54(9), pp. 3428–3439.
[0009] According to CAZy (www.cazy.org), endo-1,4-β-mannanases have been found in glycoside hydrolase families 5, 26, and 113. This invention provides polypeptides from glycoside hydrolase family 26 with mannanase activity and polynucleotides encoding these polypeptides, which are highly active in degrading different types of mannans and therefore can be used in the aforementioned applications. Summary of the Invention
[0010] This invention relates to polypeptides with mannanase activity selected from the group consisting of:
[0011] (a) A polypeptide that has at least 91% sequence identity with SEQ ID NO:4;
[0012] (b) A variant of SEQ ID NO:4, wherein the variant has mannanase activity and includes one or more substitutions, and / or one or more deletions, and / or one or more insertions or any combination thereof at positions 1 to 29;
[0013] (c) A polypeptide comprising the polypeptide of (a) or (b) and an N-terminal and / or C-terminal His-tag and / or HQ-tag;
[0014] (d) A polypeptide comprising the polypeptide of (a) or (b) and an N-terminus and / or C-terminus extension of up to 10 amino acids, such as 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10 amino acids; and
[0015] A fragment of the polypeptide of (e), (a), or (b), which has mannanase activity and has at least 90% of the length of the mature polypeptide.
[0016] The present invention further relates to detergent compositions comprising a surfactant and a polypeptide having mannanase activity, wherein the polypeptide is selected from the group consisting of:
[0017] (a) A polypeptide that has at least 81% sequence identity with SEQ ID NO:3;
[0018] (b) A variant of SEQ ID NO:4, wherein the variant has mannanase activity and includes one or more substitutions, and / or one or more deletions, and / or one or more insertions or any combination thereof at positions 1 to 50;
[0019] (c) A polypeptide comprising the polypeptide of (a) or (b) and an N-terminal and / or C-terminal His-tag and / or HQ-tag;
[0020] (d) A polypeptide comprising the polypeptide of (a) or (b) and an N-terminus and / or C-terminus extension of up to 10 amino acids, such as 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10 amino acids; and
[0021] A fragment of the polypeptide of (e), (a), or (b), which has mannanase activity and has at least 90% of the length of the mature polypeptide.
[0022] The present invention further relates to particles comprising a core particle and one or more coatings, wherein the particles comprise a polypeptide having mannanase activity as defined above, and to liquid compositions comprising a polyol and a polypeptide having mannanase activity, wherein the polypeptide is as defined above. The present invention further relates to the use of the peptide in various applications, such as degrading mannan, laundry detergent, washing, cleaning, animal feed, food, coffee extraction, degradation of cellulose materials, production of fermentation products, isolated polynucleotides encoding the peptides of the present invention, recombinant host cells, and methods for producing the peptides of the present invention.
[0023] Sequence List Overview
[0024] SEQ ID NO:1 is the DNA sequence of a natural GH26 mannanase containing a CBM35 domain, such as that isolated from the Paenibacillus woosongensis strain.
[0025] SEQ ID NO:2 is the amino acid sequence as deduced from SEQ ID NO:1.
[0026] SEQ ID NO:3 is the amino acid sequence of a mature GH26 mannanase with the CBM35 domain isolated from a strain of Bacillus subtilis.
[0027] SEQ ID NO:4 is the amino acid sequence of a truncated GH26 mannanase isolated from a strain of Bacillus subtilis, lacking the CBM35 domain.
[0028] SEQ ID NO:5 is the construct DNA sequence of GH26 mannanase containing CBM35, wherein the native secretion signal is removed and a 6xHis tag is directly added to the C-terminus of the protein.
[0029] SEQ ID NO:6 is the amino acid sequence as deduced from SEQ ID NO:5.
[0030] SEQ ID NO:7 is a construct DNA sequence of GH26 mannanase isolated from a strain of Bacillus subtilis, lacking the CBM35 domain, with a 6xHis tag directly added to the C-terminus of the protein.
[0031] SEQ ID NO:8 is the amino acid sequence as deduced from SEQ ID NO:7.
[0032] SEQ ID NO:9 is the DNA sequence of a natural GH26 mannanase containing a CBM35 domain, such as that isolated from Paenibacillus ihumii strains.
[0033] SEQ ID NO:10 is the amino acid sequence as deduced from SEQ ID NO:9.
[0034] SEQ ID NO:11 is the amino acid sequence of a mature GH26 mannanase with the CBM35 domain isolated from a strain of Bacillus yurigensis.
[0035] SEQ ID NO:12 is a construct DNA sequence of GH26 mannanase containing the CBM35 domain from a strain of Bacillus licheniformis, wherein the natural secretion signal is replaced by the Bacillus licheniformis secretion signal, and the HPHPHPHP tag is directly added to the C-terminus of the protein.
[0036] SEQ ID NO:13 is the amino acid sequence as deduced from SEQ ID NO:12.
[0037] SEQ ID NO:14 is the amino acid sequence of the secretion signal of Bacillus clausti.
[0038] SEQ ID NO:15 is the HPHPHPHP tag.
[0039] SEQ ID NO:16, SEQ ID NO:17 and SEQ ID NO:18 are N-terminal sequences determined by EDMAN degradation of GH26 mannanase from Bacillus subtilis strain.
[0040] definition
[0041] Based on the detailed description, the following abbreviations and definitions apply. Note that the singular forms “a / an” and “the” include a plural number of indicators unless the context clearly indicates otherwise. Thus, for example, reference to “an enzyme” includes multiple such enzymes, and reference to “the dosage” includes one or more dosages known to those skilled in the art and their equivalents.
[0042] Co-activity 9: The term “co-activity 9” or “AA9” refers to a polypeptide classified as a soluble polysaccharide monooxygenase (Quinlan et al., 2011, Proc. Natl. Acad. Sci. USA [Proceedings of the National Academy of Sciences] 208:15079-15084; Phillips et al., 2011, ACS Chem. Biol. [ACS Chemical Biology] 6:1399-1406; Lin et al., 2012, Structure [Structure] 20:1051-1061). According to Henrissat, 1991, Biochem. J [Journal of Biochemistry] 280:309-316 and Henrissat and Bairoch, 1996, Biochem. J [Journal of Biochemistry] 316:695-696, the AA9 polypeptide was previously classified as glycoside hydrolase family 61 (GH61).
[0043] Allelic variants: The term "allelic variant" refers to any of two or more alternative forms of a gene occupying the same chromosomal locus. Allelic variations arise naturally through mutation and can lead to polymorphism within a population. Gene mutations can be silent (encoding a polypeptide with no change) or can encode a polypeptide with a modified amino acid sequence. Allelic variants of a polypeptide are polypeptides encoded by allelic variants of a gene.
[0044] Biofilm: The term "biofilm" refers to any group of microorganisms whose cells adhere to each other on a surface, such as textiles, tableware, or hard surfaces. These adherent cells are often embedded in a matrix of extracellular polymeric substances (EPS). Biofilms (EPS) are polymeric aggregates generally composed of extracellular DNA, proteins, and polysaccharides. Biofilms can form on living or non-living surfaces. Microbial cells growing in biofilms are physiologically distinct from planktonic cells of the same organism (in contrast, planktonic cells are single cells that can float or float in a liquid medium).
[0045] Bacteria living in biofilms often exhibit significantly different characteristics from free-floating bacteria of the same species because the dense and protected environment of the membrane allows them to cooperate and interact in different ways. One role of this environment is to increase resistance to detergents and antibiotics, as the dense extracellular matrix and outer layer of the cell protect the interior of the community.
[0046] Bacteria that produce biofilms during laundry washing can be found in the following species: Acinetobacter sp., Aeromicrobium sp., Brevundimonas sp., Microbacterium sp., Micrococcus luteus, Pseudomonas sp., Staphylococcus epidermidis, and Stenotrophomonas sp.
[0047] Carbohydrate-binding module: The term "carbohydrate-binding module" refers to a region within a carbohydrate-active enzyme that provides carbohydrate-binding activity (Boraston et al., 2004, Biochem. J. [Journal of Biochemistry] 383:769-781). Most known carbohydrate-binding modules (CBMs) are continuous amino acid sequences with discrete folds. Carbohydrate-binding modules (CBMs) are typically found at the N-terminus or C-terminus of an enzyme. Some CBMs are known to be specific for cellulose. In one embodiment, this CBM is family 35 CBM (Pfam PF16990), such as those disclosed in Tunnicliffe RB, Bolam DN, Pell G, Gilbert HJ, Williamson MP; J Mol Biol. [Journal of Molecular Biology] 2005; 347:287-296.
[0048] Catalytic domain: The term "catalytic domain" refers to the region of an enzyme that contains the catalytic mechanism of the enzyme.
[0049] cDNA: The term "cDNA" refers to a DNA molecule that can be prepared by reverse transcription from mature, spliced mRNA molecules obtained from eukaryotic or prokaryotic cells. cDNA lacks intron sequences that can be present in the corresponding genomic DNA. The initial primary RNA transcript is the precursor of mRNA, which undergoes a series of steps (including splicing) to become mature spliced mRNA.
[0050] Cellulase or cellulase: The term “cellulase” or “cellulase” refers to one or more (e.g., several) enzymes that hydrolyze cellulose materials. Such enzymes include one or more endoglucanases, one or more cellobiases, one or more β-glucosidases, or combinations thereof. Two basic methods for measuring cellulase activity include (1) measuring total cellulase activity and (2) measuring individual cellulase activity (endoglucanase, cellobiase, and β-glucosidase), as described in Zhang et al., 2006, Biotechnology Advances, 24:452-481. Total cellulase activity can be measured using insoluble substrates, including Whatman No. 1 filter paper, microcrystalline cellulose, bacterial cellulose, algal cellulose, cotton, pretreated lignocellulose, etc. The most common assay for total cellulose decomposition activity is the filter paper assay using Whatman No. 1 filter paper as the substrate. This assay was established by the International Union of Pure and Applied Chemistry (IUPAC) (Ghose, 1987, Pure Appl. Chem. 59: 257-68).
[0051] Cellulase activity can be determined by measuring the increase in sugar production / release during the hydrolysis of cellulose material by one or more cellulases under the following conditions: 1-50 mg of cellulase protein / g in pretreated corn stalks (PCS) cellulose (or other pretreated cellulose material) compared to control hydrolysis without added cellulase protein, for 3-7 days at suitable temperatures (e.g., 40-80°C, e.g., 50°C, 55°C, 60°C, 65°C, or 70°C) and suitable pH (e.g., 4-9, e.g., 5.0, 5.5, 6.0, 6.5, or 7.0). Typical conditions are: 1 ml reaction, washed or unwashed PCS, 5% insoluble solids (dry weight), 50 mM sodium acetate (pH 5), 1 mM MnSO4, 50°C, 55°C, or 60°C, 72 hours, by... Sugar analysis was performed using an HPX-87H column (Bio-Rad Laboratories, Hercules, California, USA).
[0052] Chimeric polypeptide: The term "chimeric polypeptide" refers to a polypeptide with mannanase activity, which is produced by replacing the amino acid sequence of a polypeptide with mannanase activity with amino acids at homologous positions of one or more other polypeptides with mannanase activity.
[0053] Coding sequence: The term "coding sequence" refers to a polynucleotide that directly specifies the amino acid sequence of a polypeptide. The boundaries of a coding sequence are typically defined by a read frame, which begins with a start codon (e.g., ATG, GTG, or TTG) and ends with a stop codon (e.g., TAA, TAG, or TGA). Coding sequences can be genomic DNA, cDNA, synthetic DNA, or a combination thereof.
[0054] Control Sequence: The term "control sequence" refers to the nucleic acid sequence necessary for the expression of the polynucleotide encoding the mature polypeptide of the present invention. Each control sequence may be native (i.e., from the same gene) or exogenous (i.e., from different genes) for the polynucleotide encoding the polypeptide, or native or exogenous relative to each other. Such control sequences include, but are not limited to, leader sequences, polyadenylated sequences, propeptide sequences, promoters, signal peptide sequences, and transcription terminators. At a minimum, control sequences include promoters and transcription and translation termination signals. These control sequences may be provided with multiple linkers for the purpose of introducing specific restriction sites that facilitate the linking of control sequences to the coding region of the polynucleotide encoding the polypeptide.
[0055] Detergent Components: The term "detergent component" is defined herein as referring to the type of chemicals that may be used in a detergent composition. Examples of detergent components include surfactants, water-soluble auxiliaries, builders, co-builders, chelators or chelating agents, bleaching systems or bleaching components, polymers, fabric toners, fabric conditioning agents, foam boosters, defoamers, dispersants, dye transfer inhibitors, optical brighteners, fragrances, optical brighteners, bactericides, fungicides, dirt suspending agents, dirt-releasing polymers, anti-redeposition agents, enzyme inhibitors or stabilizers, enzyme activators, antioxidants, and solubilizers. A detergent composition may contain one or more detergent components of any type.
[0056] Detergent Composition: The term "detergent composition" refers to a composition of compounds intended to remove unwanted compounds from items to be cleaned, such as textiles, tableware, and hard surfaces. This detergent composition can be used, for example, to clean textiles, tableware, and hard surfaces, for both household and industrial cleaning purposes. These terms encompass any material / compound selected for use in the form of a specific type of cleaning composition and product (e.g., liquid, gel, powder, granules, paste, or spray composition), and include, but are not limited to, detergent compositions (e.g., liquid and / or solid laundry detergents and delicate fabric detergents; hard surface cleaning formulations, such as those for glass, wood, ceramic, and metal countertops and windows; carpet cleaners; stove cleaners; fabric fresheners; fabric softeners; and textile and garment pre-spotters, along with dishwashing detergents). In addition to containing the GH9 endoglucanase and / or the xanthan gum lyase of the present invention, the detergent composition may contain one or more other enzymes (such as amylase, protease, peroxidase, cellulase, β-glucanase, xyloglucanase, hemicellulase, xanthan gumase, xanthan gum lyase, lipase, acyltransferase, phospholipase, esterase, laccase, catalase, aryl esterase, amylase, α-amylase, glucosylamylase, keratinase, pectinase, pectin lyase, keratinase, reductase, oxidase, phenoloxidase, lipoxygenase, ligninase, carrageenanase, amylopectinase, tanninase, arabinosidase, hyaluronidase, chondroitinase, xyloglucanase). Enzymes, xylanases, pectin acetylesterases, polygalacturonases, rhamnogalacturonases, other endo-β-mannanases, exo-β-mannanases, pectin methylesterases, cellobiases, transglutaminases and combinations thereof, or any mixture thereof) and / or components such as surfactants, detergents, chelating agents or chelating reagents, bleaching systems or bleaching components, polymers, fabric conditioners, foaming agents, defoaming agents, dyes, fragrances, darkening inhibitors, optical brighteners, bactericides, fungicides, dirt suspending agents, corrosion inhibitors, enzyme inhibitors or stabilizers, enzyme activators, one or more transferases, hydrolases, oxidoreductases, bluing agents and fluorescent dyes, antioxidants, and solubilizers.
[0057] Dishwashing: The term "dishwashing" refers to all forms of dishwashing, such as manual or automated dishwashing. Dishwashing includes, but is not limited to, cleaning all forms of tableware, such as plates, cups, glasses, bowls, all forms of cutlery (such as spoons, knives, and forks), and serving utensils made of ceramic, plastic, metal, porcelain, glass, and acrylic.
[0058] Dishwashing Composition: The term "dishwashing composition" refers to all forms of compositions used for cleaning hard surfaces. This invention is not limited to any particular type of dishwashing composition or any particular detergent.
[0059] Expression: The term “expression” includes any step involved in the production of a polypeptide, including but not limited to: transcription, post-transcriptional modification, translation, post-translational modification, and secretion.
[0060] Expression vector: The term "expression vector" refers to a straight or circular DNA molecule that contains a polynucleotide encoding a polypeptide and is operatively linked to a control sequence that provides for its expression.
[0061] Fragment: The term "fragment" refers to a polypeptide or catalytic module or carbohydrate-binding module having one or more (e.g., several) amino acids not present at the amino and / or carboxyl termini of a mature polypeptide or domain; wherein the fragment has mannanase activity or carbohydrate-binding activity. In one aspect, the fragment comprises at least 90% of the length of the mature polypeptide, such as at least 448 amino acids of SEQ ID NO:3, or at least 297 amino acids of SEQ ID NO:4, or at least 474 amino acids of SEQ ID NO:11. In one aspect, the fragment comprises at least 92% of the length of the mature polypeptide, such as at least 458 amino acids of SEQ ID NO:3, or at least 303 amino acids of SEQ ID NO:4, or at least 484 amino acids of SEQ ID NO:11. In one aspect, the fragment comprises at least 94% of the length of the mature polypeptide, such as at least 468 amino acids of SEQ ID NO:3, or at least 310 amino acids of SEQ ID NO:4, or at least 495 amino acids of SEQ ID NO:11. In one aspect, the fragment comprises at least 96% of the length of a mature polypeptide, such as at least 478 amino acids of SEQ ID NO:3, at least 316 amino acids of SEQ ID NO:4, or at least 505 amino acids of SEQ ID NO:11. In another aspect, the fragment comprises at least 98% of the length of a mature polypeptide, such as at least 488 amino acids of SEQ ID NO:3, at least 323 amino acids of SEQ ID NO:4, or at least 516 amino acids of SEQ ID NO:11. In another aspect, the fragment comprises at least 99% of the length of a mature polypeptide, such as at least 493 amino acids of SEQ ID NO:3, at least 326 amino acids of SEQ ID NO:4, or at least 527 amino acids of SEQ ID NO:11.
[0062] Fusion polypeptide: The term "fusion polypeptide" is a polypeptide in which one polypeptide is fused to the N-terminus or C-terminus of the polypeptide of the present invention. Fusion polypeptides are produced by fusing a polynucleotide encoding another polypeptide with the polynucleotide of the present invention. Techniques for producing fusion polypeptides are known in the art and include linking the coding sequences of the polypeptides such that they conform to reading frames, and that the expression of the fusion polypeptide is controlled by one or more identical promoters and terminators. Fusion polypeptides can also be constructed using intronomer technology, wherein the fusion polypeptide is produced post-translational (Cooper et al., 1993, EMBO J. [Journal of the European Society for Molecular Biology] 12:2575-2583; Dawson et al., 1994, Science 266:776-779). The fusion polypeptide may further include a cleavage site between the two polypeptides. This site is cleaved upon secretion of the fusion protein, thereby releasing both polypeptides. Examples of cleavage sites include, but are not limited to, those disclosed in the following literature: Martin et al., 2003, J. Ind. Microbiol. Biotechnol. [Journal of Industrial Microbiology and Biotechnology] 3:568-576; Svetina et al., 2000, J. Biotechnol. [Journal of Biotechnology] 76:245-251; Rasmussen-Wilson et al., 1997, Appl. Environ. Microbiol. [Applied Environmental Microbiology] 63:3488-3493; Ward et al., 1995 Biotechnology, 13:498-503; and Contreras et al., 1991, Biotechnology, 9:378-381; Eaton et al., 1986, Biochemistry, 25:505-512; Collins-Racie et al., 1995, Biotechnology, 13:982-987; Carter et al., 1989, Proteins: Structure, Function, and Genetics, 6:240-248; and Stevens, 2003, Drug Discovery World, 4:35-48.
[0063] Hard Surface Cleaning: This article defines "hard surface cleaning" as cleaning hard surfaces, which can include floors, tables, walls, roofs, etc., along with surfaces of hard objects such as cars (car washing) and tableware (dishwashing). Dishwashing includes, but is not limited to, cleaning plates, cups, glasses, bowls, and knives (e.g., spoons, knives, forks), serving utensils, ceramics, plastics, metals, porcelain, glass, and acrylics.
[0064] Hemicellulase or hemicellulase: The term “hemicellulase” or “hemicellulase” refers to one or more (e.g., several) enzymes that can hydrolyze hemicellulose material. See, for example, Sharlom and Shoham, Current Opinion in Microbiology, 2003, 6(3):219-228). Hemicellulases are key components in the degradation of plant biomass. Examples of hemicellulases include, but are not limited to: acetylmannan esterase, acetylxylan esterase, arabinonanase, arabinofuranylase, coumarin esterase, ferulic esterase, galactosidase, glucuronidase, glucuronidase, mannanase, mannosidase, xylanase, and xylosidase. The substrates (hemicellulose) of these enzymes are a heterogeneous group of branched and linear polysaccharides that are linked to cellulose microfibers in the plant cell wall via hydrogen bonds, thereby cross-linking them into a robust network. Hemicellulose is also covalently attached to lignin, thus forming a highly complex structure together with cellulose. The variable structure and organization of hemicellulose require the synergistic action of many enzymes to achieve its complete degradation. The catalytic modules of hemicellulases are glycosidases (GH) that hydrolyze glycosidic bonds, or carbohydrate esterases (CE) that hydrolyze ester bonds on the side groups of acetic acid or ferulic acid. These catalytic modules can be assigned to the GH and CE families based on their primary sequence homology. Some families (with generally similar folds) can be further grouped into clans, labeled with letters (e.g., GH-A). The most comprehensive and up-to-date classification of these and other carbohydrate-active enzymes is available in the Carbohydrate Active Enzymes (CAZy) database. Hemicellulase activity can be measured at suitable temperatures (e.g., 40°C–80°C, e.g., 50°C, 55°C, 60°C, 65°C, or 70°C) and suitable pH (e.g., 4–9, e.g., 5.0, 5.5, 6.0, 6.5, or 7.0) according to Ghose and Bisaria, 1987, Pure & Applied Chemistry, 59:1739–1752, at suitable temperatures (e.g., 40°C–80°C, e.g., 50°C, 55°C, 60°C, 65°C, or 70°C) and suitable pH (e.g., 4–9, e.g., 5.0, 5.5, 6.0, 6.5, or 7.0).
[0065] Host cell: The term "host cell" means any cell type that is readily transformed, transfected, transduced, etc., using nucleic acid constructs or expression vectors containing the polynucleotides of the present invention. The term "host cell" encompasses any offspring of a parent cell that differs from the parent cell due to mutations occurring during replication, as well as recombinant host cells, isolated host cells (e.g., isolated recombinant host cells), and heterologous host cells (e.g., host cells that are not Myrothecium roridum host cells).
[0066] Hybrid polypeptide: The term "hybrid polypeptide" refers to a polypeptide that contains domains from two or more polypeptides, such as a binding domain from one polypeptide and a catalytic domain from another polypeptide. These domains may be fused at the N-terminus or C-terminus.
[0067] Separate: The term “separate” means a substance in a form not found in nature or in an environment in which the substance is not found in nature. Non-limiting examples of separated substances include (1) any substance that is not naturally occurring; (2) any substance that has been removed at least in part from one or more of the naturally occurring components that are naturally associated with it, including, but not limited to: any enzyme, variant, nucleic acid, protein, peptide or cofactor; (3) any substance that has been artificially altered relative to a substance found in nature; or (4) any substance that has been altered relative to other components naturally associated with it by increasing the amount of the substance (e.g., recombinant production in a host cell; multiple copies of the gene encoding the substance; and the use of a promoter stronger than that naturally associated with the gene encoding the substance).
[0068] Laundry: The term "laundry" encompasses both household and industrial laundry and refers to the process of treating textiles with a solution containing the cleaning or detergent composition of the present invention. The laundry process can be performed, for example, using a household or industrial washing machine or manually.
[0069] Mannanase: The term "mannanase" refers to a polypeptide with endo-1,4-β-mannanosidase activity (EC3.2.1.78) that catalyzes the hydrolysis of 1,4-β-D-mannoside bonds in mannan, galactomannan, and glucomannan. Other names for endo-1,4-β-mannanosidase include: mannan hydrolase of 1,4-β-D-mannan; endo-1,4-β-mannanase; endo-β-1,4-mannanase; β-mannanase B; β-1,4-mannan-4-mannan hydrolase; endo-β-mannanase; and β-D-mannanase. For the purposes of this invention, mannanase activity can be determined using the reducing end assay as described in Example 1 herein. In one aspect, these polypeptides of the present invention have at least 50%, for example at least 60%, at least 70%, at least 80%, at least 90%, at least 95%, or at least 100% of the mannanase activity of the mature polypeptide of SEQ ID NO:3 or SEQ ID NO:11.
[0070] Mature polypeptide: The term "mature polypeptide" refers to a polypeptide in its final form after translation and any post-translational modifications such as N-terminal processing, C-terminal truncation, glycosylation, phosphorylation, etc. In one aspect, the mature polypeptide is amino acids 1 to 498 of SEQ ID NO:3. In another aspect, the mature polypeptide is amino acids 1 to 330 of SEQ ID NO:4. In another aspect, the mature polypeptide is amino acids 1 to 527 of SEQ ID NO:11.
[0071] It is known in the art that host cells can produce mixtures of two or more different mature polypeptides (i.e., with different C-terminal and / or N-terminal amino acids) expressed from the same polynucleotide. It is also known in the art that different host cells process polypeptides in different ways, and therefore a host cell expressing a polynucleotide may produce different mature polypeptides (e.g., with different C-terminal and / or N-terminal amino acids) compared to another host cell expressing the same polynucleotide.
[0072] Mature polypeptide coding sequence: The term "mature polypeptide coding sequence" refers to a polynucleotide encoding a mature polypeptide having mannanase activity. In one aspect, the mature polypeptide coding sequence is nucleotides 91 to 1584 of SEQ ID NO:1 or nucleotides 124 to 1704 of SEQ ID NO:9. Nucleotides 1 to 90 of SEQ ID NO:1 and nucleotides 1 to 123 of SEQ ID NO:9 encode a signal peptide.
[0073] Odor: The term "odor" refers to an undesirable smell on a cleaned item. A cleaned item should smell fresh and clean, without any odor adhering to it. One example of odor is a compound with an unpleasant smell, which can be produced by microorganisms. Another example is sweat or body odor adhering to items that have come into contact with humans or animals. Yet another example of odor can be the smell of various fragrances, such as curry or other exotic spices adhering to an item (e.g., a textile). One way to measure an item's ability to acquire odor is through an odor assay.
[0074] Nucleic acid constructs: The term “nucleic acid construct” refers to a single-stranded or double-stranded nucleic acid molecule that is isolated from a naturally occurring gene, or modified in a way that does not normally exist in nature to contain segments of nucleic acid, or is synthesized and contains one or more control sequences.
[0075] Operable ligation: The term “operable ligation” refers to a configuration in which a control sequence is placed at an appropriate position relative to the coding sequence of a polynucleotide, such that the control sequence guides the expression of the coding sequence.
[0076] Sequence identity: The degree of association between two amino acid sequences or two nucleotide sequences is described by the parameter “sequence identity”. For the purposes of this invention, the sequence identity between two amino acid sequences is determined using the Needleman-Wunsch algorithm (Needleman and Wunsch, 1970, J. Mol. Biol. 48:443-453) implemented in the Needleman program of the EMBOSS software package (EMBOSS: The European Molecular Biology Open Software Suite, Rice et al., 2000, Trends Genet. 16:276-277) (preferably version 6.6.0 or later). The parameters used are a vacancy opening penalty of 10, a vacancy extension penalty of 0.5, and an EBLOSUM62 substitution matrix (the EMBOSS version of BLOSUM62). The output of "longest identity" marked by Nieder (obtained using the non-simplified (-nobrief) option) is used as the identity percentage and calculated as follows:
[0077] (Same residue x 100) / (Alignment length - Total number of vacancies in the alignment)
[0078] For the purposes of this invention, the Needleman-Wunsch algorithm (Needleman and Wunsch, 1970, ibid.) is used to determine sequence identity between two deoxynucleotide sequences. This algorithm is implemented using the Niedle procedure in the EMBOSS software package (EMBOSS: European Molecular Biology Open Software Suite, Rice et al., 2000, ibid.) (preferably version 5.0.0 or later). The parameters used are a vacancy opening penalty of 10, a vacancy extension penalty of 0.5, and an EDNAFULL (EMBOSS version of NCBI NUC4.4) substitution matrix. The Niedle-labeled "longest identity" output (obtained using the non-simplified (-nobrief) option) is used as the identity percentage and calculated as follows:
[0079] (Same deoxyribonucleotide x 100) / (Alignment length - Total number of vacancies in the alignment)
[0080] Subsequence: The term “subsequence” refers to a polynucleotide that omits one or more (e.g., several) nucleotides from the 5' and / or 3' end of a mature polypeptide coding sequence, wherein the subsequence encodes a fragment having mannanase activity.
[0081] Textiles: The term "textiles" means any textile material, including yarns, yarn intermediates, fibers, nonwoven materials, natural materials, synthetic materials, and any other textile material, fabrics made from these materials, and products made from these fabrics (e.g., clothing and other articles). The textiles or fabrics can be in the form of knitted fabrics, woven fabrics, denim, nonwoven fabrics, felt, yarns, and terry cloth. These textiles can be cellulose-based, such as natural cellulose, including cotton, flax / linen, jute, ramie, sisal, or coconut fiber, or man-made cellulose (e.g., derived from wood pulp), including viscose / rayon, ramie, cellulose acetate fiber (tricell), lyocell, or blends thereof. Textiles or fabrics can also be based on non-cellulose fibers, such as natural polyamides, including wool, camel hair, cashmere, mohair, rabbit hair, and silk, or synthetic polymers such as nylon, aromatic polyamides, polyesters, acrylics, polypropylenes, and spandex / elastane, or blends thereof, as well as blends of cellulose-based and non-cellulose-based fibers. Examples of blends are blends of cotton and / or rayon / viscose fibers with one or more accompanying materials, such as wool, synthetic fibers (e.g., polyamide fibers, acrylic fibers, polyester fibers, polyvinyl alcohol fibers, polyvinyl chloride fibers, polyurethane fibers, polyurea fibers, aromatic polyamide fibers), and cellulose-containing fibers (e.g., rayon / viscose fibers, ramie, flax / linen, jute, cellulose acetate fibers, lyocell fibers). Fabrics can be conventional washable garments, such as stained household clothes. When the term fabric or garment is used, the broader term textiles is intended to also be included.
[0082] Variants: The term "variant" means a polypeptide with mannanase activity that contains alterations (i.e., substitution, insertion, and / or deletion of one or more amino acid residues) at one or more positions. Substitution means replacing an amino acid occupying a position with a different amino acid; deletion means removing an amino acid occupying a position; and insertion means adding 1-3 amino acids adjacent to an amino acid occupying a position. These variants of the present invention have at least 50%, for example at least 60%, at least 70%, at least 80%, at least 90%, at least 95%, or at least 100% of the mannanase activity of the polypeptide of SEQ ID NO:3 or SEQ ID NO:11. Detailed Implementation
[0083] Peptides with mannanase activity
[0084] In a first aspect, the present invention relates to polypeptides having mannanase activity, wherein the polypeptides have at least 91%, such as at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity with SEQ ID NO:4. In one embodiment, the polypeptides differ from SEQ ID NO:4 by up to 29 amino acids, such as 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, or 29 amino acids.
[0085] In one embodiment, the polypeptide preferably comprises or consists of the amino acid sequence of SEQ ID NO:4; comprises the amino acid sequence of SEQ ID NO:4 and an N-terminal and / or C-terminal His-tag and / or HQ-tag; comprises the amino acid sequence of SEQ ID NO:4 and an N-terminal and / or C-terminal extension between 1 and 10 amino acids; or is a fragment thereof having mannanase activity and having at least 90% of the length of SEQ ID NO:4, such as at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99%. In one embodiment, the polypeptide comprises or consists of amino acids 1 to 330 of SEQ ID NO:4. In one embodiment, the polypeptide has been isolated.
[0086] In a continuation of the first aspect, the present invention relates to a variant of SEQ ID NO:4 having mannanase activity, the variant comprising one or more amino acid substitutions, and / or one or more amino acid deletions, and / or one or more amino acid insertions, or any combination thereof, at positions 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, or 29. In one embodiment, the number of positions in SEQ ID NO:4 comprising one or more amino acid substitutions and / or one or more amino acid deletions and / or one or more amino acid insertions, or any combination thereof, does not exceed 10, for example, 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10. In another embodiment, the number of substitutions and / or deletions and / or insertions in SEQ ID NO:4 does not exceed 10, for example, 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10. In another embodiment, the number of substitutions (preferably conservative substitutions) in SEQ ID NO:4 does not exceed 10, for example 1, 2, 3, 4, 5, 6, 7, 8, 9 or 10.
[0087] In any embodiment of the first aspect, the polypeptide (or variant) has at least 60%, for example at least 70%, at least 80%, at least 90%, at least 95%, or at least 100% of the mannanase activity of SEQ ID NO:4.
[0088] These amino acid changes can be minor in nature, i.e., conserved amino acid substitutions or insertions that do not significantly affect protein folding and / or activity; small deletions typically of 1–30 amino acids; small amino or carboxyl terminus extensions, such as N-terminal methionine residues; small linker peptides of up to 20–25 residues; or small extensions that facilitate purification by altering net charge or another function, such as poly-histidine tracts, antigenic epitopes, or binding domains.
[0089] Examples of conserved substitutions are found in the following group: basic amino acids (arginine, lysine, and histidine), acidic amino acids (glutamic acid and aspartic acid), polar amino acids (glutamine and asparagine), hydrophobic amino acids (leucine, isoleucine, and valine), aromatic amino acids (phenylalanine, tryptophan, and tyrosine), and small amino acids (glycine, alanine, serine, threonine, and methionine). Amino acid substitutions that generally do not alter specific reactivity are known in the art and are described, for example, by H. Neurath and RL Hill, 1979, in *The Proteins*, Academic Press, New York. Common substitutions are Ala / Ser, Val / Ile, Asp / Glu, Thr / Ser, Ala / Gly, Ala / Thr, Ser / Asn, Ala / Val, Ser / Gly, Tyr / Phe, Ala / Pro, Lys / Arg, Asp / Asn, Leu / Ile, Leu / Val, Ala / Glu, and Asp / Gly. Other examples of conservative substitutions are G to A; A to G, S; V to I, L, A, T, S; I to V, L, M; L to I, M, V; M to L, I, V; P to A, S, N; F to Y, W, H; Y to F, W, H; W to Y, F, H; R to K, E, D; K to R, E, D; H to Q, N, S; D to N, E, K, R, Q; E to Q, D, K, R, N; S to T, A; T to S, V, A; C to S, T, A; N to D, Q, H, S; Q to E, N, H, K, R.
[0090] Essential amino acids in peptides can be identified using procedures known in the art, such as site-directed mutagenesis or alanine scanning mutagenesis (Cunningham and Wells, 1989, Science 244:1081-1085). In the latter technique, a single alanine mutation is introduced at each residue in the molecule, and the mannanase activity of the resulting mutant molecule is tested to identify amino acid residues essential to the activity of the molecule. See also Hilton et al., 1996, J. Biol. Chem. 271:4699-4708. The active site of an enzyme or other biological interaction can also be determined by physical analysis of the structure, such as by techniques including nuclear magnetic resonance, crystallography, electron diffraction, or photoaffinity labeling, combined with mutation of the amino acid at the putative contact site. See, for example, de Vos et al., 1992, Science 255:306-312; Smith et al., 1992, J. Mol. Biol. 224:899-904; Wlodaver et al., 1992, FEBS Lett. 309:59-64. The identity of essential amino acids can also be inferred from comparisons with related peptides.
[0091] Using known mutagenesis, recombination, and / or tampering methods, followed by relevant screening procedures, single or multiple amino acid substitutions, deletions, and / or insertions can be made and tested, such as those disclosed in Reidhaar-Olson and Sauer, 1988, Science 241:53-57; Bowie and Sauer, 1989, Proc. Natl. Acad. Sci. USA 86:2152-2156; WO 95 / 17413; or WO 95 / 22625. Other methods that can be used include error-prone PCR, phage display (e.g., Lowman et al., 1991, Biochemistry 30:10832-10837; US Patent No. 5,223,409; WO 92 / 06204), and region-directed mutagenesis (Derbyshire et al., 1986, Gene 46:145; Ner et al., 1988, DNA 7:127).
[0092] Mutagenesis / reorganization methods can be combined with high-throughput, automated screening methods to detect the activity of cloned, mutagenesis-encoded peptides expressed by host cells (Ness et al., 1999, Nature Biotechnology 17:893-896). Mutagenesis-encoded DNA molecules encoding active peptides can be recovered from host cells and rapidly sequenced using standard methods in the art. These methods allow for the rapid determination of the importance of individual amino acid residues within the peptide.
[0093] The polypeptide can be a hybrid polypeptide or a fusion polypeptide.
[0094] In one embodiment of the first aspect, the polypeptide or variant of the first aspect of the invention further comprises a carbohydrate-binding module. In one embodiment, the carbohydrate-binding module is family 35 CBM. In another embodiment, the polypeptide or variant of the first aspect of the invention comprises a catalytic domain and a CBM, and has at least 87%, such as at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity with SEQ ID NO:3. In one embodiment, the polypeptide comprises the mature polypeptide of SEQ ID NO:2, amino acids 1 to 498 of SEQ ID NO:2, or amino acids 1 to 498 of SEQ ID NO:3, or constitutes thereof. In another embodiment, the polypeptide or variant of the first aspect of the invention comprises a catalytic domain and a CBM, and has at least 87%, such as at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity with SEQ ID NO:11. In one embodiment, the polypeptide comprises the mature polypeptide of SEQ ID NO:10, amino acids 1 to 527 of SEQ ID NO:10, or amino acids 1 to 527 of SEQ ID NO:11, or is composed of the like.
[0095] In a second aspect, the present invention relates to polypeptides having mannanase activity, wherein the polypeptides have at least 87%, such as at least 88%, at least 89%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity with SEQ ID NO:4. In one embodiment, these polypeptides differ from SEQ ID NO:3 or SEQ ID NO:11 by up to 50 amino acids, such as 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, or 50 amino acids.
[0096] In one embodiment, the polypeptide preferably comprises or consists of the amino acid sequence of SEQ ID NO:3; comprises the amino acid sequence of SEQ ID NO:3 and an N-terminal and / or C-terminal His-tag and / or HQ-tag (such as SEQ ID NO:6); comprises the amino acid sequence of SEQ ID NO:3 and an N-terminal and / or C-terminal extension between 1 and 10 amino acids; or is a fragment thereof having mannanase activity and having at least 90% of the length of SEQ ID NO:3, such as at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99%. In one embodiment, the polypeptide comprises or consists of the mature polypeptide of SEQ ID NO:2 or amino acids 1 to 498 of SEQ ID NO:2. In one embodiment, the polypeptide comprises or consists of amino acids 1 to 498 of SEQ ID NO:3. In one embodiment, the polypeptide has been isolated.
[0097] In a continuation of the second aspect, the present invention relates to variants of SEQ ID NO:3 having mannanase activity, the variants comprising one or more amino acid substitutions, and / or one or more amino acid deletions, and / or one or more amino acid insertions, or any combination thereof, at positions 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, or 50. In one embodiment, the number of positions in SEQ ID NO:3 comprising one or more amino acid substitutions and / or one or more amino acid deletions and / or one or more amino acid insertions, or any combination thereof, does not exceed 10, for example, 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10. In another embodiment, the number of substitutions and / or deletions and / or insertions in SEQ ID NO:3 does not exceed 10, for example, 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10. In yet another embodiment, the number of substitutions (preferably conservative substitutions) in SEQ ID NO:3 does not exceed 10, for example, 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10. Examples of amino acid alterations and conservative substitutions are described in the first aspect of the invention.
[0098] In any embodiment of the second aspect, the polypeptide (or variant) has at least 60%, for example at least 70%, at least 80%, at least 90%, at least 95%, or at least 100% of the mannanase activity of SEQ ID NO:3.
[0099] In one embodiment, the polypeptide preferably comprises or consists of the amino acid sequence of SEQ ID NO:11; comprises the amino acid sequence of SEQ ID NO:11 and an N-terminal and / or C-terminal His-tag and / or HQ-tag; comprises the amino acid sequence of SEQ ID NO:11 and an N-terminal and / or C-terminal extension between 1 and 10 amino acids; or is a fragment thereof having mannanase activity and having at least 90% of the length of SEQ ID NO:11, such as at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99%. In one embodiment, the polypeptide comprises or consists of the mature polypeptide of SEQ ID NO:10 or amino acids 1 to 527 of SEQ ID NO:10. In one embodiment, the polypeptide comprises or consists of amino acids 1 to 527 of SEQ ID NO:11. In one embodiment, the polypeptide has been isolated.
[0100] In a continuation of the second aspect, the present invention relates to variants of SEQ ID NO:11 having mannanase activity, the variant comprising one or more amino acid substitutions, and / or one or more amino acid deletions, and / or one or more amino acid insertions, or any combination thereof, at positions 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, or 50. In one embodiment, the number of positions in SEQ ID NO:11 containing one or more amino acid substitutions and / or one or more amino acid deletions and / or one or more amino acid insertions, or any combination thereof, does not exceed 10, for example, 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10. In another embodiment, the number of substitutions and / or deletions and / or insertions in SEQ ID NO:3 does not exceed 10, for example, 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10. In yet another embodiment, the number of substitutions (preferably conservative substitutions) in SEQ ID NO:11 does not exceed 10, for example, 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10. Examples of amino acid alterations and conservative substitutions are described in the first aspect of the invention.
[0101] In any embodiment of the second aspect, the polypeptide (or variant) has at least 60%, for example at least 70%, at least 80%, at least 90%, at least 95%, or at least 100% of the mannanase activity of SEQ ID NO:11.
[0102] Detergent compositions containing peptides with mannanase activity
[0103] In a third aspect, the present invention relates to a detergent composition comprising a surfactant and a polypeptide having mannanase activity, wherein the polypeptide has at least 81%, such as at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity with SEQ ID NO:4. In one embodiment, these polypeptides differ from SEQ ID NO:4 by up to 50 amino acids, such as 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, or 50 amino acids.
[0104] In one embodiment, the polypeptide preferably comprises or consists of the amino acid sequence of SEQ ID NO:4; comprises the amino acid sequence of SEQ ID NO:4 and an N-terminal and / or C-terminal His-tag and / or HQ-tag; comprises the amino acid sequence of SEQ ID NO:4 and an N-terminal and / or C-terminal extension between 1 and 10 amino acids; or is a fragment thereof having mannanase activity and having at least 90% of the length of SEQ ID NO:4, such as at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99%. In one embodiment, the polypeptide comprises or consists of amino acids 1 to 330 of SEQ ID NO:4. In one embodiment, the polypeptide has been isolated.
[0105] In a continuation of the third aspect, the present invention relates to a detergent composition comprising a surfactant and a variant having mannanase activity, wherein the variant comprises one or more amino acid substitutions, and / or one or more amino acid deletions, and / or one or more amino acid insertions, or any combination thereof, at positions 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, or 50 of SEQ ID NO:4. In one embodiment, the number of positions in SEQ ID NO:4 containing one or more amino acid substitutions and / or one or more amino acid deletions and / or one or more amino acid insertions, or any combination thereof, does not exceed 10, for example, 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10. In another embodiment, the number of substitutions and / or deletions and / or insertions in SEQ ID NO:4 does not exceed 10, for example, 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10. In yet another embodiment, the number of substitutions (preferably conservative substitutions) in SEQ ID NO:4 does not exceed 10, for example, 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10. Examples of amino acid alterations and conservative substitutions are described in the first aspect of the invention.
[0106] In any embodiment of the second aspect, the polypeptide (or variant) has at least 60%, for example at least 70%, at least 80%, at least 90%, at least 95%, or at least 100% of the mannanase activity of SEQ ID NO:3.
[0107] In one embodiment, the polypeptide or variant of the third aspect of the invention further comprises a carbohydrate-binding module. In one embodiment, the carbohydrate-binding module is family 35 CBM. In another embodiment, the polypeptide or variant of the first aspect of the invention comprises a catalytic domain and a CBM, and has at least 87%, such as at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity with SEQ ID NO:3. In one embodiment, the polypeptide comprises the mature polypeptide of SEQ ID NO:2, amino acids 1 to 498 of SEQ ID NO:2, or amino acids 1 to 498 of SEQ ID NO:3, or consists thereof.
[0108] In any embodiment of the second aspect, the polypeptide (or variant) has at least 60%, for example at least 70%, at least 80%, at least 90%, at least 95%, or at least 100% of the mannanase activity of SEQ ID NO:11.
[0109] In one embodiment, the polypeptide or variant of the third aspect of the invention further comprises a carbohydrate-binding module. In one embodiment, the carbohydrate-binding module is a family 35 CBM. In another embodiment, the polypeptide or variant of the first aspect of the invention comprises a catalytic domain and a CBM, and has at least 87%, such as at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity with SEQ ID NO:11. In one embodiment, the polypeptide comprises the mature polypeptide of SEQ ID NO:10, amino acids 1 to 527 of SEQ ID NO:10, or amino acids 1 to 527 of SEQ ID NO:11, or is composed of the like.
[0110] In a fourth aspect, the present invention relates to a detergent composition comprising a surfactant and a polypeptide having mannanase activity, wherein the polypeptide has at least 81%, such as at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity with SEQ ID NO:3 or SEQ ID NO:11. In one embodiment, these polypeptides differ from SEQ ID NO:3 or SEQ ID NO:11 by up to 50 amino acids, such as 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, or 50 amino acids.
[0111] In one embodiment, the polypeptide preferably comprises or consists of the amino acid sequence of SEQ ID NO:3; comprises the amino acid sequence of SEQ ID NO:3 or SEQ ID NO:11 and an N-terminal and / or C-terminal His-tag and / or HQ-tag (such as SEQ ID NO:6); comprises the amino acid sequence of SEQ ID NO:3 or SEQ ID NO:11 and an N-terminal and / or C-terminal extension between 1 and 10 amino acids; or a fragment thereof having mannanase activity and having at least 90%, such as at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99%, of the length of SEQ ID NO:3 or SEQ ID NO:11. In one embodiment, the polypeptide comprises or consists of the mature polypeptide of SEQ ID NO:2 or amino acids 1 to 498 of SEQ ID NO:2, or comprises the mature polypeptide of SEQ ID NO:10 or amino acids 1 to 527 of SEQ ID NO:10. In one embodiment, the polypeptide comprises or consists of amino acids 1 to 498 of SEQ ID NO:3 or amino acids 1 to 527 of SEQ ID NO:11. In one embodiment, the polypeptide has been isolated.
[0112] In a continuation of the fourth aspect, the present invention relates to a detergent composition comprising a surfactant and a variant having mannanase activity, wherein the variant comprises one or more amino acid substitutions, and / or one or more amino acid deletions, and / or one or more amino acid insertions, or any combination thereof, at positions 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, or 50 of SEQ ID NO:3. In one embodiment, the number of positions in SEQ ID NO:3 or SEQ ID NO:11 containing one or more amino acid substitutions and / or one or more amino acid deletions and / or one or more amino acid insertions, or any combination thereof, does not exceed 10, for example, 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10. In another embodiment, the number of substitutions and / or deletions and / or insertions in SEQ ID NO:3 or SEQ ID NO:11 does not exceed 10, for example, 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10. In yet another embodiment, the number of substitutions (preferably conservative substitutions) in SEQ ID NO:3 or SEQ ID NO:11 does not exceed 10, for example, 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10. Examples of amino acid alterations and conservative substitutions are described in the first aspect of the invention.
[0113] Examples of surfactants, as well as preferred amounts and surfactants, are discussed in the Surfactants section below.
[0114] In one embodiment of any part of the third or fourth aspect, the detergent composition may further comprise one or more components selected from the group consisting of: water-soluble auxiliaries, detergent builders, co-detergents, chelating agents, bleaching components, polymers, fabric colorants, fabric conditioning agents, foaming agents, defoaming agents, dispersants, dye transfer inhibitors, optical brighteners, fragrances, optical brighteners, bactericides, fungicides, dirt suspending agents, dirt-releasing polymers, anti-redeposition agents, enzyme inhibitors, enzyme stabilizers, enzyme activators, antioxidants, and solubilizers.
[0115] In any embodiment of the third or fourth aspect, the detergent composition may further comprise one or more additional enzymes selected from the group consisting of: amylase, protease, protease, peroxidase, cellulase, β-glucanase, xyloglucanase, hemicellulase, xanthan gumase, xanthan gum lyase, lipase, acyltransferase, phospholipase, esterase, laccase, catalase, aryl esterase, amylase, α-amylase, and glucose starch. Enzymes, keratinase, pectinase, pectin lyase, keratinase, reductase, oxidase, phenol oxidase, lipoxygenase, ligninase, carrageenanase, amylopectinase, tanninase, arabinosidase, hyaluronidase, chondroitinase, xylanase, xylanase, pectin acetylesterase, polygalacturonase, rhamnogalacturonase, other endo-β-mannanases, exo-β-mannanases, pectin methylesterase, cellobiase, and transglutaminase.
[0116] Particles containing polypeptides with mannanase activity
[0117] In a fifth aspect, the present invention relates to particles comprising a core particle and one or more coatings, wherein the particles comprise a polypeptide having a sequence identity of at least 81%, such as at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100%, with respect to SEQ ID NO:4. In one embodiment, these peptides differ from SEQ ID NO:4 by up to 50 amino acids, such as 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, or 50 amino acids.
[0118] In one embodiment, the polypeptide preferably comprises or consists of the amino acid sequence of SEQ ID NO:4; comprises the amino acid sequence of SEQ ID NO:4 and an N-terminal and / or C-terminal His-tag and / or HQ-tag; comprises the amino acid sequence of SEQ ID NO:4 and an N-terminal and / or C-terminal extension between 1 and 10 amino acids; or is a fragment thereof having mannanase activity and having at least 90% of the length of SEQ ID NO:4, such as at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99%. In one embodiment, the polypeptide comprises or consists of amino acids 1 to 330 of SEQ ID NO:4. In one embodiment, the polypeptide has been isolated.
[0119] In a continuation of the fifth aspect, the present invention relates to particles comprising a core particle and one or more coatings, wherein the particles comprise a variant of SEQ ID NO:4 having mannanase activity and one or more amino acid substitutions, and / or one or more amino acid deletions, and / or one or more amino acid insertions, or any combination thereof, at positions 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, or 50. In one embodiment, the number of positions in SEQ ID NO:4 containing one or more amino acid substitutions and / or one or more amino acid deletions and / or one or more amino acid insertions, or any combination thereof, does not exceed 10, for example, 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10. In another embodiment, the number of substitutions and / or deletions and / or insertions in SEQ ID NO:4 does not exceed 10, for example, 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10. In yet another embodiment, the number of substitutions (preferably conservative substitutions) in SEQ ID NO:4 does not exceed 10, for example, 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10. Examples of amino acid alterations and conservative substitutions are described in the first aspect of the invention.
[0120] In any embodiment of the second aspect, the polypeptide (or variant) has at least 60%, for example at least 70%, at least 80%, at least 90%, at least 95%, or at least 100% of the mannanase activity of SEQ ID NO:3 or SEQ ID NO:11.
[0121] In one embodiment, the polypeptide or variant of the fifth aspect of the invention further comprises a carbohydrate-binding module. In one embodiment, the carbohydrate-binding module is family 35 CBM. In another embodiment, the polypeptide or variant of the first aspect of the invention comprises a catalytic domain and a CBM, and has at least 87%, such as at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity with SEQ ID NO:3 or SEQ ID NO:11. In one embodiment, the polypeptide comprises the mature polypeptide of SEQ ID NO:2, amino acids 1 to 498 of SEQ ID NO:2 or amino acids 1 to 498 of SEQ ID NO:3, or composed thereof. In one embodiment, the polypeptide comprises the mature polypeptide of SEQ ID NO:10, amino acids 1 to 527 of SEQ ID NO:10 or amino acids 1 to 527 of SEQ ID NO:11, or composed thereof.
[0122] In a sixth aspect, the present invention relates to particles comprising a core particle and one or more coatings, wherein the particles comprise a polypeptide having at least 81%, such as at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity with SEQ ID NO:3 or SEQ ID NO:11. In one embodiment, these polypeptides differ from SEQ ID NO:3 or SEQ ID NO:11 by up to 50 amino acids, such as 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, or 50 amino acids.
[0123] In one embodiment, the polypeptide preferably comprises or consists of the amino acid sequence of SEQ ID NO:3 or SEQ ID NO:11; comprises the amino acid sequence of SEQ ID NO:3 or SEQ ID NO:11 and an N-terminal and / or C-terminal His-tag and / or HQ-tag (such as SEQ ID NO:6); comprises the amino acid sequence of SEQ ID NO:3 or SEQ ID NO:11 and an N-terminal and / or C-terminal extension between 1 and 10 amino acids; or a fragment thereof having mannanase activity and having at least 90% of the length of SEQ ID NO:3 or SEQ ID NO:11, such as at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99%. In one embodiment, the polypeptide comprises or consists of the mature polypeptide of SEQ ID NO:2 or amino acids 1 to 498 of SEQ ID NO:2. In one embodiment, the polypeptide comprises or consists of amino acids 1 to 498 of SEQ ID NO:3. In one embodiment, the polypeptide comprises or consists of the mature polypeptide of SEQ ID NO:10 or amino acids 1 to 527 of SEQ ID NO:10. In one embodiment, the polypeptide comprises or consists of amino acids 1 to 527 of SEQ ID NO:11. In one embodiment, the polypeptide has been isolated.
[0124] In a continuation of the sixth aspect, the present invention relates to particles comprising a core particle and one or more coatings, wherein the particles comprise a variant of SEQ ID NO:3 or SEQ ID NO:11 having mannanase activity and one or more amino acid substitutions, and / or one or more amino acid deletions, and / or one or more amino acid insertions, or any combination thereof, at positions 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, or 50. In one embodiment, the number of positions in SEQ ID NO:3 or SEQ ID NO:11 containing one or more amino acid substitutions and / or one or more amino acid deletions and / or one or more amino acid insertions, or any combination thereof, does not exceed 10, for example, 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10. In another embodiment, the number of substitutions and / or deletions and / or insertions in SEQ ID NO:3 or SEQ ID NO:11 does not exceed 10, for example, 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10. In yet another embodiment, the number of substitutions (preferably conservative substitutions) in SEQ ID NO:3 or SEQ ID NO:11 does not exceed 10, for example, 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10. Examples of amino acid alterations and conservative substitutions are described in the first aspect of the invention.
[0125] The granules as described in any of the fifth and sixth aspects may further comprise one or more formulations, as discussed in the formulations section below. Preferred formulations are glycerol, ethylene glycol, 1,2-propanediol or 1,3-propanediol, sodium chloride, sodium benzoate, potassium sorbate, sodium sulfate, potassium sulfate, magnesium sulfate, sodium thiosulfate, calcium carbonate, sodium citrate, dextrin, glucose, sucrose, sorbitol, lactose, starch and cellulose, or any combination thereof.
[0126] In one embodiment of any part of the fifth or sixth aspect, the particle may further comprise one or more additional enzymes selected from the group consisting of: amylase, protease, peroxidase, cellulase, β-glucanase, xyloglucanase, hemicellulase, xanthan gumase, xanthan gum lyase, lipase, acyltransferase, phospholipase, esterase, laccase, catalase, aryl esterase, amylase, α-amylase, glucosylamylase, Keratinase, pectinase, pectin lyase, keratinase, reductase, oxidase, phenol oxidase, lipoxygenase, ligninase, carrageenanase, amylopectinase, tanninase, arabinosidase, hyaluronidase, chondroitinase, xylanase, xylanase, pectin acetylesterase, polygalacturonase, rhamnogalacturonase, other endo-β-mannanases, exo-β-mannanases, pectin methylesterase, cellobiase, and transglutaminase.
[0127] Liquid formulations containing peptides with mannanase activity
[0128] In a seventh aspect, the present invention relates to a liquid composition comprising a polyol and a polypeptide having mannanase activity, wherein the polypeptide has at least 81%, such as at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity with SEQ ID NO:4. In one embodiment, these polypeptides differ from SEQ ID NO:4 by up to 50 amino acids, such as 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, or 50 amino acids.
[0129] In one embodiment, the polypeptide preferably comprises or consists of the amino acid sequence of SEQ ID NO:4; comprises the amino acid sequence of SEQ ID NO:4 and an N-terminal and / or C-terminal His-tag and / or HQ-tag; comprises the amino acid sequence of SEQ ID NO:4 and an N-terminal and / or C-terminal extension between 1 and 10 amino acids; or is a fragment thereof having mannanase activity and having at least 90% of the length of SEQ ID NO:4, such as at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99%. In one embodiment, the polypeptide comprises or consists of amino acids 1 to 330 of SEQ ID NO:4. In one embodiment, the polypeptide has been isolated.
[0130] In a continuation of the seventh aspect, the present invention relates to a liquid composition comprising a polyol and a variant having mannanase activity, wherein the variant comprises one or more amino acid substitutions, and / or one or more amino acid deletions, and / or one or more amino acid insertions, or any combination thereof, at positions 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, or 50 of SEQ ID NO:4. In one embodiment, the number of positions in SEQ ID NO:4 containing one or more amino acid substitutions and / or one or more amino acid deletions and / or one or more amino acid insertions, or any combination thereof, does not exceed 10, for example, 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10. In another embodiment, the number of substitutions and / or deletions and / or insertions in SEQ ID NO:4 does not exceed 10, for example, 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10. In yet another embodiment, the number of substitutions (preferably conservative substitutions) in SEQ ID NO:4 does not exceed 10, for example, 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10. Examples of amino acid alterations and conservative substitutions are described in the first aspect of the invention.
[0131] In any embodiment of the second aspect, the polypeptide (or variant) has at least 60%, for example at least 70%, at least 80%, at least 90%, at least 95%, or at least 100% of the mannanase activity of SEQ ID NO:3 or SEQ ID NO:11.
[0132] In one embodiment, the polypeptide or variant of the seventh aspect of the invention further comprises a carbohydrate-binding module. In one embodiment, the carbohydrate-binding module is family 35 CBM. In another embodiment, the polypeptide or variant of the first aspect of the invention comprises a catalytic domain and a CBM, and has at least 87%, such as at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity with SEQ ID NO:3 or SEQ ID NO:11. In one embodiment, the polypeptide comprises the mature polypeptide of SEQ ID NO:2, amino acids 1 to 498 of SEQ ID NO:2, or amino acids 1 to 498 of SEQ ID NO:3 or SEQ ID NO:11, or is composed of the like.
[0133] In an eighth aspect, the present invention relates to a liquid composition comprising a polyol and a polypeptide having mannanase activity, wherein the polypeptide has at least 81%, such as at least 82%, at least 83%, at least 84%, at least 85%, at least 86%, at least 87%, at least 88%, at least 89%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity with SEQ ID NO:3 or SEQ ID NO:11. In one embodiment, these polypeptides differ from SEQ ID NO:3 or SEQ ID NO:11 by up to 50 amino acids, such as 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, or 50 amino acids.
[0134] In one embodiment, the polypeptide preferably comprises or consists of the amino acid sequence of SEQ ID NO:3 or SEQ ID NO:11; comprises the amino acid sequence of SEQ ID NO:3 or SEQ ID NO:11 and an N-terminal and / or C-terminal His-tag and / or HQ-tag (such as SEQ ID NO:6); comprises the amino acid sequence of SEQ ID NO:3 and an N-terminal and / or C-terminal extension between 1 and 10 amino acids; or a fragment thereof having mannanase activity and having at least 90%, such as at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, or at least 99%, of the length of SEQ ID NO:3 or SEQ ID NO:11. In one embodiment, the polypeptide comprises or consists of the mature polypeptide of SEQ ID NO:2 or amino acids 1 to 498 of SEQ ID NO:2. In one embodiment, the polypeptide comprises or consists of amino acids 1 to 498 of SEQ ID NO:3. In one embodiment, the polypeptide comprises or consists of the mature polypeptide of SEQ ID NO:10 or amino acids 1 to 527 of SEQ ID NO:10. In one embodiment, the polypeptide comprises or consists of amino acids 1 to 527 of SEQ ID NO:11. In one embodiment, the polypeptide has been isolated.
[0135] In a continuation of the eighth aspect, the present invention relates to a liquid composition comprising a polyol and a variant having mannanase activity, wherein the variant comprises one or more amino acid substitutions, and / or one or more amino acid deletions, and / or one or more amino acid insertions, or any combination thereof, at positions 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, or 50 of SEQ ID NO:3. In one embodiment, the number of positions in SEQ ID NO:3 or SEQ ID NO:11 containing one or more amino acid substitutions and / or one or more amino acid deletions and / or one or more amino acid insertions, or any combination thereof, does not exceed 10, for example, 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10. In another embodiment, the number of substitutions and / or deletions and / or insertions in SEQ ID NO:3 or SEQ ID NO:11 does not exceed 10, for example, 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10. In yet another embodiment, the number of substitutions (preferably conservative substitutions) in SEQ ID NO:3 or SEQ ID NO:11 does not exceed 10, for example, 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10. Examples of amino acid alterations and conservative substitutions are described in the first aspect of the invention.
[0136] In one embodiment of any part of the seventh or eighth aspect, the polyol is selected from the group consisting of glycerol, sorbitol, propylene glycol (MPG), ethylene glycol, diethylene glycol, triethylene glycol, 1,2-propanediol or 1,3-propanediol, dipropylene glycol, polyethylene glycol (PEG) with an average molecular weight of less than about 600, and polypropylene glycol (PPG) with an average molecular weight of less than about 600, more preferably selected from the group consisting of glycerol, sorbitol, and propylene glycol (MPG) or any combination thereof.
[0137] In one embodiment of any part of the seventh or eighth aspect, the liquid formulation comprises 5%-80% of polyol (i.e., the total amount of polyol), preferably 15%-75% of polyol, more preferably 25%-70% of polyol, more preferably 35%-65% of polyol, or most preferably 40%-60% of polyol. In one embodiment of any part of the seventh or eighth aspect, the liquid formulation comprises 5%-80% of a polyol, preferably 15%-75% of a polyol, more preferably 25%-70% of a polyol, more preferably 35%-65% of a polyol, or most preferably 40%-60% of a polyol, wherein the polyol is selected from the group consisting of: glycerol, sorbitol, propylene glycol (MPG), ethylene glycol, diethylene glycol, triethylene glycol, 1,2-propanediol or 1,3-propanediol, dipropylene glycol, polyethylene glycol (PEG) with an average molecular weight of less than about 600, and polypropylene glycol (PPG) with an average molecular weight of less than about 600. In one embodiment of any part of the seventh or eighth aspect, the liquid formulation comprises 5%-80% of a polyol, preferably 15%-75% of a polyol, more preferably 25%-70% of a polyol, more preferably 35%-65% of a polyol, or most preferably 40%-60% of a polyol, wherein the polyol is selected from the group consisting of glycerol, sorbitol and propylene glycol (MPG).
[0138] In one embodiment of any part of the seventh or eighth aspect, the formulation further comprises 0.001% to 2.0% w / w of a preservative. In one embodiment, the preservative is selected from the group consisting of: phenoxyethanol, 1,2-benzothiazolin-3(2H)-one, sodium sorbate, potassium sorbate, sodium benzoate, potassium benzoate, methylisothiazolinone, chloromethylisothiazolinone, methylparaben, ethylparaben, propylparaben, butylparaben, quaternary ammonium salts (such as BAC / ADBAC; alkylbenzylammonium chloride, dioctyldimethylammonium chloride, dialcyldimethylammonium chloride, cetrimonium chloride), essential oils, and organic acids or any combination thereof. In one embodiment, the liquid formulation comprises 0.02% to 1.5% w / w of a preservative, more preferably 0.05% to 1.0% w / w of a preservative, or most preferably 0.1% to 0.5% w / w of a preservative. In another embodiment, the liquid formulation comprises 0.001% to 2.0% w / w of a preservative (i.e., the total amount of preservative), preferably 0.02% to 1.5% w / w of a preservative, more preferably 0.05% to 1.0% w / w of a preservative, or most preferably 0.1% to 0.5% w / w of a preservative, wherein the preservative is selected from the group consisting of phenoxyethanol, 1,2-benzothiazoline-3(2H)-one, sodium sorbate, potassium sorbate, sodium benzoate and potassium benzoate, or any combination thereof.
[0139] In one embodiment of any part of the seventh or eighth aspect, the dosage of the mannanase is between 0.0001% and 10% w / w in a liquid formulation, such as 0.001% to 0.1% w / w peptide, 0.01% to 1.0% w / w peptide, or 0.1% to 10% w / w peptide.
[0140] In one embodiment of any part of the seventh or eighth aspect, the liquid formulation comprises one or more formulations (such as those described herein), preferably selected from the following list of formulations consisting of: glycerol, ethylene glycol, 1,2-propanediol or 1,3-propanediol, sodium chloride, sodium benzoate, potassium sorbate, sodium sulfate, potassium sulfate, magnesium sulfate, sodium thiosulfate, calcium carbonate, sodium citrate, dextrin, glucose, sucrose, sorbitol, lactose, starch, PVA, acetate and phosphate, preferably selected from the following list of formulations consisting of: 1,2-propanediol, 1,3-propanediol, sodium sulfate, dextrin, cellulose, sodium thiosulfate, kaolin and calcium carbonate.
[0141] In one embodiment of any part of the seventh or eighth aspect, the liquid formulation may further comprise one or more additional enzymes selected from the group consisting of: amylase, protease, peroxidase, cellulase, β-glucanase, xyloglucanase, hemicellulase, xanthan gumase, xanthan gum lyase, lipase, acyltransferase, phospholipase, esterase, laccase, catalase, aryl esterase, amylase, α-amylase, glucosylamylase Keratinase, pectinase, pectin lyase, keratinase, reductase, oxidase, phenol oxidase, lipoxygenase, ligninase, carrageenanase, amylopectinase, tanninase, arabinosidase, hyaluronidase, chondroitinase, xyloglucanase, xylanase, pectin acetylesterase, polygalacturonase, rhamnogalacturonase, other endo-β-mannanases, exo-β-mannanases, pectin methylesterase, cellobiase, and transglutaminase.
[0142] Sources of peptides with mannanase activity
[0143] The polypeptides of the present invention having mannanase activity can be obtained from microorganisms of any genus. For the purposes of this invention, the term "obtained from" as used herein in conjunction with a given source should mean that the polypeptide encoded by the polynucleotide is produced by that source or by a strain that has inserted a polynucleotide from that source. In one aspect, the polypeptide obtained from a given source is secreted extracellularly.
[0144] The polypeptide can be a fungal polypeptide. For example, the polypeptide can be a polypeptide with mannanase activity from a phylum such as Firmicutes.
[0145] In one respect, the polypeptide is a mannanase derived from fungi of the class Bacilli, such as those from the order Bacillales, family Paenibacillaceae, genus Paenibacillus, or species of Paenibacillus or Paenibacillus.
[0146] It should be understood that, for the aforementioned species, this invention covers both perfect and imperfect states, and other taxonomic equivalents, such as asexual forms, regardless of their known species names. Those skilled in the art will readily identify the appropriate equivalents.
[0147] Strains of these species are readily available to the public at many culture collections, such as the American Type Culture Collection (ATCC), the German Microbial and Cell Culture Collection (DSMZ), the Centralbureau Voor Schimmelcultures (CBS), and the Agricultural Research Service Patent Culture Collection, Northern Regional Research Center (NRRL).
[0148] The polypeptide can be identified and obtained from other sources, including microorganisms isolated from nature (e.g., soil, compost, water, etc.) or DNA samples obtained directly from natural materials (e.g., soil, compost, water, etc.), using the probes mentioned above. Techniques for directly isolating microorganisms and DNA from natural habitats are well known in the art. The polynucleotide encoding the polypeptide can then be obtained by similarly screening a library of genomic DNA or cDNA from another microorganism or a mixed DNA sample. Once the polynucleotide encoding the polypeptide has been detected with one or more probes, the polynucleotide can be isolated or cloned using techniques known to those skilled in the art (see, for example, Sambrook et al., 1989, ibid.).
[0149] Polynucleotides
[0150] The present invention also relates to polynucleotides encoding the polypeptides of the present invention, as described herein. In one embodiment, the polynucleotide encoding the polypeptides of the present invention has been isolated.
[0151] Techniques for isolating or cloning polynucleotides are known in the art and include isolation from genomic DNA or cDNA or combinations thereof. Polynucleotides can be cloned from genomic DNA, for example, by detecting cloned DNA fragments with shared structural features using well-known polymerase chain reaction (PCR) or antibody screening of expression libraries. See, for example, Innis et al., 1990, PCR: A Guide to Methods and Application, Academic Press, New York. Other nucleic acid amplification procedures can be used, such as ligase chain reaction (LCR), ligation-activated transcription (LAT), and polynucleotide-based amplification (NASBA). These polynucleotides can be cloned from strains of the genus *Bacillus* or from related organisms of the order *Bacillus*, and therefore, for example, can be allelic or species variants of the polypeptide coding region of the polynucleotide.
[0152] Nucleic acid constructs
[0153] The present invention also relates to nucleic acid constructs comprising a polynucleotide of the present invention operably linked to one or more control sequences, which, under conditions compatible with the control sequences, direct the expression of the coding sequence in a suitable host cell.
[0154] The polynucleotide can be manipulated in many ways to provide polypeptide expression. Depending on the expression vector, manipulating the polynucleotide before insertion into the vector may be desirable or necessary. Techniques for modifying polynucleotides using recombinant DNA methods are well known in the art.
[0155] The control sequence may be a promoter, i.e., a polynucleotide recognized by the host cell for expressing the polypeptide encoding the present invention. The promoter contains a transcriptional control sequence mediating polypeptide expression. The promoter can be any polynucleotide exhibiting transcriptional activity in the host cell, including mutant, truncated, and heterozygous promoters, and can be a gene encoding an extracellular or intracellular polypeptide that is homologous or heterologous to that of the host cell.
[0156] Examples of suitable promoters for directing transcription of the nucleic acid constructs of the present invention in bacterial host cells are promoters obtained from the following genes: Bacillus amyloliquefaciens α-amylase gene (amyQ), Bacillus licheniformis α-amylase gene (amyL), Bacillus licheniformis penicillinase gene (penP), Bacillus thermophilus maltose amylase gene (amyM), Bacillus subtilis fructan sucrase gene (sacB), Bacillus subtilis xylA and xylB genes, and Bacillus thuringiensis cryIIIA gene (Agaisse and Lereclus, 1994, Molecular). Microbiology 13:97-107), Escherichia coli lac operon, Escherichia coli trc promoter (Egon et al., 1988, Gene 69:301-315), Streptomyces agar hydrolase gene (dagA) and prokaryotic β-lactamase gene (Villa-Kamaroff et al., 1978, Natl. Acad. Sci. USA 75:3727-3731), and tac promoter (DeBoer et al., 1983, Natl. Acad. Sci. USA 80:21-25). Other promoters are described in Gilbert et al., 1980, Scientific American 242:74-94, “Useful proteins from recombinant bacteria”; and Sambrook et al., 1989, ibid. An example of a tandem promoter is disclosed in WO 99 / 43835.
[0157] Examples of suitable promoters for guiding the transcription of the nucleic acid constructs of this invention in filamentous fungal host cells are promoters obtained from the genes of: Aspergillus nidulans acetamase, Aspergillus niger neutral α-amylase, Aspergillus niger acid-stable α-amylase, Aspergillus niger or Aspergillus awamori glucosylamylase (glaA), Aspergillus oryzae TAKA amylase, Aspergillus oryzae alkaline protease, Aspergillus oryzae triose phosphate isomerase, Fusarium oxysporum trypsin-like protease (WO 96 / 00787), Fusarium oxysporum amygdalinase (WO 00 / 56900), Fusarium oxysporum Daria (WO 00 / 56900), Fusarium oxysporum Quinn (WO 96 / 00787). 00 / 56900), *Rhizopus oryzae* lipase, *Rhizopus oryzae* aspartic protease, *Trichoderma reesei* β-glucosidase, *Trichoderma reesei* cellobiose hydrolase I, *Trichoderma reesei* cellobiose hydrolase II, *Trichoderma reesei* endoglucanase I, *Trichoderma reesei* endoglucanase II, *Trichoderma reesei* endoglucanase III, *Trichoderma reesei* endoglucanase V, *Trichoderma reesei* xylanase I, *Trichoderma reesei* xylanase II, *Trichoderma reesei* xylanase III, *Trichoderma reesei* β-xylosidase, and *Trichoderma reesei* translation Elongation factors, and the NA2-tpi promoter (a modified promoter derived from an Aspergillus neutral α-amylase gene, wherein an untranslated pre-progenitor is replaced by an untranslated pre-progenitor of an Aspergillus triose phosphate isomerase gene; non-limiting examples include modified promoters derived from an Aspergillus niger neutral α-amylase gene, wherein an untranslated pre-progenitor is replaced by an untranslated pre-progenitor of an Aspergillus nidulans or Aspergillus oryzae triose phosphate isomerase gene); and mutant promoters, truncated promoters, and heterozygous promoters thereof. Other promoters are described in U.S. Patent No. 6,011,147.
[0158] In yeast hosts, useful promoters are derived from the genes of the following: *Saccharomyces cerevisiae* enolase (ENO-1), *Saccharomyces cerevisiae* galactokinase (GAL1), *Saccharomyces cerevisiae* alcohol dehydrogenase / glyceraldehyde-3-phosphate dehydrogenase (ADH1, ADH2 / GAP), *Saccharomyces cerevisiae* triose phosphate isomerase (TPI), *Saccharomyces cerevisiae* metallothionein (CUP1), and *Saccharomyces cerevisiae* 3-phosphate glycerate kinase. Other useful promoters in yeast host cells are described by Romanos et al., 1992, Yeast [Yeast] 8:423-488.
[0159] The control sequence can also be a transcription terminator recognized by the host cell to terminate transcription. This terminator is operatively linked to the 3' end of the polynucleotide encoding the polypeptide. Any terminator that is functional in the host cell can be used in this invention.
[0160] The preferred terminator for bacterial host cells is derived from the following genes: Bacillus clausti alkaline protease (aprH), Bacillus licheniformis α-amylase (amyL), and Escherichia coli ribosomal RNA (rrnB).
[0161] Preferred terminators for filamentous fungal host cells are derived from the following genes: Aspergillus nidulans acetamase, Aspergillus nidulans o-aminobenzoic acid synthase, Aspergillus niger glucosylamylase, Aspergillus niger α-glucosidase, Aspergillus oryzae TAKA amylase, Fusarium oxysporum trypsin-like protease, Trichoderma reesei β-glucosidase, Trichoderma reesei cellobiose hydrolase I, Trichoderma reesei cellobiose hydrolase II, Trichoderma reesei endoglucanase I, Trichoderma reesei endoglucanase II, Trichoderma reesei endoglucanase III, Trichoderma reesei endoglucanase V, Trichoderma reesei xylanase I, Trichoderma reesei xylanase II, Trichoderma reesei xylanase III, Trichoderma reesei β-xylosidase, and Trichoderma reesei translation elongation factor.
[0162] Preferred terminators for yeast host cells are derived from the genes of *Saccharomyces cerevisiae* enolase, *Saccharomyces cerevisiae* cytochrome C (CYC1), and *Saccharomyces cerevisiae* glyceraldehyde-3-phosphate dehydrogenase. Other useful terminators for yeast host cells are described by Romanos et al. (1992, ibid.).
[0163] The control sequence can also be a mRNA stabilizing region downstream of the promoter and upstream of the coding sequence of the gene, which increases the expression of the gene.
[0164] Examples of suitable mRNA stable regions were obtained from the following: Bacillus thuringiensis cryIIIA gene (WO 94 / 25612) and Bacillus subtilis SP82 gene (Hue et al., 1995, Journal of Bacteriology 177:3465-3471).
[0165] The control sequence can also be a leader sequence, which is the untranslated region of mRNA that is important for translation in the host cell. This leader is operatively linked to the 5' end of the polynucleotide encoding the polypeptide. Any leader sequence that is functional in the host cell can be used.
[0166] Preferred leader sequences for use in filamentous fungal host cells were obtained from the genes of Aspergillus oryzae TAKA amylase and Aspergillus nidulans triose phosphate isomerase.
[0167] Suitable leader sequences for yeast host cells are obtained from the genes of the following enzymes: Saccharomyces cerevisiae enolase (ENO-1), Saccharomyces cerevisiae 3-phosphoglycerate kinase, Saccharomyces cerevisiae α factor, and Saccharomyces cerevisiae alcohol dehydrogenase / glyceraldehyde-3-phosphate dehydrogenase (ADH2 / GAP).
[0168] The control sequence can also be a polyadenylation sequence, operatively linked to the 3' end of the polynucleotide and recognized by the host cell during transcription as a signal to add polyadenylation residues to the transcribed mRNA. Any polyadenylation sequence that is functional in the host cell can be used.
[0169] Preferred polyadenylation sequences for use in filamentous fungal host cells were obtained from the genes of the following enzymes: Aspergillus nidulans o-aminobenzoic acid synthase, Aspergillus niger glucosidase, Aspergillus niger α-glucosidase, Aspergillus oryzae TAKA amylase, and Fusarium oxysporum trypsin-like protease.
[0170] Useful polyadenylation sequences in yeast host cells are described by Guo and Sherman, 1995, Mol. Cellular Biol. [Molecular Cell Biology] 15: 5983-5990.
[0171] The control sequence can also be a signal peptide coding region encoding a signal peptide that is linked to the N-terminus of the polypeptide and guides the polypeptide into the secretory pathway of the cell. The 5' end of the coding sequence of a polynucleotide may inherently contain a signal peptide coding sequence that is naturally linked to a segment of the coding sequence of the polypeptide within the translation reading frame. Alternatively, the 5' end of the coding sequence may contain a signal peptide coding sequence that is exogenous to the coding sequence. In cases where the coding sequence does not naturally contain a signal peptide coding sequence, an exogenous signal peptide coding sequence may be required. Alternatively, an exogenous signal peptide coding sequence may simply replace the natural signal peptide coding sequence to enhance polypeptide secretion. However, any signal peptide coding sequence that guides the secretory pathway of the expressed polypeptide into the host cell can be used.
[0172] Effective signal peptide coding sequences for bacterial host cells are obtained from the genes of Bacillus NCIB 11837 producing maltose amylase, Bacillus subtilis protease, Bacillus subtilis β-lactamase, Bacillus thermophilus α-amylase, Bacillus thermophilus neutral proteases (nprT, nprS, nprM), and Bacillus subtilis prsA. Additional signal peptides are described by Simonen and Palva, 1993, Microbiological Reviews 57:109-137.
[0173] Effective signal peptide coding sequences for filamentous fungal host cells are obtained from the genes of the following enzymes: Aspergillus niger neutral amylase, Aspergillus niger glucosylase, Aspergillus oryzae TAKA amylase, Aspergillus oryzae cellulase, Aspergillus oryzae endoglucanase V, Aspergillus sparseis lipase, and Rhizopus oryzae aspartic protease.
[0174] Useful signal peptides for yeast host cells are derived from the genes of *Saccharomyces cerevisiae* α-factor and *Saccharomyces cerevisiae* invertase. Sequences encoding other useful signal peptides are described by Romanos et al. (1992, ibid.).
[0175] The control sequence can also be a propeptide-coding sequence encoding the propeptide located at the N-terminus of the polypeptide. The resulting polypeptide is called a proenzyme or propeptide progenitor (or, in some cases, a zymogen). The propeptide progenitor is usually inactive and can be converted into an active polypeptide by catalytic cleavage or autocatalytic cleavage of the propeptide progenitor. Propeptide-coding sequences can be obtained from the following genes: Bacillus subtilis alkaline protease (aprE), Bacillus subtilis neutral protease (nprT), Thermophilus laccase (WO 95 / 33836), Rhizopus oryzae aspartic protease, and Saccharomyces cerevisiae α-factor.
[0176] When both the signal peptide sequence and the propeptide sequence are present, the propeptide sequence is located immediately adjacent to the N-terminus of the polypeptide, and the signal peptide sequence is located immediately adjacent to the N-terminus of the propeptide sequence.
[0177] It is also desirable to add regulatory sequences that regulate the expression of host cell growth-related polypeptides. Examples of regulatory sequences are those that cause gene expression to be turned on or off in response to chemical or physical stimuli, including the presence of regulatory compounds. Regulatory sequences in prokaryotic systems include the lac, tac, and trp operon systems. In yeast, the ADH2 or GAL1 systems can be used. In filamentous fungi, the *Aspergillus niger* glucosylamylase promoter, the *Aspergillus oryzae* TAKAα-amylase promoter and *Aspergillus oryzae* glucosylamylase promoter, the *Trichoderma reesei* cellobiose hydrolase I promoter, and the *Trichoderma reesei* cellobiose hydrolase II promoter can be used. Other examples of regulatory sequences are those sequences that allow gene amplification. In eukaryotic systems, these regulatory sequences include dihydrofolate reductase genes amplified in the presence of methotrexate and metallothionein genes amplified with heavy metals. In these cases, the polynucleotide encoding the polypeptide will be operatively linked to the regulatory sequence.
[0178] expression carrier
[0179] The present invention also relates to recombinant expression vectors comprising the polynucleotide of the present invention, a promoter, and transcription and translation termination signals. Different nucleotides and control sequences can be linked together to produce a recombinant expression vector, which may include one or more convenient restriction enzyme sites to allow insertion or substitution of the polynucleotide encoding the polypeptide at these sites. Alternatively, the polynucleotide can be expressed by inserting the polynucleotide or a nucleic acid construct containing the polynucleotide into a suitable vector for expression. In producing the expression vector, the coding sequence is located within the vector, such that the coding sequence is operatively linked to the suitable control sequence for expression.
[0180] Recombinant expression vectors can be any vector (e.g., plasmids or viruses) that can readily undergo recombinant DNA procedures and induce polynucleotide expression. The choice of vector will typically depend on its compatibility with the host cell to which it will be introduced. Vectors can be linear or closed circular plasmids.
[0181] The vector can be a self-replicating vector, that is, a vector that exists as an extrachromosomal entity and replicates independently of chromosome replication, such as a plasmid, extrachromosomal element, microchromosome, or artificial chromosome. The vector can contain any means to ensure self-replication. Alternatively, the vector can be one that integrates into the genome when introduced into a host cell and replicates along with one or more chromosomes in which it has been integrated. Furthermore, a single vector or plasmid, or two or more vectors or plasmids collectively containing the total DNA of the host cell genome to be introduced, or transposons can be used.
[0182] The vector preferably contains one or more selective markers that allow for convenient selection of cells such as transformed cells, transfected cells, and transduced cells. A selective marker is a gene whose product provides resistance to biocides or viruses, resistance to heavy metals, or prototrophic auxotrophic traits, etc.
[0183] Examples of selective bacterial markers include the dal gene in Bacillus licheniformis or Bacillus subtilis, or markers that confer antibiotic resistance (such as ampicillin, chloramphenicol, kanamycin, neomycin, spectinomycin, or tetracycline resistance). Suitable markers for yeast host cells include, but are not limited to: ADE2, HIS3, LEU2, LYS2, MET3, TRP1, and URA3. Selective markers for filamentous fungal host cells include, but are not limited to: adeA (phosphoribonucleoylaminoimidazolium-succinate formamide synthase), adeB (phosphoribonucleoylaminoimidazolium synthase), amdS (acetamipase), argB (ornithine carbamoyltransferase), bar (glufosinate acetyltransferase), hph (hygromycin phosphotransferase), niaD (nitrate reductase), pyrG (orotate nucleoside-5'-phosphate decarboxylase), sC (adenosyl sulfate transtransferase), and trpC (o-aminobenzoic acid synthase), and their equivalents. Preferred genes for use in Aspergillus cells include the amdS and pyrG genes from Aspergillus nidulans or Aspergillus oryzae, and the bar gene from Streptomyces hygroscopicus. Preferred genes for use in Trichoderma cells include the adeA, adeB, amdS, hph, and pyrG genes.
[0184] Selective labeling can be a biselective labeling system as described in WO 2010 / 039889. In one aspect, biselective labeling is the hph-tk biselective labeling system.
[0185] The vector preferably contains one or more elements that allow the vector to integrate into the host cell’s genome or to replicate autonomously in the cell independently of the genome.
[0186] For integration into the host cell genome, the vector can rely on a polynucleotide sequence encoding the polypeptide or any other element of the vector for integration into the genome via homologous or non-homologous recombination. Alternatively, the vector may contain additional polynucleotides to guide integration into the host cell genome at a precise location on the chromosome via homologous recombination. To increase the likelihood of integration at a precise location, the integrative element should contain a sufficient number of nucleic acids, such as 100 to 10,000 base pairs, 400 to 10,000 base pairs, and 800 to 10,000 base pairs, that have high sequence identity with the corresponding target sequence to enhance the probability of homologous recombination. The integrative element can be any sequence homologous to the target sequence within the host cell genome. Furthermore, the integrative element can be a non-coding or coding polynucleotide. On the other hand, the vector can integrate into the host cell genome via non-homologous recombination.
[0187] For autonomous replication, the vector may also contain an origin of replication, which enables the vector to replicate autonomously within the host cell discussed in this context. The origin of replication can be any plasmid replicon that mediates autonomous replication and functions within the cell. The terms "origin of replication" or "plasmid replicon" refer to the polynucleotide that enables a plasmid or vector to replicate in vivo.
[0188] Examples of bacterial origins of replication are the origins of replication of plasmids pBR322, pUC19, pACYC177, and pACYC184, which allow replication in Escherichia coli, and the origins of replication of plasmids pUB110, pE194, pTA1060, and pAMβ1, which allow replication in Bacillus.
[0189] Examples of replication origins used in yeast host cells include the 2-micron replication origin, ARS1, ARS4, a combination of ARS1 and CEN3, and a combination of ARS4 and CEN6.
[0190] Examples of useful origins of replication in filamentous fungal cells are AMA1 and ANS1 (Gems et al., 1991, Gene 98:61-67; Cullen et al., 1987, Nucleic Acids Res. 15:9163-9175; WO00 / 24883). The AMA1 gene can be isolated and plasmids or vectors containing the gene can be constructed according to the methods disclosed in WO 00 / 24883.
[0191] More than one copy of the polynucleotide of the present invention can be inserted into a host cell to increase polypeptide production. An increased copy number of the polynucleotide can be obtained by integrating at least one additional copy of the sequence into the host cell genome or by including an amplifiable selective marker gene along with the polynucleotide, wherein cells containing the amplified copy of the selective marker gene, and thus additional copies of the polynucleotide, can be selected by culturing cells in the presence of a suitable selective reagent.
[0192] The procedures for connecting the above-described elements to construct the recombinant expression vector of the present invention are well known to those skilled in the art (see, for example, Sambrook et al., 1989, ibid.).
[0193] host cells
[0194] This invention also relates to recombinant host cells containing polynucleotides of the invention operably linked to one or more control sequences that direct the production of polypeptides of the invention. A construct or vector containing the polynucleotide is introduced into the host cell such that the construct or vector is maintained as a chromosomal integrase or as an autonomously replicating extrachromosomal vector, as previously described. The term "host cell" encompasses any parental cell progeny that is not entirely identical to the parental cell due to mutations occurring during replication. The selection of the host cell will depend largely on the gene encoding the polypeptide and its origin.
[0195] The host cell can be any cell useful in the recombinant production of the polypeptides of the present invention, such as prokaryotic or eukaryotic cells.
[0196] Prokaryotic host cells can be any Gram-positive or Gram-negative bacteria. Gram-positive bacteria include, but are not limited to: Bacillus, Clostridium, Enterococcus, Geobacillus, Lactobacillus, Lactococcus, Bacillus macrocephala, Staphylococcus, Streptococcus, and Streptomyces. Gram-negative bacteria include, but are not limited to: Campylobacter, Escherichia coli, Flavobacterium, Fusobacterium, Helicobacter, Coliform, Neisseria, Pseudomonas, Salmonella, and Ureaplasma.
[0197] The bacterial host cell can be any Bacillus genus cell, including but not limited to Bacillus alkalophilus, Bacillus amyloliquefaciens, Bacillus brevis, Bacillus circulans, Bacillus croceus, Bacillus coagulans, Bacillus sclerosus, Bacillus splenium, Bacillus stenosis, Bacillus licheniformis, Bacillus megaterium, Bacillus brevis, Bacillus thermophilus, Bacillus subtilis, and Bacillus thuringiensis cells.
[0198] The bacterial host cell can also be any streptococcal cell, including but not limited to Streptococcus equi, Streptococcus pyogenes, Streptococcus mammae, and Streptococcus equi subsp. veterinaryis.
[0199] The bacterial host cell can also be any Streptomyces cell, including but not limited to: non-chromogenic Streptomyces, insecticidal Streptomyces, blue Streptomyces, gray Streptomyces, and light blue Streptomyces cells.
[0200] DNA can be introduced into Bacillus cells through the following methods: protoplast transformation (see, for example, Chang and Cohen, 1979, Mol. Gen. Genet. [Molecular Genetics and Genomics] 168:111-115), competent cell transformation (see, for example, Young and Spizizen, 1961, J. Bacteriol. [Journal of Bacteriology] 81:823-829; or Dubnau and Davidoff-Abelson, 1971, J. Mol. Biol. [Journal of Molecular Biology] 56:209-221), electroporation (see, for example, Shigekawa and Dower, 1988, Biotechniques [Biotechnology] 6:742-751), or conjugation (see, for example, Koehler and Thorne, 1987, J. Bacteriol. [Journal of Bacteriology] 169:5271-5278). DNA can be introduced into E. coli cells by protoplast transformation (see, for example, Hanahan, 1983, J. Mol. Biol. [Journal of Molecular Biology] 166:557-580) or electroporation (see, for example, Dower et al., 1988, Nucleic Acids Res. [Nucleic Acid Research] 16:6127-6145). DNA can be introduced into Streptomyces cells in the following ways: protoplast transformation, electroporation (see, for example, Gong et al., 2004, Folia Microbiol. (Praha) 49:399-405), conjugation (see, for example, Mazodier et al., 1989, J. Bacteriol. 171:3583-3585), or transduction (see, for example, Burke et al., 2001, Proc. Natl. Acad. Sci. USA 98:6289-6294). DNA can be introduced into Pseudomonas cells by means of electroporation (see, for example, Choi et al., 2006, J. Microbiol. Methods 64:391-397) or conjugation (see, for example, Pinedo and Smets, 2005, Appl. Environ. Microbiol. 71:51-57).DNA can be introduced into Streptococcus cells in the following ways: natural competence (see, for example, Perry and Kuramitsu, 1981, Infect. Immun. 32:1295-1297), protoplast transformation (see, for example, Catt and Jollick, 1991, Microbios 68:189-207), electroporation (see, for example, Buckley et al., 1999, Appl. Environ. Microbiol. 65:3800-3804), or conjugation (see, for example, Clewell, 1981, Microbiol. Rev. 45:409-436). However, any method known in the art for introducing DNA into host cells can be used.
[0201] The host cell can also be a eukaryotic cell, such as a mammalian, insect, plant, or fungal cell.
[0202] The host cell can be a fungal cell. As used herein, “fungus” includes Ascomycota, Basidiomycota, Chytridiomycota, Zygomycota, Oomycota, and all mitotic fungi (as defined by Hawksworth et al. in Ainsworth and Bisby’s Dictionary of The Fungi, 8th edition, 1995, CAB International, University Press, Cambridge, UK).
[0203] The host cell for fungi can be a yeast cell. As used herein, “yeast” includes ascosporogenous yeast (Endomycetales), basidiosporogenous yeast, and yeasts belonging to the Fungi Imperfecti (Blastomycetes). Since the classification of yeast may change in the future, for the purposes of this invention, yeast should be defined as described in *Biology and Activities of Yeast* (edited by Skinner, Passmore, and Davenport, Soc. App. Bacteriol. Symposium Series No. 9, 1980).
[0204] Yeast host cells can be cells from the genera *Candida*, *Hansenula*, *Klufera*, *Pichia*, *Saccharomyces*, *Saccharomyces*, or *Yarrowia*, such as *Kluyveromyces lactis*, *Kalvatia*, *Saccharomyces cerevisiae*, *Saccharomyces sacchari*, *Saccharomyces davidiana*, *Douglas*, *Klufera*, *Nordiya*, *Ovoyces*, or *Yarrowia lipolytica*.
[0205] Fungal host cells can be filamentous fungal cells. "Filamentous fungi" includes all filamentous forms within the phylum Eumycota and subphyla Oomycota (as defined by Hawksworth et al., 1995, ibid.). Filamentous fungi are typically characterized by a hyphal wall composed of chitin, cellulose, glucan, chitosan, mannan, and other complex polysaccharides. Vegetative growth occurs through hyphal extension, and carbon metabolism is obligate aerobic. In contrast, yeast (such as Saccharomyces cerevisiae) undergoes vegetative growth through budding of single-celled cells, and carbon metabolism can be fermentative.
[0206] The host cells of filamentous fungi can be cells from genera such as *Apertoire*, *Aspergillus*, *Bjerkandera*, *Pseudomonas*, *Aureospora*, *Coprinus*, *Coriolus*, *Cryptococcus*, *Filibasidium*, *Fusarium*, *Pyrophyllus*, *Pleurotus*, *Mucor*, *Pyrophyllus*, *Pleurotus ... or *Trichoderma*.
[0207] For example, the host cells of filamentous fungi can be *Aspergillus amblymorii*, *Aspergillus sulphureus*, *Aspergillus fumigatus*, *Aspergillus japonicus*, *Aspergillus nidus*, *Aspergillus oryzae*, *Bjerkandera adusta*, *Ceriporiopsis saneirina*, *Ceriporiopsis caregiea*, *Ceriporiopsis gilvescens*, *Ceriporiopsis pannocinta*, *Ceriporiopsis rivulosa*, *Ceriporiopsis subrufa*, *Ceriporiopsis subvermispora*, *Chrysosporium inops*, *Chrysosporium lucknowense*, and *Chrysosporium foetida*. merdarium), rent spores, Chrysosporium queenslandicum, tropical golden spores, Chrysosporium zonatum, Coprinus cinereus, Coriolushirsutus, Fusarium spores, Fusarium cereals, Fusarium kuwai, Fusarium scabra, Fusarium graminearum, Fusarium graminearum, Fusarium heterosporum, Fusarium hyacinthus, Fusarium oxysporum, Fusarium multibranchs, Fusarium pink, Fusarium elderberry, Fusarium scabra, Fusarium fimbriatum, Fusarium sulfideum, Fusarium spheroides, Fusarium spheroides, Fusarium variegatum, Fusarium moniliforme ... radiata), Pleurotus eryngii, Trametes villosa, Trametes versicolor, Trichoderma harzianum, Trichoderma corningensis, Trichoderma longibranchii, Trichoderma reesei, or green Trichoderma cells.
[0208] Fungal cells can be transformed in a manner known per se through methods involving protoplast formation, protoplast transformation, and cell wall regeneration. Suitable procedures for transforming Aspergillus and Trichoderma host cells are described in the following references: EP 238023, Yelton et al., 1984, Proc. Natl. Acad. Sci. USA [Proceedings of the National Academy of Sciences] 81:1470-1474 and Christensen et al., 1988, Bio / Technology [Biology / Technology] 6:1419-1422. Suitable methods for transforming Fusarium species are described by Malardier et al., 1989, Gene [Gene] 78:147-156 and WO 96 / 00787. Yeast can be transformed using procedures described in the following literature: Becker and Guarente, eds., Abelson, JN and Simon, MI, Guide to Yeast Genetics and Molecular Biology, Methods in Enzymology, Vol. 194, pp. 182-187, Academic Press, Inc., New York; Ito et al., 1983, J. Bacteriol. 153:163; and Hinnen et al., 1978, Proc. Natl. Acad. Sci. USA 75:1920.
[0209] Production methods
[0210] The present invention also relates to a method for producing the polypeptide of the invention (e.g., an in vitro or ex vivo production method), the method comprising: (a) culturing cells in their wild-type form to produce the polypeptide under conditions favorable to the production of the polypeptide; and optionally, (b) recovering the polypeptide. In one aspect, the cells are *Bacillus* cells. In another aspect, the cells are *Bacillus pineniformis* cells or *Bacillus ylangi* cells.
[0211] The present invention also relates to a method for generating the polypeptide of the invention (e.g., an in vitro or ex vivo generation method), the method comprising (a) culturing the recombinant host cell of the invention under conditions favorable for generating the polypeptide; and optionally, (b) recovering the polypeptide.
[0212] The host cells are cultured in a nutrient medium suitable for producing peptides using methods known in the art. For example, cells can be cultured by shake flask culture or by small-scale or large-scale fermentation (including continuous, batch, fed-batch, or solid-state fermentation) in a laboratory or industrial fermenter, in a suitable medium and under conditions that allow for peptide expression and / or isolation. Using procedures known in the art, the culture occurs in a suitable nutrient medium containing carbon and nitrogen sources and inorganic salts. Suitable media are available from commercial suppliers or can be prepared according to publicly available compositions (e.g., in the catalogue of the American Type Culture Collection). If the peptide is secreted into the nutrient medium, it can be recovered directly from the medium. If the peptide is not secreted, it can be recovered from cell lysates.
[0213] Peptides can be detected using methods known in the art that are specific to peptides. These detection methods include, but are not limited to, the use of specific antibodies, the formation of enzyme products, or the disappearance of enzyme substrates. For example, enzyme assays can be used to determine the activity of a peptide.
[0214] Peptides can be recovered using methods known in the art. For example, peptides can be recovered from nutrient media using conventional methods, including but not limited to collection, centrifugation, filtration, extraction, spray drying, evaporation, or precipitation. In one aspect, fermentation broth containing peptides can be recovered.
[0215] Peptides can be purified to obtain substantially pure peptides using a variety of procedures known in the art, including but not limited to: chromatography (e.g., ion exchange, affinity, hydrophobicity, chromatographic focusing, and size exclusion), electrophoresis procedures (e.g., preparative isoelectric focusing), differential solubility (e.g., ammonium sulfate precipitation), SDS-PAGE, or extraction (see, for example, Protein Purification, edited by Janson and Ryden, VCH Publishers, New York, 1989).
[0216] In an alternative approach, instead of recovering the polypeptide, the host cell of the present invention expressing the polypeptide is used as the source of the polypeptide.
[0217] Fermentation broth preparations or cell compositions
[0218] The present invention also relates to fermentation broth formulations or cell compositions comprising the polypeptides of the present invention. The fermentation broth product further comprises additional components used in the fermentation process, such as cells (including host cells containing genes encoding the polypeptides of the present invention, these host cells being used to produce the target polypeptide), cell debris, biomass, fermentation medium, and / or fermentation products. In some embodiments, the composition is a cell-killing whole culture medium containing one or more organic acids, killed cells and / or cell debris, and a culture medium.
[0219] As used herein, the term "fermentation broth" refers to a preparation produced by cell fermentation that undergoes little or no recovery and / or purification. For example, fermentation broth is produced when a microbial culture is incubated to saturation under carbon-limited conditions that allow protein synthesis (e.g., expression of enzymes by the host cell) and secretion of proteins into the cell culture medium. This fermentation broth may contain unfractionated or fractionated contents of the fermentation material obtained at the end of fermentation. Typically, the fermentation broth is unfractionated and contains used culture medium and cell debris remaining after, for example, removal of microbial cells (e.g., filamentous fungal cells) by centrifugation. In some embodiments, the fermentation broth contains used cell culture medium, extracellular enzymes, and viable and / or non-viable microbial cells.
[0220] In one embodiment, the fermentation broth formulation and cell composition comprise a first organic acid component (an organic acid containing at least one to five carbons and / or its salt) and a second organic acid component (an organic acid containing at least six or more carbons and / or its salt). In a particular embodiment, the first organic acid component is acetic acid, formic acid, propionic acid, a salt thereof, or a mixture of two or more of the foregoing; and the second organic acid component is benzoic acid, cyclohexanecarboxylic acid, 4-methylvaleric acid, phenylacetic acid, a salt thereof, or a mixture of two or more of the foregoing.
[0221] In one aspect, the composition contains one or more organic acids and optionally further contains killed cells and / or cell debris. In one embodiment, these killed cells and / or cell debris are removed from the cell-killing whole culture medium to provide a composition free of these components.
[0222] These fermentation broth formulations or cell compositions may further contain preservatives and / or antimicrobial (e.g., bacteriostatic) agents, including but not limited to sorbitol, sodium chloride, potassium sorbate, and other reagents known in the art.
[0223] The cell-killing whole culture or composition may contain ungraded contents of the fermentation material obtained at the end of fermentation. Typically, the cell-killing whole culture or composition comprises used culture medium and cell debris present after microbial cells (e.g., filamentous fungal cells) have been grown to saturation and incubated under carbon-limited conditions to allow protein synthesis. In some embodiments, the cell-killing whole culture or composition contains used cell culture medium, extracellular enzymes, and killed filamentous fungal cells. In some embodiments, methods known in the art can be used to permeate and / or lyse the microbial cells present in the cell-killing whole culture or composition.
[0224] The whole culture medium or cell composition described herein is typically a liquid, but may contain insoluble components, such as killed cells, cell debris, culture medium components, and / or one or more insoluble enzymes. In some embodiments, insoluble components may be removed to provide a clear liquid composition.
[0225] The whole culture medium formulations and cell compositions of the present invention can be produced by the methods described in WO 90 / 15861 or WO 2010 / 096673.
[0226] Cleaning compositions and / or detergent compositions
[0227] The present invention also relates to compositions comprising the mannanase of the present invention, such as cleaning compositions and / or detergent compositions.
[0228] In one embodiment, the present invention relates to cleaning compositions and / or detergent compositions comprising the mannanase of the invention and suitable surfactants. In one embodiment, the detergent composition may be suitable for a specific purpose, such as laundry (particularly household laundry), dishwashing, or hard surface cleaning.
[0229] Therefore, in one embodiment, the polypeptide of the first or second aspect, the detergent composition of the third or fourth aspect, the granules of the fifth or sixth aspect, or the liquid formulation of the seventh or eighth aspect can be used for laundry, washing or cleaning textiles and / or hard surfaces (such as dishwashing). In one embodiment, the polypeptide has an enzymatic detergency benefit (i.e., the enzymes of the present invention improve cleaning performance compared to the same composition without enzymes).
[0230] The detergent compositions of the present invention can be formulated as, for example, hand-wash or machine-wash detergent compositions, including a laundry additive composition suitable for pre-treating stained fabrics and a fabric softener composition for rinsing, or formulated as detergent compositions for general household hard surface cleaning operations, or formulated for hand-wash or machine-wash dishwashing operations. The detergent compositions of the present invention can be applied to hard surface cleaning, automatic dishwashing applications, and in conjunction with cosmetic applications, such as dentures, teeth, hair, and skin.
[0231] The detergent compositions of the present invention can be in any convenient form, such as sticks, tablets, powders, granules, pastes, or liquids. Liquid detergents can be aqueous, typically containing up to 70% water and 0-30% organic solvents, or they can be non-aqueous.
[0232] Unless otherwise stated, all component or composition levels provided herein are given with reference to the activity level of that component or composition and do not include impurities that may be present in commercially available sources, such as residual solvents or byproducts.
[0233] The mannanase of the present invention is typically incorporated into detergent compositions (pods / caps, liquid detergents or powder detergents) at a level of 0.001% to 10% of enzyme protein by weight of the composition, such as 0.001% to 0.1%, 0.01% to 1.0% or 0.1% to 10% of enzyme protein by weight of the composition.
[0234] The mannanases of the present invention are typically incorporated into the washing composition in such amounts that their concentration in the washing water is 0.0001 to 1 ppm of enzyme protein, such as 0.0001 to 0.01 ppm, 0.001 to 0.1 ppm, or 0.01 to 1 ppm of enzyme protein in the washing water.
[0235] In some preferred embodiments, the detergent compositions provided herein are typically formulated such that, during aqueous cleaning operations, the wash water has a pH of from about 5.0 to about 11.5, or, in alternative embodiments, even from about 6.0 to about 10.5, for example, from about 5 to about 11, from about 5 to about 10, from about 5 to about 9, from about 5 to about 8, from about 5 to about 7, from about 6 to about 11, from about 6 to about 10, from about 6 to about 9, from about 6 to about 8, from about 6 to about 7, from about 7 to about 11, from about 7 to about 10, from about 7 to about 9, or from about 7 to about 8. In some preferred embodiments, particulate or liquid laundry detergent products are formulated such that the wash water has a pH of from about 5.5 to about 8. Techniques for controlling the pH at recommended usage levels include the use of buffers, alkalis, acids, etc., and are well known to those skilled in the art.
[0236] Enzyme component weights are based on total protein. Unless otherwise specified, all percentages and ratios are by weight. Unless otherwise specified, all percentages and ratios are based on the total composition. In the illustrated detergent compositions, enzyme levels are expressed by weight of purified enzymes as a percentage of the total composition, and detergent components are expressed by weight of the total composition unless otherwise stated.
[0237] The enzyme of the present invention is also used in detergent additive products. Detergent additive products containing the mannanase of the present invention are ideally suited for inclusion in the washing process when, for example, the temperature is low, such as about 40°C or lower, the pH is between 6 and 8, and the washing time is short, such as less than 30 minutes.
[0238] The detergent additive product may be the mannanase of the present invention, and preferably another enzyme. In one embodiment, the additive is packaged in a dosage form for addition to the cleaning process. A single dose may comprise a pill, tablet, gelcap, or other single-dose unit comprising powder and / or liquid. In some embodiments, fillers and / or one or more carrier materials are included, suitable fillers or carrier materials including, but not limited to, various salts of sulfates, carbonates, and silicates, as well as talc, clay, etc. In some embodiments, fillers and / or carrier materials for liquid compositions include water and / or low molecular weight primary and secondary alcohols (including polyols and diols). Examples of such alcohols include, but are not limited to, methanol, ethanol, propanol, and isopropanol.
[0239] In a particularly preferred embodiment, the mannanase according to the invention is used in a particulate composition or liquid, the mannanase being in the form of encapsulated particles. In one embodiment, the encapsulating material is selected from the group consisting of carbohydrates, natural or synthetic gums, chitin and chitosan, cellulose and cellulose derivatives, silicates, phosphates, borates, polyvinyl alcohol, polyethylene glycol, paraffin wax, and combinations thereof.
[0240] The compositions according to the invention typically comprise one or more detergent ingredients. The term "detergent composition" includes articles and cleaning and treatment compositions. Unless otherwise specified, the term "cleaning composition" includes all-purpose or "heavy-duty" cleaners in flake, granular, or powder form, especially laundry detergents; all-purpose cleaners in liquid, gel, or paste form, especially so-called heavy-duty liquid types; liquid de-icing detergents; hand-washing dishwashing agents or light-duty dishwashing agents, especially high-foaming types; and machine-washing dishwashing agents, including various flake, granular, liquid, and rinsing aid types for home and institutional use. The compositions may also be in unit-dose packages, including those known in the art and those that are water-soluble, water-insoluble, and / or water-permeable.
[0241] In embodiments where the cleaning and / or detergent components may be incompatible with the mannanase of the present invention, suitable methods may be used to separate the cleaning and / or detergent components from the mannanase (i.e., prevent them from contacting each other) until the combination of the two components is appropriate. Such separation methods include any suitable methods known in the art (e.g., capsules, sachets, tablets, and physical separation, such as by using water-soluble pouches having one or more compartments).
[0242] In some embodiments, the enzymes used herein are stabilized by providing a water-soluble source of zinc (II), calcium (II), and / or magnesium (II) ions in the finished composition, along with other metal ions (e.g., barium (II), scandium (II), iron (II), manganese (II), aluminum (III), tin (II), cobalt (II), copper (II), nickel (II), and vanadium oxide (IV)). The enzymes in the detergent compositions of the present invention can also be stabilized using conventional stabilizers such as polyols (e.g., propylene glycol or glycerol), sugars or sugar alcohols, lactic acid, and can be formulated as described, for example, in WO 92 / 19709 and WO 92 / 19708. The enzymes of the present invention can also be stabilized by adding reversible enzyme inhibitors, such as protein-type (as described in EP 544 777) or borate-type reversible enzyme inhibitors. Other enzyme stabilizers are well known in the art, such as peptidaldehyde and protein hydrolysates. For example, peptidaldehyde or ketones can be used to stabilize the mannanase according to the invention, as described in WO2005 / 105826 and WO2009 / 118375.
[0243] As mentioned above, the protected enzyme contained in the detergent composition of the present invention can be prepared according to the method disclosed in EP 238 216.
[0244] The composition can be expanded with one or more reagents to prevent biofilm formation or remove existing biofilms. These reagents may include, but are not limited to, dispersants, surfactants, detergents, other enzymes, antimicrobial agents, and biocides.
[0245] The compositions of the present invention can be applied to metering elements intended for use in automated metering devices. Metering elements comprising the compositions of the present invention can be placed in delivery cartridges as described in WO 2007 / 052004 and WO 2007 / 0833141. The metering elements can have an elongated shape and are arranged in an array to form delivery cartridges, which are alternatives to automated metering dispensing devices as described in case WO2007 / 051989. The delivery cartridges are placed in automated metering delivery devices, such as those described in WO 2008 / 053191.
[0246] Suitable disclosures regarding automatic metering devices can be found in WO 2007 / 083139, WO 2007 / 051989, WO 2007 / 083141, WO 2007 / 083142 and EP 2361964.
[0247] Formulation of granular mannanase
[0248] Dust-free particles can be produced, for example, as disclosed in US 4,106,991 and US 4,661,452, and can optionally be coated by methods known in the art. Examples of wax-coated materials are poly(ethylene oxide) products (polyethylene glycol, PEG) having an average molar weight of 1,000 to 20,000; ethoxylated nonylphenol having 16 to 50 ethylene oxide units; ethoxylated fatty alcohols containing 12 to 20 carbon atoms and having 15 to 80 ethylene oxide units; fatty alcohols; fatty acids; and monoglycerides and diglycerides and triglycerides of fatty acids. Examples of film-forming coating materials suitable for use by fluidized bed technology are given in GB 1483591. Liquid enzyme preparations can be stabilized, for example, by adding polyols (such as propylene glycol), sugars or sugar alcohols, lactic acid or boric acid according to established methods. The protected enzyme can be prepared according to the methods disclosed in EP 238,216.
[0249] The mannanase can be formulated as granules, for example, as co-granules combining one or more enzymes. Each enzyme will then be present in multiple granules, ensuring a more uniform distribution of the enzyme in the detergent. This also reduces the physical isolation of different enzymes due to varying particle sizes. A method for producing multi-enzyme co-granules for the detergent industry is disclosed in www.ip.com Publication IPCOM000200739D.
[0250] Another example of enzyme formulation using co-particles is disclosed in WO 2013 / 188331, which relates to a detergent composition comprising (a) a multi-enzyme co-particle; (b) less than 10% wt zeolite (anhydrous base); and (c) less than 10% w / w phosphate (anhydrous base), wherein the enzyme co-particles contain a water pool component from 10% to 98% w / w, and the composition additionally contains a detergent water pool component from 20% to 80% w / w.
[0251] One embodiment of the present invention relates to an enzyme particle / granule comprising the mannanase of the present invention. The particle consists of a core and optionally one or more coatings (outer layers) surrounding the core.
[0252] Typically, the particle size (measured as equivalent sphere diameter (volume-average particle size)) is 20-2000 μm, specifically 50-1500 μm, 100-1500 μm, or 250-1200 μm.
[0253] The core may contain additional materials such as fillers, fibrous materials (cellulose or synthetic fibers), stabilizers, solubilizers, suspending agents, viscosity modifiers, light spheres, plasticizers, salts, lubricants, and fragrances.
[0254] The core may include adhesives such as synthetic polymers, waxes, fats, or carbohydrates.
[0255] The core, typically a homogeneous blend, can contain salts of polyvalent cations, reducing agents, antioxidants, peroxide decomposition catalysts, and / or acidic buffer components.
[0256] The core can consist of inert particles into which the enzyme is adsorbed or applied (e.g., via fluidized bed coating) to the surface of the inert particles.
[0257] The diameter of the core can be 20-2000μm, specifically 50-1500μm, 100-1500μm, or 250-1200μm.
[0258] The core can be prepared by blends of granulated components, for example by methods including granulation techniques such as crystallization, precipitation, pan-coating, fluidized bed coating, fluidized bed agglomeration, rotary atomization, extrusion, granulation, spheronization, particle size reduction, drum granulation, and / or high-shear granulation.
[0259] Methods for preparing the core can be found in *Handbook of Powder Technology*; *CECapes: Particle Size Enlargement*; Volume 1; 1980; Elsevier. Preparation methods include known feed and pellet formulation techniques, such as:
[0260] a) Products produced by spray drying, in which a solution containing liquid enzymes is atomized in a spray drying tower to form small droplets, which are dried as they settle in the tower to form enzyme-containing particulate material. This method can be used to produce very small particles (Michael S. Showell (ed.); Powdered detergents; Surfactant Science Series; 1998; Vol. 71; pp. 140-142; Marcel Dekker).
[0261] (b) Layered products, wherein an enzyme is coated as a layer around pre-formed inert core particles, wherein the enzyme-containing solution is typically atomized in a fluidized bed apparatus, the pre-formed core particles are fluidized, and the enzyme-containing solution adheres to the core particles and is dried until a dry enzyme layer remains on the surface of the core particles. If useful core particles of the desired size can be found, particles of the desired size can be obtained in this manner. This type of product is described, for example, in WO 97 / 23606.
[0262] c) Absorbed core particles, wherein the enzyme is not coated as a layer surrounding the core, but rather absorbed on and / or within the surface of the core. Such a method is described in WO 97 / 39116.
[0263] d) Extruded or pelletized products, in which an enzyme-containing paste is compressed into pellets or extruded and cut into particles under pressure through small openings, followed by drying of these particles. These particles typically have a fairly large size because the material with the extrusion openings (usually a flat plate with perforations) limits the allowable pressure drop through the openings. Furthermore, when using small openings, the very high extrusion pressure increases the amount of heat generated in the enzyme paste, which is detrimental to the enzyme (see also Michael S. Showell (ed.); Powdered detergents; Surfactant Science Series; 1998; Vol. 71; pp. 140-142; Marcel Dekker).
[0264] e) A granulated product in which an enzyme-containing powder is suspended in molten wax and, for example, sprayed into a cooling chamber via a rotary sprayer, the droplets rapidly solidify (Michael S. Showell (ed.); Powdered Detergents, Surfactant Science Series; 1998; Vol. 71; pp. 140-142; Marcel Dekker). The resulting product is one in which the enzyme is uniformly distributed throughout the inert material rather than concentrated on its surface. Furthermore, US 4,016,040 and US 4,713,245 are relevant documents to this technique.
[0265] f) A mixer-granulated product in which a liquid is added to a dry powder composition, such as a commonly used granulating component, to introduce the enzyme via the liquid or powder or both. The liquid and powder are mixed, and because the water content of the liquid is absorbed by the dry powder, the dry powder components begin to adhere and aggregate, and particles are formed to create granules containing the enzyme. This method is described in US 4,106,991 and related documents EP 170360, EP 304332, EP 304331, WO 90 / 09440, and WO 90 / 09428. In specific products of this method, in which various high-shear mixers can be used as granulators, granules consisting of enzymes, fillers, and binders are mixed with cellulose fibers to strengthen the granules, resulting in so-called T-granulates. The strengthened granules are more robust, and less enzyme dust is released.
[0266] g) Particle size reduction, in which core particles are generated by grinding or crushing larger enzyme-containing particles, pellets, flat sheets, briquettes, etc. The desired core particle fraction is obtained by sieving the grinding or crushing product. Oversized and undersized particles can be recovered. Particle size reduction is described in (Martin Rhodes (ed.); Principles of Powder Technology; 1990; Chapter 10; John Wiley & Sons).
[0267] h) Fluidized bed granulation. Fluidized bed granulation involves suspending microparticles in an airflow and spraying liquid through a nozzle onto the fluidized particles. The particles hit by the sprayed droplets become wetted and sticky. The sticky particles collide with and adhere to other particles, forming granules.
[0268] i) These cores can be dried, such as in a fluidized bed dryer. Those skilled in the art can use other methods known for drying granules in the feed or detergent industries. Drying is preferably carried out at a product temperature from 25°C to 90°C. For some enzymes, it is important that the enzyme-containing core contains a small amount of water before coating. If water-sensitive enzymes are coated before excess water is removed, moisture will be trapped in the core and may negatively affect enzyme activity. After drying, these cores preferably contain 0.1-10% w / w of water.
[0269] The core of the enzyme particle / particle may be surrounded by at least one coating, for example, to improve storage stability, reduce dust formation during processing, or for coloring the particle. The one or more optional coatings may include salt coatings or other suitable coating materials such as polyethylene glycol (PEG), methyl hydroxypropyl cellulose (MHPC), and polyvinyl alcohol (PVA). Examples of enzyme particles with multiple coatings are shown in WO 93 / 07263 and WO 97 / 23606.
[0270] The coating may be applied in an amount of at least 0.1% (e.g., at least 0.5%, 1%, or 5%) of the core weight. This amount may be at most 100%, 70%, 50%, 40%, or 30%.
[0271] The coating is preferably at least 0.1 μm thick, specifically at least 0.5 μm, at least 1 μm, or at least 5 μm. In one specific embodiment, the coating thickness is less than 100 μm. In a more specific embodiment, the coating thickness is less than 60 μm. In an even more specific embodiment, the total coating thickness is less than 40 μm.
[0272] The coating should seal the core unit by forming a substantially continuous layer. A substantially continuous layer should be understood as a coating with very few or no pores, such that the sealed / enclosed core unit has very few or no uncoated areas. The layer or coating should in particular be uniform in thickness.
[0273] The coating may further contain other materials known in the art, such as fillers, anti-sticking agents, pigments, dyes, plasticizers and / or adhesives, such as titanium dioxide, kaolin, calcium carbonate or talc.
[0274] Salt coating may comprise at least 60% salt by weight (w / w), for example, at least 65%, at least 70%, at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, or at least 99% by weight (w / w).
[0275] The salt can be added from a salt solution (where the salt is completely dissolved) or from a salt suspension (where the fine particles are less than 50 μm, such as less than 10 μm or less than 5 μm).
[0276] The salt coating may contain a single salt or a mixture of two or more salts. The salt may be water-soluble, specifically having a solubility of at least 0.1 g in 100 g of water at 20°C, preferably at least 0.5 g / 100 g of water, for example, at least 1 g / 100 g of water, for example, at least 5 g / 100 g of water.
[0277] The salt can be an inorganic salt, such as a sulfate, sulfite, phosphate, phosphonate, nitrate, chloride, or carbonate, or a salt of a simple organic acid (less than 10 carbon atoms, such as 6 or fewer carbon atoms), such as a citrate, malonate, or acetate. Examples of cations in these salts are alkali or alkaline earth metal ions, ammonium ions, or first transition metal ions, such as sodium, potassium, magnesium, calcium, zinc, or aluminum. Examples of anions include chloride, bromine, iodine, sulfate, sulfite, bisulfite, thiosulfate, phosphate, dihydrogen phosphate, dibasic phosphate, hypophosphite, dihydrogen pyrophosphate, tetraborate, borate, carbonate, bicarbonate, silicate, citrate, malate, maleate, malonic acid, succinate, lactate, formate, acetate, butyrate, propionate, benzoate, tartrate, ascorbate, or gluconate. Specifically, alkali or alkaline earth metal salts of sulfate, sulfite, phosphate, phosphonate, nitrate, chloride, or carbonate, or salts of simple organic acids such as citrate, malonate, or acetate can be used.
[0278] The salt in the coating may have a constant humidity of more than 60% at 20°C, specifically more than 70%, more than 80%, or more than 85%, or it may be another hydrated form of the salt (e.g., anhydrous). The salt coating may be as described in WO 00 / 01793 or WO 2006 / 034710.
[0279] A specific example of a suitable salt is NaCl (CH3) 20℃ =76%), Na2CO3(CH 20℃ =92%), NaNO3(CH 20℃ =73%), Na2HPO4(CH 20℃ =95%), Na3PO4(CH 25℃ =92%), NH4Cl(CH 20℃ =79.5%), (NH4)2HPO4(CH 20℃ =93.0%), NH4H2PO4(CH 20℃ =93.1%), (NH4)2SO4(CH20℃ =81.1%), KCl(CH 20℃ =85%), K2HPO4(CH 20℃ =92%), KH2PO4(CH 20℃ =96.5%), KNO3(CH 20℃ =93.5%), Na2SO4(CH 20℃ =93%), K2SO4(CH 20℃ =98%), KHSO4(CH 20℃ =86%), MgSO4(CH 20℃ =90%), ZnSO4(CH 20℃ =90%) and sodium citrate (CH 25℃ =86%). Other examples include NaH2PO4, (NH4)H2PO4, CuSO4, Mg(NO3)2, and magnesium acetate.
[0280] The salt can be in anhydrous form, or it can be a hydrated salt, i.e., a crystalline salt hydrate with one or more bound water crystals, as described, for example, in WO 99 / 32595. Specific examples include anhydrous sodium sulfate (Na₂SO₄), anhydrous magnesium sulfate (MgSO₄), magnesium sulfate heptahydrate (MgSO₄·7H₂O), zinc sulfate heptahydrate (ZnSO₄·7H₂O), disodium hydrogen phosphate heptahydrate (Na₂HPO₄·7H₂O), magnesium nitrate hexahydrate (Mg(NO₃)₂(6H₂O)), sodium citrate dihydrate, and magnesium acetate tetrahydrate. Preferably, the salt is used as a salt solution, for example, using a fluidized bed.
[0281] Therefore, in another aspect, the present invention provides particles comprising:
[0282] (a) Containing a core of mannanase according to the invention, and
[0283] (b) Optionally, a coating consisting of one or more layers surrounding the core.
[0284] Other enzymes
[0285] In one embodiment, the mannanase of the present invention is combined with one or more enzymes, such as at least two enzymes, more preferably at least three, four or five enzymes. Preferably, the enzyme has different substrate specificities, such as proteolytic activity, starch-degrading activity, lipolytic activity, hemicellulose-degrading activity or pectin-degrading activity.
[0286] Detergent additives and detergent compositions may include one or more enzymes, such as proteases, lipases, keratases, amylases, carbohydrate enzymes, cellulases, pectinases, mannanases, arabinases, galactanases, xylanases, oxidases (e.g., laccases), and / or peroxidases.
[0287] Typically, the properties of one or more selected enzymes should be compatible with the selected detergent (i.e., optimal pH, compatibility with other enzymes and non-enzyme components, etc.), and the one or more enzymes should be present in an effective amount.
[0288] Cellulase Suitable cellulases include those of animal, plant, or microbial origin. Particularly suitable cellulases include those of bacterial or fungal origin. This includes chemically modified or protein-engineered variants. Suitable cellulases include cellulases from the genera *Bacillus*, *Pseudomonas*, *Pyrophyllus*, *Fusarium*, *Clostridium*, and *Cladosporium*, such as the fungal cellulases produced by *Pyrophyllus*, *Thermophyllus*, and *Fusarium* as disclosed in US 4,435,307, US 5,648,263, US 5,691,178, US 5,776,757, and WO 89 / 09259.
[0289] Particularly suitable cellulases are alkaline or neutral cellulases that offer color-care benefits. Examples of such cellulases are those described in EP 0 495 257, EP 0 531 372, WO 96 / 11262, WO 96 / 29397, and WO 98 / 08940. Other examples are, for instance, those cellulases described in WO 94 / 07998, EP 0 531 315, US 5,457,046, US 5,686,593, US 5,763,254, WO 95 / 24471, WO 98 / 12307, and WO 1999 / 001544.
[0290] Commercially available cellulases include Celluzyme TM and Carezyme TM (Novozymes A / S), Clazinase TM and Puradax HA TM (Genencor International Inc.) and KAC-500(B) TM (Kao Corporation).
[0291] proteaseSuitable proteases include those of bacterial, fungal, plant, viral, or animal origin, such as microbial or plant origin. Microbial origin is preferred. This includes chemically modified or protein-engineered variants. It can be an alkaline protease, such as a serine protease or a metalloproteinase. Serine proteases can be, for example, from the S1 family (such as trypsin) or the S8 family (such as subtilisin). Metalloproteinases can be, for example, thermophilic bacterial proteases from the M4 family or other metalloproteinases, such as those from the M5, M7, or M8 families.
[0292] The term "subtilisinase" refers to a subgroup of serine proteases according to Siezen et al., Protein Engineering, 4(1991) 719-737 and Siezen et al., Protein Science, 6(1997) 501-523. Serine proteases are a subgroup of proteases characterized by the presence of a serine residue at its active site that forms a covalent adduct with the substrate. Subtilisins can be classified into six subclasses: the subtilisin family, the thermophilic protease family, the proteinase K family, the lanathionine antibiotic peptidase family, the Kexin family, and the Pyrolysin family.
[0293] Examples of subtilisin enzymes are those derived from the genus Bacillus, such as Bacillus lentus, Bacillus alkalophilus, Bacillus subtilis, Bacillus amyloliquefaciens, Bacillus pumilus, and Bacillus gibsonii as described in US 7262042 and WO 09 / 021867; and subtilisin lentus, subtilisin Novo, subtilisin Carlsberg, Bacillus licheniformis, subtilisin BPN', subtilisin 309, subtilisin 147, and subtilisin 168 as described in WO 89 / 06279, and protease PD138 as described in (WO 93 / 18140). Other useful proteases may be those described in WO 92 / 175177, WO 01 / 016285, WO 02 / 026024, and WO 02 / 016547. Examples of trypsin-like proteases are trypsins (e.g., those of porcine or bovine origin) and Fusarium proteases (described in WO 89 / 06270, WO 94 / 25583, and WO 05 / 040372), as well as chymotrypsins derived from the genus Cellumonas (described in WO 05 / 052161 and WO 05 / 052146).
[0294] Further preferred proteases are alkaline proteases from Bacillus tarda DSM 5483 (as described in, for example, WO95 / 23221), and their variants (described in WO 92 / 21760, WO 95 / 23221, EP 1921147 and EP 1921148).
[0295] Examples of metalloproteinases are neutral metalloproteinases as described in WO 07 / 044993 (Genetronics International), such as those derived from Bacillus amyloliquefaciens.
[0296] Examples of useful proteases are the variants described in the following: WO 92 / 19729, WO 96 / 034946, WO98 / 20115, WO 98 / 20116, WO 99 / 011768, WO 01 / 44452, WO 03 / 006602, WO 04 / 03186, WO 04 / 041979, WO 07 / 006305, WO 11 / 036263, WO 11 / 036264, especially with a variant that has a substitution in one or more of the following positions: 3, 4, 9, 15, 27, 36, 57, 68, 76, 87, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 106, 118, 120, 123, 128, 129, 130, 160, 167, 170, 194, 195, 199, 205, 206, 217, 218, 222, 224, 232, 235, 236, 245, 248, 252 and 274, numbered using BPN'. More preferred protease variants may include the following mutations: S3T, V4I, S9R, A15T, K27R, *36D, V68A, N76D, N87S,R, *97E, A98S, S99G,D,A, S99AD, S101G,M,R S103A, V104I,Y,N, S106A, G118V,R, H120D,N, N123S, S128L, P129Q, S130A, G160D, Y167A, R170S, A194P, G195E, V199M, V205I, L217D, N218D, M222S, A232V, K235L, Q236H, Q245R, N252K, T274A (numbered using BPN').
[0297] Suitable commercially available proteases include those sold under the following trade names: Duralase TM Durazym TM , Ultra Ultra Ultra Ultra and (Novozymes), those sold under the following product names: Purafect Preferenz TM Purafect Purafect Purafect Effectenz TM , as well as (Danisco / DuPont), Axapem TM (Gist-Brocases NV), BLAP (sequence shown in Figure 29 of US5352604) and its variants (Henkel AG) and KAP (Bacillus subtilis protease) from Kao Corporation.
[0298] Lipase Suitable lipases include those from animal, plant, or microbial sources. Particularly suitable lipases include those from bacterial or fungal sources. This includes chemically modified or protein-engineered variants. Examples of useful lipases include those from the genus *Pyrophyllus* (synonymous with *Thermophyllus*), such as those from *Pyrophyllus latiflorus* (*Thermophyllus latiflorus*) as described in EP 258 068 and EP 305 216, or those from specific *Pyrophyllus* as described in WO 96 / 13580; *Pseudomonas* lipases, such as those from *Pseudomonas alkaloidus* or *Pseudomonas alkaloidus* (EP 218 272), *Pseudomonas cepacia* (EP 331376), *Pseudomonas schrenckii* (GB 1,372,034), *Pseudomonas fluorescens*, *Pseudomonas* species strain SD 705 (WO 95 / 06720 and WO 96 / 27002), and *Pseudomonas wisconsinii* (WO 96 / 12012); and *Bacillus* lipases, such as those from *Bacillus subtilis* (Dartois et al., 1993, Biochemica et al.). Biophysica Acta [Acta Biochimica et Biophysica Sinica], 1131:253-360), Bacillus stearothermophilus (JP 64 / 744992) or Bacillus pumilus (WO 91 / 16422).
[0299] Other examples are lipase variants, such as those described in WO 92 / 05249, WO 94 / 01541, EP 407 225, EP 260105, WO 95 / 35381, WO 96 / 00292, WO 95 / 30744, WO 94 / 25578, WO 95 / 14783, WO 95 / 22615, WO 97 / 04079, and WO 97 / 07202.
[0300] Preferred commercially available lipases include Lipolase TM Lipolase Ultra TM and Lipex TM (Novozymes)
[0301] amylase:Suitable amylases that can be used with the mannanase of the present invention can be α-amylases or glucosylamylases and can be of bacterial or fungal origin. This includes chemically modified or protein-engineered variants. Amylases include, for example, α-amylases obtained from specific strains of Bacillus, such as Bacillus licheniformis (described in more detail in GB 1,296,839). Suitable amylases include the amylase having SEQ ID NO:3 in WO 95 / 10603 or a variant thereof having 90% sequence identity with SEQ ID NO:3. Preferred variants are described in SEQ ID NO:4 of WO 94 / 02597, WO 94 / 18314, WO 97 / 43424 and WO 99 / 019467, such as variants having substitutions in one or more of the following positions: 15, 23, 105, 106, 124, 128, 133, 154, 156, 178, 179, 181, 188, 190, 197, 201, 202, 207, 208, 209, 211, 243, 264, 304, 305, 391, 408 and 444. Different suitable amylases include the amylase having SEQ ID NO:6 of WO 02 / 010355 or a variant thereof having 90% sequence identity with SEQ ID NO:6. Preferred variants of SEQ ID NO:6 are those with deletions at positions 181 and 182 and substitutions at position 193. Other suitable amylases are hybrid α-amylases comprising residues 1-33 of the α-amylase derived from *Bacillus amyloliquefaciens* shown in SEQ ID NO:6 of WO 2006 / 066594 and residues 36-483 of the α-amylase from *Bacillus licheniformis* shown in SEQ ID NO:4 of WO 2006 / 066594, or variants thereof having 90% sequence identity. Preferred variants of such hybrid α-amylases are those with substitutions, deletions, or insertions at one or more of the following positions: G48, T49, G107, H156, A181, N190, M197, I201, A209, and Q264. The most preferred variant of the hybrid α-amylase containing residues 1-33 of the α-amylase derived from Bacillus amyloliquefaciens as shown in SEQ ID NO:6 of WO 2006 / 066594 and residues 36-483 of SEQ ID NO:4 is those having the following substitutions:
[0302] M197T;
[0303] H156Y+A181T+N190F+A209V+Q264S; or
[0304] G48A+T49I+G107A+H156Y+A181T+N190F+I201F+A209V+Q264S。
[0305] Other suitable amylases are those having SEQ ID NO:6 in WO 99 / 019467 or variants thereof having 90% sequence identity with SEQ ID NO:6. Preferred variants of SEQ ID NO:6 are those having substitutions, deletions, or insertions at one or more of the following positions: R181, G182, H183, G184, N195, I206, E212, E216, and K269. Particularly preferred amylases are those having deletions at positions R181 and G182, or positions H183 and G184. Other amylases that can be used are those having SEQ ID NO:1, SEQ ID NO:3, SEQ ID NO:2, or SEQ ID NO:7 in WO 96 / 023873 or variants thereof having 90% sequence identity with SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, or SEQ ID NO:7. Preferred variants of SEQ ID NO:1, SEQ ID NO:2, SEQ ID NO:3, or SEQ ID NO:7 are those with substitution, deletion, or insertion at one or more of the following positions: 140, 181, 182, 183, 184, 195, 206, 212, 243, 260, 269, 304, and 476. More preferred variants are those with deletion at positions 181 and 182 or positions 183 and 184. The most preferred amylase variant of SEQ ID NO:1, SEQ ID NO:2, or SEQ ID NO:7 is those with deletion at positions 183 and 184 and substitution at one or more of positions 140, 195, 206, 243, 260, 304, and 476. Other amylases that can be used are SEQ ID NO:2 of WO 08 / 153815, SEQ ID NO:10 of WO 01 / 66712, or variants thereof that have 90% sequence identity with SEQ ID NO:2 of WO 08 / 153815 or 90% sequence identity with SEQ ID NO:10 of WO 01 / 66712. Preferred variants of SEQ ID NO:10 of WO 01 / 66712 are those with substitutions, deletions, or insertions at one or more of the following positions: 176, 177, 178, 179, 190, 201, 207, 211, and 264. Another suitable amylase is SEQ ID NO:2 of WO 09 / 061380 or a variant thereof that has 90% sequence identity with SEQ ID NO:2.Preferred variants of SEQ ID NO:2 are those having a C-terminal truncation and / or substitution, deletion, or insertion in one or more of the following positions: Q87, Q98, S125, N128, T131, T165, K178, R180, S181, T182, G183, M201, F202, N225, S243, N272, N282, Y305, R309, D319, Q320, Q359, K444, and G475. More preferred variants of SEQ ID NO:2 are those having substitutions in one or more of the following positions: Q87E,R, Q98R, S125A, N128C, T131I, T165I, K178L, T182G, M201L, F202Y, N225E,R, N272E,R, S243Q,A,E,D, Y305R, R309A, Q320R, Q359E, K444E, and G475K, and / or those having deletions in positions R180 and / or S181 or T182 and / or G183. The most preferred amylase variants of SEQ ID NO:2 are those having the following substitutions:
[0306] N128C+K178L+T182G+Y305R+G475K;
[0307] N128C+K178L+T182G+F202Y+Y305R+D319T+G475K;
[0308] S125A+N128C+K178L+T182G+Y305R+G475K; or
[0309] S125A+N128C+T131I+T165I+K178L+T182G+Y305R+G475K, wherein the variant is C-terminally truncated and optionally further includes a substitution at position 243 and / or a deletion at positions 180 and / or 181. Other suitable amylases are α-amylases having SEQ ID NO:12 in WO 01 / 66712 or variants having at least 90% sequence identity with SEQ ID NO:12. Preferred amylase variants are those with substitutions, deletions, or insertions at one or more of the following positions in SEQ ID NO:12 in WO 01 / 66712: R28, R118, N174; R181, G182, D183, G184, G186, W189, N195, M202, Y298, N299, K302, S303, N306, R310, N314; R320, H324, E345, Y396, R400, W439, R444, N445, K446, Q449, R458, N471, N484. Particularly preferred amylases include variants having deletions of D183 and G184 and having substitutions for R118K, N195F, R320K, and R458K, as well as variants having additional substitutions at one or more positions selected from the group consisting of M9, G149, G182, G186, M202, T257, Y295, N299, M323, E345, and A339, with variants having additional substitutions at all of these positions being most preferred. Other examples are amylase variants, such as those described in WO 2011 / 098531, WO 2013 / 001078, and WO 2013 / 001087. Commercially available amylases include Duramyl. TM Termonyl TM Fungaly TM Stainzyme TM Stainzyme Plus TM Natalase TM Liquozyme X and BAN TM (From Novozymes) and Rapidase TM Purastar TM / Effectenz TM Powerase and Preferenz S100 (from Genentech International / DuPont).
[0310] Peroxidase / oxidase:Suitable peroxidases / oxidases include those of plant, bacterial, or fungal origin. This includes chemically modified or protein-engineered variants. Examples of useful peroxidases include peroxidases from the genus *Coprinus*, such as those from *Coprinus spp.*, and their variants, such as those described in WO 93 / 24618, WO 95 / 10602, and WO 98 / 15257.
[0311] Lechinase / β-glucanase Suitable lechinase include those of bacterial or fungal origin. They can be chemically modified or protein engineered. Examples of useful β-glucanases include those described in WO 2015 / 144824 (Novozymes) and WO 99 / 06516 (Henkel KGAA).
[0312] Commercially available peroxidases include Guardzyme TM (Novozymes)
[0313] One or more detergent enzymes can be incorporated into a detergent composition by adding a single additive containing one or more enzymes, or by adding a combination of additives containing all of these enzymes. The detergent additives of the present invention, i.e., single or combined additives, can be formulated into, for example, granules, liquids, slurries, etc. Preferred detergent additive formulations are granules, particularly dust-free granules as described above; liquids, particularly stabilized liquids; or slurries.
[0314] surfactants
[0315] Typically, the detergent composition comprises (by weight of the composition) one or more surfactants in the following ranges: 0% to 50%, preferably from 2% to 40%, more preferably from 5% to 35%, more preferably from 7% to 30%, most preferably from 10% to 25%, and even more preferably from 15% to 20%. In a preferred embodiment, the detergent is a liquid or powder detergent comprising less than 40%, preferably less than 30%, more preferably less than 25%, and even more preferably less than 20% of surfactant by weight. The composition may contain 1% to 15%, preferably from 2% to 12%, 3% to 10%, most preferably 4% to 8%, and even more preferably 4% to 6% of one or more surfactants. Preferred surfactants are anionic surfactants, nonionic surfactants, cationic surfactants, amphoteric surfactants, amphoteric surfactants, or mixtures thereof. Preferably, the main component of the surfactant is anionic. Suitable anionic surfactants are well known in the art and may include fatty acid carboxylates (soap), branched, linear, and random-chain alkyl sulfates or fatty alcohol sulfates or primary alcohol sulfates or alkylbenzene sulfonates (e.g., LAS and LAB) or phenylalkane sulfonates or alkenyl sulfonates or alkenylbenzene sulfonates or alkyl ethoxy sulfates or fatty alcohol ether sulfates or α-olefin sulfonates or dodecenyl / tetradecnyl succinic acid. Anionic surfactants may be alkoxylated. The detergent composition may also contain from 1 wt% to 10 wt% of a nonionic surfactant, preferably from 2 wt% to 8 wt%, more preferably from 3 wt% to 7 wt%, and even more preferably less than 5 wt% of a nonionic surfactant. Suitable nonionic surfactants are well known in the art and may include alcohol ethoxylates, and / or alkyl ethoxylates, and / or alkylphenol ethoxylates, and / or glucamides (e.g., fatty acid N-glucosyl N-methylamide), and / or alkyl polyglucosides and / or mono- or diethanolamides or fatty acid amides. The detergent composition may also contain from 0 wt% to 10 wt% of a cationic surfactant, preferably from 0.1 wt% to 8 wt%, more preferably from 0.5 wt% to 7 wt%, and even more preferably less than 5 wt% of a cationic surfactant. Suitable cationic surfactants are well known in the art and may include alkyl quaternary ammonium compounds, and / or alkyl pyridinium compounds and / or alkyl quaternary phosphonium compounds and / or alkyl trithionium compounds. The composition preferably includes a surfactant in an amount of 100 ppm to 5,000 ppm that provides surfactant to the washing liquid during washing. The composition typically forms a washing liquid upon contact with water, containing 0.5 g / L to 10 g / L of the detergent composition.Many suitable surfactant compounds are available and well described in the literature, for example by Schwartz, Perry and Berch in “Surface-Active Agents and Detergents”, Volume I and Volume 11.
[0316] builder
[0317] The primary function of detergent builders is to chelate divalent metal ions (such as calcium and magnesium ions) from the washing solution, which would otherwise negatively interact with the surfactant system. Builders also effectively remove metal ions and inorganic contaminants from the fabric surface, thereby improving the removal of particulate and beverage stains. Builders are also a source of alkalinity and buffer the pH of the wash water to a level between 9.5 and 11. This buffering capacity is also called reserve alkalinity and should preferably be greater than 4.
[0318] The detergent compositions of the present invention may comprise one or more detergent builders or builder systems. Many suitable builder systems are described in the literature, for example in Powdered Detergents, Surfactant Science Series, Volume 71, Marcel Dekker, Inc. The builder may comprise from 0% to 60%, preferably from 5% to 45%, more preferably from 10% to 40%, most preferably from 15% to 35%, and even more preferably from 20% to 30% of the subject composition by weight. The composition may contain from 0% to 15%, preferably from 1% to 12%, 2% to 10%, most preferably from 3% to 8%, and even most preferably from 4% to 6% of the builder by weight.
[0319] Builders include, but are not limited to, alkali metal salts, ammonium salts, and alkanol ammonium salts of polyphosphates (e.g., STPP tripolyphosphate), alkali metal silicates, alkaline earth metal salts, and alkali metal carbonates, aluminosilicate builders (e.g., zeolites), and polycarboxylic acid compounds, ether hydroxy polycarboxylic acid esters, copolymers of maleic anhydride with ethylene or vinyl methyl ether, 1,3,5-trihydroxybenzene-2,4,6-trisulfonic acid, and carboxymethoxysuccinic acid, various alkali metal salts, ammonium salts, and substituted ammonium salts of polyacetic acid (such as ethylenediaminetetraacetic acid and hypozoxytriacetic acid), together with polycarboxylic acid esters such as benzohexacarboxylic acid, succinic acid, citric acid, oxydisuccinic acid, polymaleic acid, phenyl 1,3,5-tricarboxylic acid, carboxymethoxysuccinic acid, and their soluble salts. Ethanolamines (MEA, DEA, and TEA) can also contribute to the buffering capacity of liquid detergents.
[0320] bleach
[0321] The detergent compositions of the present invention may include one or more bleaching agents. Specifically, powdered detergents may include one or more bleaching agents. Suitable bleaching agents include other light bleaching agents, pre-formed peracids, hydrogen peroxide sources, bleaching activators, hydrogen peroxide, bleaching catalysts, and mixtures thereof. Typically, when using a single bleaching agent, the compositions of the present invention may include from about 0.1% to about 50% or even from about 0.1% to about 25% by weight of the subject cleaning composition. Examples of suitable bleaching agents include:
[0322] (1) Other photobleaching agents, such as vitamin K3;
[0323] (2) Preformed peracids: Suitable preformed peracids include, but are not limited to, compounds selected from the group consisting of: peroxycarboxylic acids and salts, percarbonic acids and salts, perimidic acids and salts, peroxymonosulfate and salts (e.g., potassium persulfate (Oxone) and mixtures thereof). Suitable peroxycarboxylic acids include hydrophobic and hydrophilic peracids having the chemical formula R-(C=O)OOM, wherein R is an alkyl group (optionally branched), and when the peracid is hydrophobic, it has 6 to 14 carbon atoms or 8 to 12 carbon atoms, and when the peracid is hydrophilic, it has fewer than 6 carbon atoms or even fewer than 4 carbon atoms; and M is a counterion, such as sodium, potassium, or hydrogen.
[0324] (3) Hydrogen peroxide sources, such as inorganic hydrogen peroxide salts, including alkali metal salts such as perborates (typically monohydrates or tetrahydrates), percarbonates, persulfates, superphosphates, sodium salts of persilicates, and mixtures thereof. In one aspect of the invention, the inorganic hydrogen peroxide salt is selected from the group consisting of perborates, sodium salts of percarbonates, and mixtures thereof. When used, the inorganic hydrogen peroxide salt is typically present in an amount from 0.05 wt% to 40 wt% or 1 wt% to 30 wt% of the total composition and is typically incorporated into such compositions as a crystalline solid that can be coated. Suitable coatings include inorganic salts, such as alkali metal silicates, carbonates, or borates, or mixtures thereof, or organic materials, such as water-soluble or water-dispersible polymers, waxes, oils, or fatty soaps. Useful bleaching compositions are described in U.S. Patent Nos. 5,576,282 and 6,306,812;
[0325] (4) A bleaching activator having R-(C=O)-L, wherein R is an alkyl group (optionally branched), having from 6 to 14 carbon atoms or from 8 to 12 carbon atoms when the bleaching activator is hydrophobic, and having fewer than 6 carbon atoms or even fewer than 4 carbon atoms when the bleaching activator is hydrophilic; and L is a leaving group. Examples of suitable leaving groups are benzoic acid and its derivatives—especially benzenesulfonates. Suitable bleaching activators include dodecanoyl oxybenzene sulfonate, decanoyl oxybenzene sulfonate, decanoyl oxybenzoic acid or its salts, 3,5,5-trimethylhexanoyl oxybenzene sulfonate, tetraacetylethylenediamine (TAED), and nonanoyl oxybenzene sulfonate (NOBS). Suitable bleaching activators are also disclosed in WO 98 / 17767. Although any suitable bleaching activator can be used, in one aspect of the invention, the subject cleaning composition may include NOBS, TAED, or a mixture thereof; and
[0326] (5) Bleaching catalysts capable of accepting oxygen atoms from peroxyacids and transferring those oxygen atoms to oxidizable substrates are described in WO 2008 / 007319. Suitable bleaching catalysts include, but are not limited to: iminium cationic and polyionic; iminium zwitterionic; modified amines; modified amine oxides; N-sulfonylimides; N-phosphonylimides; N-acylimides; thiadiazole dioxide; perfluoroimides; cyclic glycoketones and mixtures thereof. The bleaching catalyst will typically be included in the detergent composition at levels ranging from 0.0005% to 0.2%, from 0.001% to 0.1%, or even from 0.005% to 0.05% by weight.
[0327] When present, the peracid and / or bleaching activator are typically present in the composition in amounts from about 0.1 wt% to about 60 wt%, from about 0.5 wt% to about 40 wt%, or even from about 0.6 wt% to about 10 wt%. One or more hydrophobic peracids or their precursors may be used in combination with one or more hydrophilic peracids or their precursors.
[0328] The amounts of hydrogen peroxide source and peracid or bleaching activator can be selected such that the molar ratio of available oxygen (from the peroxide source) to peracid is from 1:1 to 35:1, or even 2:1 to 10:1.
[0329] auxiliary materials
[0330] Dispersant - The detergent compositions of the present invention may also contain a dispersant. Specifically, powdered detergents may contain a dispersant. Suitable water-soluble organic materials include homopolymerized or copolymerized acids or salts thereof, wherein the polycarboxylic acid comprises at least two carboxyl groups separated from each other by no more than two carbon atoms.
[0331] Dye transfer inhibitors – The detergent compositions of the present invention may further include one or more dye transfer inhibitors. Suitable polymeric dye transfer inhibitors include, but are not limited to, polyvinylpyrrolidone polymers, polyamine N-oxide polymers, copolymers of N-vinylpyrrolidone and N-vinylimidazole, polyvinyloxazolidinone, and polyvinylimidazole or mixtures thereof. When present in the subject composition, the dye transfer inhibitor may be present at a level from about 0.0001% to about 10%, from about 0.01% to about 5%, or even from about 0.1% to about 3% by weight of the composition.
[0332] Fluorescent brighteners – The detergent compositions of the present invention will also preferably contain additional components that can color the items being cleaned, such as fluorescent brighteners or optical brighteners. Any fluorescent brightener suitable for use in laundry detergent compositions may be used in the compositions of the present invention. The most commonly used fluorescent brighteners are those belonging to the following categories: diaminostilbene-sulfonic acid derivatives, diarylpyrazoline derivatives, and diphenyl-bistyrene derivatives.
[0333] Preferred optical brighteners are Tinopal DMS and Tinopal CBS, available from Ciba-Geigy AG (Basel, Switzerland). Tinopal DMS is the disodium salt of 4,4'-bis-(2-morpholino-4-anilino-s-triazine-6-ylamino)stilbene disulfonate. Tinopal CBS is the disodium salt of 2,2'-bis-(phenyl-styryl)disulfonate.
[0334] Another preferred option is the commercially available Parawhite KX fluorescent whitening agent, supplied by Paramount Minerals and Chemicals in Mumbai, India.
[0335] Other fluorescent agents suitable for use in this invention include 1-3-diarylpyrazoline and 7-aminoalkylcoumarin.
[0336] Suitable levels of fluorescent brighteners range from a low level of about 0.01 wt%, from 0.05 wt%, from about 0.1 wt%, or even from a low level of about 0.2 wt% to a high level of 0.5 wt% or even 0.75 wt%.
[0337] Fabric colorants – The detergent compositions of the present invention may further include fabric colorants, such as dyes or pigments that, when formulated in the detergent composition, can be deposited on the fabric upon contact with a washing liquid comprising the detergent composition, thereby altering the color of the fabric through visible light absorption. Fluorescent whitening agents emit at least some visible light. In contrast, fabric colorants alter the color of a surface when they absorb at least a portion of the visible spectrum. Suitable fabric colorants include dyes and dye-clay conjugates, and may also include pigments. Suitable dyes include small molecule dyes and polymer dyes. Suitable small molecule dyes include those selected from the group consisting of dyes falling under the ColourIndex (CI) classification: Direct Blue, Direct Red, Direct Violet, Acid Blue, Acid Red, Acid Violet, Basic Blue, Basic Violet, and Basic Red, or mixtures thereof, as described, for example, in WO 2005 / 03274, WO 2005 / 03275, WO 2005 / 03276, and EP 1 876 226. The detergent composition preferably contains from about 0.00003 wt% to about 0.2 wt%, from about 0.00008 wt% to about 0.05 wt%, or even from about 0.0001 wt% to about 0.04 wt% of a fabric toner. The composition may contain from 0.0001 wt% to 0.2 wt% of a fabric toner, which may be particularly preferred when the composition is in the form of a unit-dose packet.
[0338] Soil-releasing polymers – The detergent compositions of the present invention may also include one or more soil-releasing polymers that help remove dirt from fabrics, such as cotton and polyester-based fabrics, particularly hydrophobic dirt from polyester-based fabrics. Soil-releasing polymers may be, for example, polymers based on nonionic or anionic terephthalic acid, polyvinylcaprolactam and related copolymers, vinyl graft copolymers, polyester polyamides, see, for example, Powdered Detergents, Surfactant Science Series, Volume 71, Chapter 7, Marcel Dekker, Inc. Another type of soil-releasing polymer is an amphiphilic alkoxylated oil stain cleaning polymer comprising a core structure and a plurality of alkoxylated groups attached to the core structure. The core structure may comprise a polyolefin imine structure or a polyalkanolamine structure as described in detail in WO 2009 / 087523. Furthermore, any graft copolymer is a suitable soil-releasing polymer. Suitable graft copolymers are described in more detail in WO 2007 / 138054, WO 2006 / 108856, and WO 2006 / 113314. Other fouling-releasing polymers are substituted polysaccharide structures, especially substituted cellulose structures, such as modified cellulose derivatives, as described in EP 1 867 808 or WO 2003 / 040279. Suitable cellulose polymers include cellulose, cellulose ethers, cellulose esters, cellulose amides, and mixtures thereof. Suitable cellulose polymers include anionic modified cellulose, nonionic modified cellulose, cationic modified cellulose, zwitterionic modified cellulose, and mixtures thereof. Suitable cellulose polymers include methylcellulose, carboxymethylcellulose, ethylcellulose, hydroxyethylcellulose, hydroxypropyl methylcellulose, ester carboxymethylcellulose, and mixtures thereof.
[0339] Anti-redeposition agent - The detergent compositions of the present invention may further include one or more anti-redeposition agents, such as carboxymethyl cellulose (CMC), polyvinyl alcohol (PVA), polyvinylpyrrolidone (PVP), polyethylene oxide and / or polyethylene glycol (PEG), homopolymers of acrylic acid, copolymers of acrylic acid and maleic acid, and ethoxylated polyethyleneimine. The cellulose-based polymers described above under the category of dirt-releasing polymers may also function as anti-redeposition agents.
[0340] Other suitable auxiliary materials include, but are not limited to, anti-shrinkage agents, anti-wrinkle agents, bactericides, adhesives, carriers, dyes, enzyme stabilizers, fabric softeners, fillers, foam regulators, water-soluble additives, fragrances, pigments, defoamers, solvents, structurants and / or structural elastics for liquid detergents.
[0341] In one aspect, the detergent is a compressed liquid laundry detergent composition comprising: a) at least about 10%, preferably from 20% to 80% by weight of the composition, a surfactant selected from anionic surfactants, nonionic surfactants, soaps, and mixtures thereof; b) from about 1% to about 30%, preferably from 5% to 30% by weight of the composition, a non-amino functional solvent from about 1% to about 15%, preferably from 3% to 10% by weight of the composition; and d) from about 5% to about 20% by weight of the composition. The performance additives are selected from chelating agents, dirt-releasing polymers, enzymes, and mixtures thereof; wherein the compressed liquid laundry detergent composition comprises at least one of the following: (i) the surfactant having an anionic surfactant to nonionic surfactant weight ratio from about 1.5:1 to about 5:1, the surfactant comprising from about 15% to about 40% anionic surfactant and from about 5% to about 40% soap by weight of the composition; (ii) from about 0.1% to about 10% foaming agent by weight of the composition, selected from foaming polymers, cationic surfactants, facultative zwitterionic surfactants, amine oxide surfactants, amphoteric surfactants, and mixtures thereof; and (ii) both of (i) and (ii). All components are described in WO 2007 / 130562. Additional polymers that may be used in these detergent formulations are described in WO 2007 / 149806.
[0342] In another aspect, the detergent is a compressed granular (powdered) detergent comprising: a) at least about 10%, preferably from 15% to 60% by weight of the composition, of a surfactant selected from anionic surfactants, nonionic surfactants, soaps, and mixtures thereof; b) from about 10% to 80%, preferably from 20% to 60% by weight of the composition, wherein the detergent may be a mixture selected from: i) phosphate detergents, preferably less than 20%, more preferably less than 10%, and even more preferably less than 5% of the total detergent being phosphate detergents; ii) zeolite detergents, preferably less than 20%, more preferably less than 10%, and even more preferably less than 5% of the total detergent being zeolite detergents. iii) citrate, preferably 0 to 5% of the total detergent builder is citrate detergent builder; iv) polycarboxylate, preferably 0 to 5% of the total detergent builder is polycarboxylate detergent builder; v) carbonate, preferably 0 to 30% of the total detergent builder is carbonate detergent builder; and vi) sodium silicate, preferably 0 to 20% of the total detergent builder is sodium silicate detergent builder; c) from about 0 to 25% of filler, such as sulfate, preferably from 1% to 15%, more preferably from 2% to 10%, more preferably from 3% to 5% of filler, by weight of the composition; and d) from about 0.1% to 20% of enzyme, preferably from 1% to 15%, more preferably from 2% to 10% of enzyme, by weight of the composition.
[0343] For detergent formulators, the dirt and stains that are important are composed of many different substances, and a range of different enzymes with varying substrate specificities have been developed for use in both cleaning of clothing and hard surfaces (e.g., dishwashing). These enzymes are believed to provide the benefits of enzymatic washing because they specifically improve stain removal during the cleaning process in which they are applied, compared to the same process without enzymes. Cleaning enzymes known in the art include, for example, glycosylases, amylases, proteases, lipases, cellulases, hemicellulases, xylanases, keratinases, and pectinases.
[0344] In a preferred aspect of the invention, the mannanase of the present invention can be combined with at least two enzymes. These additional enzymes are described in detail in the "Other Enzymes" section, more preferably at least three, four, or five enzymes. Preferably, these enzymes have different substrate specificities, such as carbohydrate-degrading activity, proteolytic activity, starch-degrading activity, lipolytic activity, hemicellulose-degrading activity, or pectin-degrading activity. The enzyme combination can be, for example, the mannanase of the present invention with another detergency enzyme, such as the mannanase of the present invention with a protease, the mannanase of the present invention with a serine protease, the mannanase of the present invention with an amylase, the mannanase of the present invention with a cellulase, the mannanase of the present invention with a lipase, the mannanase of the present invention with a keratinase, the mannanase of the present invention with a pectinase, or the mannanase of the present invention with an anti-redeposition enzyme. More preferably, the mannanase of the present invention is combined with at least two other cleaning enzymes, such as the mannanase, lipase, and amylase of the present invention; or the mannanase, protease, and amylase of the present invention; or the mannanase, protease, and lipase of the present invention; or the mannanase, protease, and pectinase of the present invention; or the mannanase, protease, and cellulase of the present invention; or the mannanase, protease, and hemicellulase of the present invention; or the mannanase, protease, and keratinase of the present invention; or the mannanase, amylase, and pectinase of the present invention; or the mannanase, amylase, and keratinase of the present invention; or the mannanase, amylase, and cellulase of the present invention; or the mannanase, amylase, and hemicellulase of the present invention; or the mannanase, lipase, and pectinase of the present invention; or the mannanase, lipase, and keratinase of the present invention; or the mannanase, lipase, and cellulase of the present invention; or the mannanase, lipase, and hemicellulase of the present invention. Even more preferably, the mannanase of the present invention can be combined with at least three other cleaning enzymes, such as the mannanase, protease, lipase and amylase of the present invention; or the mannanase, protease, amylase and pectinase of the present invention; or the mannanase, protease, amylase and keratinase of the present invention; or the mannanase, protease, amylase and cellulase of the present invention; or the mannanase, protease, amylase and hemicellulase of the present invention; or the mannanase, amylase, lipase and pectinase of the present invention; or the mannanase, amylase, lipase and keratinase of the present invention; or the mannanase, amylase, lipase and cellulase of the present invention; or the mannanase, amylase, lipase and hemicellulase of the present invention; or the mannanase, protease, lipase and pectinase of the present invention; or the mannanase, protease, lipase and keratinase of the present invention; or the mannanase, protease, lipase and cellulase of the present invention; or the mannanase, protease and hemicellulase of the present invention.The mannanase according to the invention can be combined with any enzyme selected from a non-exhaustive list, which includes: carbohydrate enzymes (e.g., amylase), hemicellulase, pectinase, cellulase, xanthan gumase or amylopectinase, peptidase, protease or lipase.
[0345] In a preferred embodiment, the mannanase of the present invention is combined with a serine protease, such as an S8 family protease, e.g.
[0346] In another embodiment of the invention, the mannanase of the invention can be combined with one or more metalloproteinases, such as M4 metalloproteinase, including... Or thermophilic proteases. Such combinations may further include combinations of other detergent enzymes as outlined above.
[0347] This cleaning or textile care process can be, for example, a laundry process, a dishwashing process, or the cleaning of hard surfaces (e.g., bathroom tiles, floors, countertops, drains, sinks, and basins). The laundry process can be, for example, household laundry, but it can also be industrial laundry. Furthermore, the present invention relates to a method for washing fabrics and / or clothing, wherein the method comprises treating the fabric with a washing solution containing a detergent composition and at least one mannanase of the present invention. For example, the cleaning or textile care process can be carried out during machine cleaning or during manual washing. The washing solution can be, for example, an aqueous washing solution containing a detergent composition.
[0348] The washed and cleaned fabrics and / or garments, or the textile care process of the present invention, can be conventional washable garment washing, such as household washing. Preferably, the main part of the garment washing is garments and fabrics, including knitwear, woven fabrics, denim, non-woven fabrics, felt, yarn, and terry cloth. These fabrics can be cellulose-based, such as natural cellulose, including cotton, flax, linen, jute, ramie, sisal, or coconut fiber; or man-made cellulose (e.g., derived from wood pulp), including viscose / rayon, ramie, cellulose acetate fiber (tricell), lyocell fiber, or blends thereof. These fabrics can also be non-cellulose-based, such as natural polyamides, including wool, camel hair, cashmere, mohair, rabbit hair, and silk; or synthetic polymers, such as nylon, aromatic polyamides, polyester, acrylic, polypropylene, and spandex / elastic fibers; or blends thereof, as well as blends of cellulose-based and non-cellulose-based fibers. Examples of blends are blends of cotton and / or rayon / viscose fibers with one or more accompanying materials, such as wool, synthetic fibers (e.g., polyamide fibers, acrylic fibers, polyester fibers, polyvinyl alcohol fibers, polyvinyl chloride fibers, polyurethane fibers, polyurea fibers, aramid fibers), and cellulose-containing fibers (e.g., rayon / viscose fibers, ramie, flax, linen, jute, cellulose acetate fibers, lyocell fibers).
[0349] In recent years, there has been a growing interest in replacing components in detergents, stemming from the use of renewable biological components such as enzymes and peptides to replace petrochemicals without compromising washing performance. New enzymes are needed to achieve similar or improved washing performance compared to conventional detergent compositions when the composition alters the activity of new enzymes or when these new enzymes possess alternative and / or improved properties compared to commonly used detergent enzymes (such as proteases, lipases, and amylases).
[0350] A typical detergent composition includes a variety of components besides enzymes, each with a different function. Some components, like surfactants, reduce the surface tension of the detergent, allowing the stains being cleaned to be lifted and dispersed and subsequently washed away. Other components, such as bleaching systems, typically remove color through oxidation, and many bleaches also have strong bactericidal properties and are used for disinfection and sterilization. Still other components, such as builders and chelating agents, soften the wash water, for example, by removing metal ions from the liquid.
[0351] In one specific embodiment, the present invention relates to the use of a composition comprising the mannanase of the present invention in the washing of clothing or tableware, wherein the enzyme composition further comprises at least one or more of the following: surfactant, detergent builder, chelating agent or chelating reagent, bleaching system or bleaching component.
[0352] In a preferred embodiment of the invention, the amounts of surfactant, builder, chelating agent or chelating reagent, bleaching system and / or bleaching component are reduced compared to the amounts used without the addition of the mannanase of the invention. Preferably, at least one component of the surfactant, builder, chelating agent, bleaching system and / or bleaching component is present in an amount that is 1%, for example 2%, for example 3%, for example 4%, for example 5%, for example 6%, for example 7%, for example 8%, for example 9%, for example 10%, for example 15%, for example 20%, for example 25%, for example 30%, for example 35%, for example 40%, for example 45%, for example 50%, for example 45%, for example 50%, less than the amount of the component in a system without the addition of the mannanase of the invention (such as the conventional amount of such a component). In one aspect, the mannanase of the present invention is used in a detergent composition, wherein the composition does not contain at least one component, which is a surfactant, a detergent builder, a chelating agent or chelating reagent, a bleaching system or bleaching component and / or a polymer.
[0353] Washing method
[0354] The detergent compositions of the present invention are ideally suited for use in laundry applications. Therefore, the present invention includes a method for washing fabrics. This method includes the step of contacting a fabric to be washed with a cleaning laundry solution comprising the detergent composition according to the present invention. The fabric may include any fabric that can be washed under normal consumer use conditions. The solution preferably has a pH from about 5.5 to about 8. These compositions can be used in the solution at concentrations from about 100 ppm, preferably 500 ppm to about 15,000 ppm. The water temperature typically ranges from about 5°C to about 90°C, including about 10°C, about 15°C, about 20°C, about 25°C, about 30°C, about 35°C, about 40°C, about 45°C, about 50°C, about 55°C, about 60°C, about 65°C, about 70°C, about 75°C, about 80°C, about 85°C, and about 90°C. The water-to-fabric ratio typically ranges from about 1:1 to about 30:1.
[0355] In specific embodiments, the washing method is performed at a pH ranging from about 5.0 to about 11.5, or in alternative embodiments, even at a pH ranging from about 6 to about 10.5, such as about 5 to about 11, about 5 to about 10, about 5 to about 9, about 5 to about 8, about 5 to about 7, about 5.5 to about 11, about 5.5 to about 10, about 5.5 to about 9, about 5.5 to about 8, about 5.5 to about 7, about 6 to about 11, about 6 to about 10, about 6 to about 9, about 6 to about 8, about 6 to about 7, about 6.5 to about 11, about 6.5 to about 10, about 6.5 to about 9, about 6.5 to about 8, about 6.5 to about 7, about 7 to about 11, about 7 to about 10, about 7 to about 9, or about 7 to about 8, preferably about 5.5 to about 9, and more preferably about 6 to about 8.
[0356] In a specific embodiment, the washing method is performed at the following hardness levels: from about 0°dH to about 30°dH, for example, about 1°dH, about 2°dH, about 3°dH, about 4°dH, about 5°dH, about 6°dH, about 7°dH, about 8°dH, about 9°dH, about 10°dH, about 11°dH, about 12°dH, about 13°dH, about 14°dH, about 15°dH, about 16°dH, about 17°dH, about 18°dH, about 19°dH, about 20°dH, about 21°dH, about 22°dH, about 23°dH, about 24°dH, about 25°dH, about 26°dH, about 27°dH, about 28°dH, about 29°dH, and about 30°dH. Under typical European washing conditions, the hardness is approximately 15°dH, under typical American washing conditions, it is approximately 6°dH, and under typical Asian washing conditions, it is approximately 3°dH.
[0357] This invention relates to a method for cleaning fabrics, tableware, or hard surfaces using a detergent composition containing the mannanase of this invention.
[0358] One preferred embodiment relates to a cleaning method comprising the step of contacting the object with a cleaning composition comprising the mannanase of the present invention under conditions suitable for cleaning the object. In one preferred embodiment, the cleaning composition is a detergent composition and the process is a laundry or dishwashing process.
[0359] Another embodiment relates to a method for removing stains from a fabric, the method comprising contacting the fabric with a composition comprising the mannanase of the present invention under conditions suitable for cleaning the object.
[0360] Low temperature applications
[0361] One embodiment of the present invention relates to a method for performing laundry, dishwashing, or industrial cleaning, the method comprising contacting a surface to be cleaned with the mannanase of the present invention, wherein the laundry, dishwashing, industrial, or institutional cleaning is performed at a temperature of about 40°C or lower. Another embodiment of the present invention relates to the use of mannanase in laundry, dishwashing, or cleaning processes, wherein the temperature in the laundry, dishwashing, or industrial cleaning is about 40°C or lower.
[0362] In another embodiment, the present invention relates to the use of mannanase according to the invention in a protein removal process, wherein the temperature during the protein removal process is about 40°C or below.
[0363] In each of the methods and uses defined above, the washing temperature is about 40°C or lower, for example, about 39°C or lower, for example, about 38°C or lower, for example, about 37°C or lower, for example, about 36°C or lower, for example, about 35°C or lower, for example, about 34°C or lower, for example, about 33°C or lower, for example, about 32°C or lower, for example, about 31°C or lower, for example, about 30°C or lower, for example, about 29°C or lower, for example, about 28°C or lower, for example, about 27°C or lower, for example, about 26°C or lower, for example, about 25°C or lower, for example, about 24°C or lower, for example, about 23°C or lower, for example, about 22°C. °C or lower, for example, about 21 °C or lower, for example, about 20 °C or lower, for example, about 19 °C or lower, for example, about 18 °C or lower, for example, about 17 °C or lower, for example, about 16 °C or lower, for example, about 15 °C or lower, for example, about 14 °C or lower, for example, about 13 °C or lower, for example, about 12 °C or lower, for example, about 11 °C or lower, for example, about 10 °C or lower, for example, about 9 °C or lower, for example, about 8 °C or lower, for example, about 7 °C or lower, for example, about 6 °C or lower, for example, about 5 °C or lower, for example, about 4 °C or lower, for example, about 3 °C or lower, for example, about 2 °C or lower, for example, about 1 °C or lower.
[0364] In another preferred embodiment, the washing temperature is in the range of about 5°C to 40°C, for example, about 5°C to 30°C, about 5°C to 20°C, about 5°C to 10°C, about 10°C to 40°C, about 10°C to 30°C, about 10°C to 20°C, about 15°C to 40°C, about 15°C to 30°C, about 15°C to 20°C, about 20°C to 40°C, about 20°C to 30°C, about 25°C to 40°C, about 25°C to 30°C, or about 30°C to 40°C. In a particularly preferred embodiment, the washing temperature is about 20°C, about 30°C, or about 40°C.
[0365] Animal feed and feed additives
[0366] This invention also relates to animal feeds and animal feed additives including the mannanase of this invention.
[0367] In one aspect, the animal feed or animal feed additive comprises a polypeptide of the first or second aspect and one or more components selected from a table of vitamins, minerals and amino acids.
[0368] In one aspect, the animal feed or animal feed additive comprises particles of aspect five or six and one or more components selected from a table of vitamins, minerals and amino acids.
[0369] In one aspect, the animal feed or animal feed additive comprises a liquid formulation of aspect seven or eight and one or more components selected from a table of vitamins, minerals and amino acids.
[0370] In one embodiment, the animal feed or animal feed additive further comprises one or more additional enzymes selected from the group consisting of: acetylxylan esterase, acylglycerol lipase, amylase, α-amylase, β-amylase, arabinofuranoside, cellobiase, cellulase, ferulic acid esterase, galactanase, α-galactosidase, β-galactosidase, β-glucanase, β-glucosidase, lysophospholipase, lysozyme, α-mannoside, β-mannoside (mannanase), phytase, phospholipase A1, phospholipase A2, phospholipase D, protease, amylopectinase, pectin esterase, triacylglycerol lipase, xylanase, β-xylosidase, or any combination thereof.
[0371] In one embodiment, the animal feed or animal feed additive contains one or more microorganisms selected from the group consisting of: Bacillus subtilis, Bacillus licheniformis, Bacillus amyloliquefaciens, Bacillus cereus, Bacillus pumilus, Bacillus polymyxa, Bacillus megaterium, Bacillus coagulans, Bacillus circumflex, Bifidobacterium bifidum, Bifidobacterium animalis, species of Bifidobacterium, species of Carnivora, Clostridium butyricum, species of Clostridium, Enterococcus faecalis, species of Enterococcus, species of Lactobacillus, Lactobacillus acidophilus, Lactobacillus sausageii, Lactobacillus rhamnosus, Lactobacillus reuteri, Lactobacillus salivarius, Lactococcus lactis, species of Lactococcus, species of Leuconostoc, Giant cellulococcus ehrlich, species of Giant cellulococcus, Pediococcus lactis, species of Pediococcus, Propionibacterium terbinafine, species of Propionibacterium, and species of Streptococcus, or any combination thereof.
[0372] application
[0373] The mannanase of this invention can be used in applications where the degradation of mannan is required. Examples of its use include the production of bioethanol from cork and palm kernel filter cake, its use in improving animal feed, and in the hydrolysis of coffee. Furthermore, guar gum is used in many food products and in the oil and gas industry, so the mannanase of this invention can be used in detergents to remove mannan-containing stains, in hydraulic fracturing to create subsurface fracturing extending from boreholes into rock formations, thereby increasing the rate at which fluids can be generated in the rock formation, or for cleaning borehole filter cake. Therefore, mannan can be used in the fracturing of subsurface formations created by boreholes, or mannan can be used as a component in borehole filter cake.
[0374] In one aspect, the polypeptide of the first or second aspect, the detergent composition of the third or fourth aspect, the particles of the fifth or sixth aspect, or the liquid formulation of the seventh or eighth aspect can be used for the degradation of mannans, such as linear mannans, galactomannans, glucomannans, and galactoglucomannans. In another aspect, the polypeptide of the first or second aspect, the detergent composition of the third or fourth aspect, the particles of the fifth or sixth aspect, or the liquid formulation of the seventh or eighth aspect can be used for the process of degrading mannans, such as linear mannans, galactomannans, glucomannans, and galactoglucomannans.
[0375] In one aspect, the polypeptide of the first or second aspect, the detergent composition of the third or fourth aspect, the particles of the fifth or sixth aspect, or the liquid formulation of the seventh or eighth aspect can be used to control the viscosity of drilling fluids. In one aspect, the polypeptide of the first or second aspect, the detergent composition of the third or fourth aspect, the particles of the fifth or sixth aspect, or the liquid formulation of the seventh or eighth aspect can be used to fracture subsurface formations created by a borehole.
[0376] The mannanase of the present invention can be used to prevent, reduce, or remove odors from articles. Therefore, in one embodiment, the polypeptide of the first or second aspect, the detergent composition of the third or fourth aspect, the granules of the fifth or sixth aspect, or the liquid formulation of the seventh or eighth aspect can be used to prevent, reduce, or remove odors from articles.
[0377] Use of the mannanase of the present invention in preventing, reducing or removing biofilms
[0378] Biofilms develop on textiles when microorganisms are present on the surface and adhere to it. Some microorganisms tend to adhere to the surface of items such as textiles. Some microorganisms adhere to such surfaces and form biofilms. Biofilms can be sticky, and the adhered microorganisms and / or biofilms can be difficult to remove. Furthermore, due to the sticky nature of biofilms, they adhere to dirt. Commercially available laundry detergent compositions do not remove such adhered microorganisms or biofilms.
[0379] This invention relates to the use of a polypeptide of the first or second aspect, a detergent composition of the third or fourth aspect, granules of the fifth or sixth aspect, or a liquid formulation of the seventh or eighth aspect for preventing, reducing, or removing biofilm from articles, wherein the polypeptide is derived from a fungal source, and wherein the article is a textile. In one embodiment, the polypeptide of the first or second aspect, the detergent composition of the third or fourth aspect, the granules of the fifth or sixth aspect, or the liquid formulation of the seventh or eighth aspect can be used to prevent, reduce, or remove stickiness from articles.
[0380] Uses of the mannanase of the present invention in food processing and animal feed
[0381] Several anti-nutritional factors can limit the use of certain plant materials in the preparation of animal feed and human food. For example, plant materials containing oligomannans (such as mannan, galactomannan, glucomannan, and galactoglucomannan) can reduce the digestibility and absorption of nutrient compounds (such as minerals, vitamins, sugars, and fats) by animals. Specifically, these negative effects are due to the high viscosity of mannan-containing polymers and their ability to absorb nutrient compounds. These effects can be mitigated by using enzymes that degrade mannan-containing polymers, namely endo-β-mannanases (such as the mannanases described herein), which allow for the inclusion of higher proportions of mannan-containing polymers from inexpensive plant materials in feed, thereby reducing feed costs. Therefore, through the activity of the mannanases of the present invention, mannan-containing polymers are broken down into simpler sugars that can be more easily assimilated to provide additional energy. Therefore, the present invention further relates to the use of the mannanases of the present invention in the processing and / or production of food or animal feed.
[0382] Therefore, the present invention relates to animal feed compositions and / or animal feed additive compositions and / or pet foods containing the mannanase of the present invention.
[0383] The present invention further relates to a method for preparing such animal feed compositions, and / or animal feed additive compositions and / or pet foods, the method comprising mixing the mannanase of the present invention with one or more animal feed ingredients and / or animal feed additive ingredients and / or pet food ingredients.
[0384] Furthermore, the present invention also relates to the use of the mannanase of the present invention in the preparation of animal feed compositions and / or animal feed additive compositions and / or pet foods.
[0385] The use of the mannanase of the present invention for degrading cellulosic materials and / or producing fermentation products.
[0386] Mannan can be used to degrade cellulose materials, to generate fermentation products, and to ferment cellulose materials. For example, in a method for generating fermentation products, the method includes: (a) saccharifying the cellulose material with an enzyme composition comprising a polypeptide of a first or second aspect, particles of a fifth or sixth aspect, or a liquid formulation of a seventh or eighth aspect; (b) fermenting the saccharified cellulose material with one or more fermenting microorganisms to generate fermentation products; and (c) recovering the fermentation products from the fermentation. The cellulose material can be pretreated prior to saccharification. In one embodiment, the enzyme composition comprises one or more enzymes selected from the group consisting of: cellulase, AA9 polypeptide, hemicellulase, esterase, patulin, lignin-degrading enzyme, oxidoreductase, pectinase, protease, and swelling agent.
[0387] In another embodiment, the present invention relates to a method for fermenting cellulosic materials, the method comprising: fermenting the cellulosic material with one or more fermenting microorganisms, wherein the cellulosic material is saccharified with an enzyme composition comprising a polypeptide of a first or second aspect, particles of a fifth or sixth aspect, or a liquid formulation of a seventh or eighth aspect. The cellulosic material may be pretreated prior to saccharification. In one embodiment, the enzyme composition comprises one or more enzymes selected from the group consisting of: cellulase, AA9 polypeptide, hemicellulase, esterase, patulin, lignin-degrading enzyme, oxidoreductase, pectinase, protease, and swelling agent.
[0388] Use of the mannanase of the present invention in fermented beverages
[0389] In one aspect, the present invention relates to a method for preparing fermented beverages such as beer or wine, the method comprising mixing a polypeptide of the first or second aspect, particles of the fifth or sixth aspect, or a liquid formulation of the seventh or eighth aspect, with malt and / or adjuvants.
[0390] Another aspect relates to a method of providing a fermented beverage, the method comprising the step of contacting mash and / or wort with a polypeptide of the first or second aspect, particles of the fifth or sixth aspect, or a liquid preparation of the seventh or eighth aspect.
[0391] In the context of this invention, the term "fermented beverage" is intended to include any beverage, such as wine or beer, produced by a method that includes a fermentation process, such as microbial, bacterial, and / or yeast fermentation.
[0392] In one aspect of the invention, the fermented beverage is beer. The term "beer" means any fermented wort produced by fermenting / brewing starchy plant material. Generally, beer is produced from malt or adjuncts, or any combination of malt and adjuncts, as starchy plant material. As used herein, the term "malt" is understood to mean any germinated cereal grain, such as germinated barley or wheat.
[0393] As used herein, the term "adjunct" refers to any plant material containing starch and / or sugar that is not malt (such as barley or wheat malt). Examples of adjuncts that can be used as a starch source include materials such as ordinary corn grits, refined corn grits, brewer's yeast, rice, sorghum, refined corn starch, barley, barley starch, hulled barley, wheat, wheat starch, baked cereals, cereal flakes, rye, oats, potatoes, cassava, tapioca, and syrups (such as corn syrup, cane syrup, invert sugar syrup, barley and / or wheat syrup).
[0394] As used herein, the term “wine” refers to any aqueous slurry containing plant material such as cereal flour (e.g., including crushed barley malt, crushed barley) and / or other adjuncts or combinations thereof, which is subsequently mixed with water to separate wort and waste.
[0395] As used in this article, the term "malt extract" refers to the unfermented liquid run-off that remains after the extraction of cereal flour during starch mashing.
[0396] The use of the mannanase of the present invention for processing coffee extract.
[0397] The mannanase of the present invention can also be used to hydrolyze galactomannan present in liquid coffee extracts. In some preferred embodiments, the mannanase of the present invention is used to inhibit gel formation during freeze-drying of liquid coffee extracts. The reduction in extract viscosity decreases energy consumption during drying. In some other preferred embodiments, to reduce enzyme consumption and avoid contamination of the coffee extract, the mannanase of the present invention is applied in an immobilized form. This use is also disclosed in EP 676 145.
[0398] Generally, coffee extract is incubated in the presence of the isolated mannanase or a fragment or variant thereof of the present invention under conditions suitable for hydrolyzing galactomannan present in liquid coffee extract.
[0399] Therefore, in one embodiment, the present invention relates to a method for producing coffee extract, the method comprising the following steps:
[0400] (a) Providing roasted and ground coffee beans;
[0401] (b) Add the coffee bean water and the polypeptide of the first or second aspect, the particles of the fifth or sixth aspect, or the liquid preparation of the seventh or eighth aspect;
[0402] (c) Incubation to produce an aqueous coffee extract; and
[0403] (d) Separate the coffee extract from the extracted coffee beans.
[0404] Use of the mannanase of the present invention in baked goods
[0405] In another aspect, the present invention relates to a method for preparing a baked product, the method comprising adding a polypeptide of the first or second aspect, particles of the fifth or sixth aspect, or a liquid formulation of the seventh or eighth aspect to dough, and then baking the dough.
[0406] Examples of baked products are well known to those skilled in the art and include bread, rolls, crepes, sweet fermented dough, rolls, cakes, savory biscuits, cookies, bread rolls, waffles, wafers, tortillas, breakfast cereals, extruded products, etc.
[0407] The mannanase of this invention can be added to dough as part of a bread improver composition. Bread improvers are compositions containing multiple ingredients that improve dough properties and the quality of baked products (e.g., bread and cakes). Bread improvers are typically added to industrial baking processes due to their beneficial effects (e.g., dough stability and bread texture and volume). Bread improvers typically contain fats and oils, as well as additives (such as emulsifiers, enzymes, antioxidants, oxidants, stabilizers, and reducing agents). In addition to the mannanase of this invention, other enzymes may also be present in bread improvers, including amylases, hemicellulases, starch-degrading complexes, lipases, proteases, xylanases, pectinases, amylopectinases, non-starch polysaccharide degrading enzymes, and oxidoreductases (such as glucose oxidase, lipoxygenase, or ascorbic acid oxidase).
[0408] In one aspect, the mannanase of the present invention can be added to dough as part of a bread improver composition, the bread improver composition further comprising glucomannan and / or galactomannan sources such as konjac gum, guar gum, carob gum (Ceratonia siliqua), dried coconut meal, ivory nut mannan (Phyteleohas macrocarpa), seaweed mannan extract, coconut meal, and cell walls of brewer's yeast (which may be dried or used in the form of brewer's yeast extract).
[0409] Another aspect of the invention relates to the use of the mannanase of the invention in dough for improving dough tolerance, softness, and stickiness. Preferably, the dough to which the mannanase of the invention may be added is not pure wheat flour dough, but contains, in addition to or in place of pure wheat flour, bran or oat, rice, millet, corn, or legume flour.
[0410] Another aspect of the invention relates to the use of any of the mannanases of the invention in dough for improving crumb structure and delaying staling of the final baked product, such as bread.
[0411] Use of the mannanase of the present invention in dairy products
[0412] In one aspect of the invention, the mannanase of the invention can be added to milk or any other dairy product for which glucomannan and / or galactomannan are also added. Typical sources of glucomannan and / or galactomannan are listed above in the baking context and include guar gum or konjac gum. When found at a favorable population density in the large intestine or colon, the combination of the mannanase of the invention with glucomannan and / or galactomannan releases mannanase hydrolysates (mannooligosaccharides) that act as soluble prebiotics by promoting the selective growth and proliferation of probiotics (particularly Bifidobacteria and Lactobacillus lactis), which are generally associated with good health.
[0413] In one aspect, the present invention relates to a method for preparing milk or dairy products, the method comprising adding (a) glucomannan, galactomannan and / or galactoglucomannan and (b) a polypeptide of the first or second aspect, particles of the fifth or sixth aspect, or a liquid preparation of the seventh or eighth aspect to the milk or dairy products.
[0414] In one aspect of the invention, the mannanase of the present invention is used in combination with any glucomannan or galactomannan before or after being added to a dairy-based food to produce a dairy-based food containing prebiotic mannan hydrolysates. In another aspect of the invention, dairy products thus produced containing mannan oligosaccharides can increase the population of beneficial human gut microbiota, and in yet another aspect of the invention, the dairy-based food may contain the mannanase of the present invention as well as any source of glucomannan and / or galactomannan and / or galactoglucomannan, and the dosage is sufficient for inoculation with at least one bacterial strain known to be beneficial in the human large intestine (such as Bifidobacterium or Lactobacillus). Preferably, the dairy-based food is yogurt or a milk beverage.
[0415] The use of mannanase of the present invention in pulp bleaching
[0416] The mannanase of the present invention can be further used for the enzymatic bleaching of pulp (e.g., chemical pulp, semi-chemical pulp, kraft pulp, mechanical pulp, or pulp prepared by the sulfite process). Therefore, the present invention relates to a method for bleaching pulp, the method comprising incubating the pulp together with a polypeptide of the first or second aspect, a detergent composition of the third or fourth aspect, particles of the fifth or sixth aspect, or a liquid formulation of the seventh or eighth aspect.
[0417] In some embodiments, the pulp is chlorine-free pulp bleached with oxygen, ozone, peroxide, or peroxyacid. In some embodiments, the mannanase of the present invention is used for enzymatic bleaching of pulp exhibiting low lignin content, the pulp being produced by a modified pulping method or a continuous pulping method. In some other embodiments, the mannanase of the present invention is used alone or preferably in combination with xylanase and / or endoglucanase and / or α-galactosidase and / or cellobiase.
[0418] The invention is further summarized in the following paragraphs:
[0419] 1. A polypeptide having mannanase activity, the polypeptide being selected from the group consisting of:
[0420] (a) A polypeptide having at least 91%, such as at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity with SEQ ID NO:4;
[0421] (b) A variant of SEQ ID NO:4, wherein the variant has mannanase activity and includes one or more substitutions, and / or one or more deletions, and / or one or more insertions or any combination thereof at positions 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28 or 29;
[0422] (c) A polypeptide comprising the polypeptide of (a) or (b) and an N-terminal and / or C-terminal His-tag and / or HQ-tag;
[0423] (d) A polypeptide comprising the polypeptide of (a) or (b) and an N-terminus and / or C-terminus extension of up to 10 amino acids, such as 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10 amino acids; and
[0424] A fragment of the polypeptide of (e), (a), or (b), which has mannanase activity and has at least 90% of the length of the mature polypeptide.
[0425] 2. The polypeptide as described in Item 1, wherein the polypeptide further comprises a carbohydrate-binding module (CBM).
[0426] 3. The polypeptide as described in Project 2, wherein the carbohydrate-binding module is a family 35CBM.
[0427] 4. The polypeptide as described in any one of items 2 to 3, wherein the polypeptide has at least 87%, for example at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity with SEQ ID NO:3 or SEQ ID NO:11.
[0428] 5. The polypeptide as described in Item 1, comprising or consisting of amino acids 1 to 330 of SEQ ID NO:4, a mature polypeptide of SEQ ID NO:2 or amino acids 1 to 498 of SEQ ID NO:3, a mature polypeptide of SEQ ID NO:10 or amino acids 1 to 527 of SEQ ID NO:11.
[0429] 6. A polypeptide having mannanase activity, the polypeptide being selected from the group consisting of:
[0430] (a) A polypeptide having at least 87%, such as at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity with SEQ ID NO:3 or SEQ ID NO:11;
[0431] (b) A polypeptide encoded by a polynucleotide having at least 87%, such as at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity with the mature polypeptide encoding sequence of SEQ ID NO:1 or SEQ ID NO:9;
[0432] (c) A variant of SEQ ID NO:3 or SEQ ID NO:11, wherein the variant has mannanase activity and contains one or more substitutions, and / or one or more deletions, and / or one or more insertions or any combination thereof at positions 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49 or 50;
[0433] (d) A polypeptide comprising the polypeptide of (a), (b) or (c) and an N-terminal and / or C-terminal His-tag and / or HQ-tag;
[0434] (e) a polypeptide comprising the polypeptide of (a), (b), or (c) and an N-terminus and / or C-terminus extension of up to 10 amino acids, such as 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10 amino acids; and
[0435] (f) A fragment of the polypeptide of (a), (b) or (c) having mannanase activity and having at least 90% of the length of a mature polypeptide.
[0436] 7. The polypeptide as described in Item 6, comprising or consisting of the mature polypeptide of SEQ ID NO:2 or amino acids 1 to 498 of SEQ ID NO:3, or the mature polypeptide of SEQ ID NO:10 or amino acids 1 to 527 of SEQ ID NO:11.
[0437] 8. A composition comprising a polypeptide as described in any one of items 1 to 7.
[0438] 9. A composition comprising a polypeptide as described in any one of items 1 to 7 and one or more components selected from the group consisting of: surfactants, water-soluble auxiliaries, detergent builders, co-detergents, chelating agents, bleaching components, polymers, fabric toners, fabric conditioning agents, foaming agents, defoaming agents, dispersants, dye transfer inhibitors, optical brighteners, fragrances, optical brighteners, bactericides, fungicides, dirt suspending agents, dirt-releasing polymers, anti-redeposition agents, enzyme inhibitors, enzyme stabilizers, enzyme activators, antioxidants, and solubilizers.
[0439] 10. The composition of any one of items 8 to 9, wherein the composition further comprises one or more additional enzymes.
[0440] 11. The composition as described in Item 19, wherein the additional enzyme is selected from the group consisting of: amylase, protease, protease, peroxidase, cellulase, β-glucanase, xyloglucanase, hemicellulase, xanthan gumase, xanthan gum lyase, lipase, acyltransferase, phospholipase, esterase, laccase, catalase, aryl esterase, amylase, α-amylase, glucosylamylase, cutinase, pectinase, pectin lyase. Keratinase, reductase, oxidase, phenol oxidase, lipoxygenase, ligninase, carrageenanase, amylopectinase, tanninase, arabinosidase, hyaluronidase, chondroitinase, xyloglucanase, xylanase, pectin acetylesterase, polygalacturonase, rhamnogalacturonase, other endo-β-mannanases, exo-β-mannanases, pectin methylesterase, cellobiase and transglutaminase, or any combination thereof.
[0441] 12. A detergent composition comprising a surfactant and a polypeptide having mannanase activity, wherein the polypeptide is selected from the group consisting of:
[0442] (a) A polypeptide having at least 81%, such as at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity with SEQ ID NO:4;
[0443] (b) A variant of SEQ ID NO:4, wherein the variant has mannanase activity and contains one or more substitutions, and / or one or more deletions, and / or one or more insertions or any combination thereof at positions 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49 or 50;
[0444] (c) A polypeptide comprising the polypeptide of (a) or (b) and an N-terminal and / or C-terminal His-tag and / or HQ-tag;
[0445] (d) A polypeptide comprising the polypeptide of (a) or (b) and an N-terminus and / or C-terminus extension of up to 10 amino acids, such as 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10 amino acids; and
[0446] A fragment of the polypeptide of (e), (a), or (b), which has mannanase activity and has at least 90% of the length of the mature polypeptide.
[0447] 13. The detergent composition of item 12, wherein the polypeptide further comprises a carbohydrate binding module (CBM).
[0448] 14. The detergent composition as described in item 13, wherein the carbohydrate binding module is family 35CBM.
[0449] 15. The detergent composition of any one of items 13 to 14, wherein the polypeptide has at least 81%, such as at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity with SEQ ID NO:3 or SEQ ID NO:11.
[0450] 16. The detergent composition of item 12, wherein the detergent composition comprises or consists of amino acids 1 to 330 of SEQ ID NO:4, a mature polypeptide of SEQ ID NO:2, or amino acids 1 to 498 of SEQ ID NO:3, a mature polypeptide of SEQ ID NO:10, or amino acids 1 to 527 of SEQ ID NO:11.
[0451] 17. A detergent composition comprising a surfactant and a polypeptide having mannanase activity, wherein the polypeptide is selected from the group consisting of:
[0452] (a) A polypeptide having at least 81%, such as at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity with SEQ ID NO:3 or SEQ ID NO:11;
[0453] (b) A polypeptide encoded by a polynucleotide having at least 81%, for example at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity with the mature polypeptide encoding sequence of SEQ ID NO:1 or SEQ ID NO:9;
[0454] (c) A variant of SEQ ID NO:3 or SEQ ID NO:11, wherein the variant has mannanase activity and contains one or more substitutions, and / or one or more deletions, and / or one or more insertions or any combination thereof at positions 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49 or 50;
[0455] (d) A polypeptide comprising the polypeptide of (a), (b) or (c) and an N-terminal and / or C-terminal His-tag and / or HQ-tag;
[0456] (e) a polypeptide comprising the polypeptide of (a), (b), or (c) and an N-terminus and / or C-terminus extension of up to 10 amino acids, such as 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10 amino acids; and
[0457] (f) A fragment of the polypeptide of (a), (b) or (c) having mannanase activity and having at least 90% of the length of a mature polypeptide.
[0458] 18. The detergent composition of item 17, wherein the detergent composition comprises or consists of a mature polypeptide of SEQ ID NO:2 or amino acids 1 to 498 of SEQ ID NO:3, or a mature polypeptide of SEQ ID NO:10 or amino acids 1 to 527 of SEQ ID NO:11.
[0459] 19. The detergent composition of any one of items 12 to 18, further comprising one or more components selected from the group consisting of: water-soluble auxiliaries, detergent builders, co-detergents, chelating agents, bleaching components, polymers, fabric colorants, fabric conditioning agents, foaming agents, defoaming agents, dispersants, dye transfer inhibitors, optical brighteners, fragrances, optical brighteners, bactericides, fungicides, dirt suspending agents, dirt-releasing polymers, anti-redeposition agents, enzyme inhibitors, enzyme stabilizers, enzyme activators, antioxidants, and solubilizers.
[0460] 20. The detergent composition of any one of items 18 to 19, wherein the detergent composition further comprises one or more additional enzymes.
[0461] 21. The detergent composition of item 20, wherein the additional enzyme is selected from the group consisting of: amylase, protease, protease, peroxidase, cellulase, β-glucanase, xyloglucanase, hemicellulase, xanthan gumase, xanthan gum lyase, lipase, acyltransferase, phospholipase, esterase, laccase, catalase, aryl esterase, amylase, α-amylase, glucosylamylase, cutinase, pectinase, pectin lyase. Enzymes, keratinases, reductases, oxidases, phenol oxidases, lipoxygenases, ligninases, carrageenanases, amylopectinases, tanninases, arabinosidases, hyaluronidases, chondroitinases, xylanases, xylanases, pectin acetylesterases, polygalacturonases, rhamnogalacturonases, other endo-β-mannanases, exo-β-mannanases, pectin methylesterases, cellobiases and transglutaminases, or any combination thereof.
[0462] 22. A particle comprising a core particle and one or more coatings, wherein the particle comprises a polypeptide selected from the group consisting of mannanase activity:
[0463] (a) A polypeptide having at least 81%, such as at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity with SEQ ID NO:4;
[0464] (b) A variant of SEQ ID NO:4, wherein the variant has mannanase activity and contains one or more substitutions, and / or one or more deletions, and / or one or more insertions or any combination thereof at positions 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49 or 50;
[0465] (c) A polypeptide comprising the polypeptide of (a) or (b) and an N-terminal and / or C-terminal His-tag and / or HQ-tag;
[0466] (d) A polypeptide comprising the polypeptide of (a) or (b) and an N-terminus and / or C-terminus extension of up to 10 amino acids, such as 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10 amino acids; and
[0467] A fragment of the polypeptide of (e), (a), or (b), which has mannanase activity and has at least 90% of the length of the mature polypeptide.
[0468] 23. The particles as described in item 22, wherein the polypeptide further comprises a carbohydrate-binding module (CBM).
[0469] 24. The particles as described in item 23, wherein the carbohydrate binding module is family 35CBM.
[0470] 25. The particle of any one of items 23 to 24, wherein the polypeptide has at least 81%, for example at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity with SEQ ID NO:3.
[0471] 26. The particles as described in item 22, wherein the particles comprise or consist of amino acids 1 to 330 of SEQ ID NO:4, a mature polypeptide of SEQ ID NO:2 or amino acids 1 to 498 of SEQ ID NO:3, a mature polypeptide of SEQ ID NO:10 or amino acids 1 to 527 of SEQ ID NO:11.
[0472] 27. A particle comprising a core particle and one or more coatings, wherein the particle comprises a polypeptide selected from the group consisting of mannanase activity:
[0473] (a) A polypeptide having at least 81%, such as at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity with SEQ ID NO:3 or SEQ ID NO:11;
[0474] (b) A polypeptide encoded by a polynucleotide having at least 81%, for example at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity with the mature polypeptide encoding sequence of SEQ ID NO:1 or SEQ ID NO:9;
[0475] (c) A variant of SEQ ID NO:3 or SEQ ID NO:11, wherein the variant has mannanase activity and contains one or more substitutions, and / or one or more deletions, and / or one or more insertions or any combination thereof at positions 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49 or 50;
[0476] (d) A polypeptide comprising the polypeptide of (a), (b) or (c) and an N-terminal and / or C-terminal His-tag and / or HQ-tag;
[0477] (e) a polypeptide comprising the polypeptide of (a), (b), or (c) and an N-terminus and / or C-terminus extension of up to 10 amino acids, such as 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10 amino acids; and
[0478] (f) A fragment of the polypeptide of (a), (b) or (c) having mannanase activity and having at least 90% of the length of a mature polypeptide.
[0479] 28. The particles as described in item 27, wherein the particles comprise or consist of a mature polypeptide of SEQ ID NO:2 or amino acids 1 to 498 of SEQ ID NO:3, a mature polypeptide of SEQ ID NO:10 or amino acids 1 to 527 of SEQ ID NO:11.
[0480] 29. Particles as described in any one of items 22 to 28, wherein the coating comprises salt and / or wax and / or flour.
[0481] 30. The particle as described in any one of items 22 to 29, wherein the particle further comprises one or more additional enzymes.
[0482] 31. The particles as described in Item 30, wherein the additional enzyme is selected from the group consisting of: amylase, protease, protease, peroxidase, cellulase, β-glucanase, xyloglucanase, hemicellulase, xanthan gumase, xanthan gum lyase, lipase, acyltransferase, phospholipase, esterase, laccase, catalase, aryl esterase, amylase, α-amylase, glucosylamylase, cutinase, pectinase, pectin lyase, Keratinase, reductase, oxidase, phenol oxidase, lipoxygenase, ligninase, carrageenanase, amylopectinase, tanninase, arabinosidase, hyaluronidase, chondroitinase, xyloglucanase, xylanase, pectin acetylesterase, polygalacturonase, rhamnogalacturonase, other endo-β-mannanases, exo-β-mannanases, pectin methylesterase, cellobiase and transglutaminase, or any combination thereof.
[0483] 32. A liquid composition comprising a polyol and a polypeptide having mannanase activity, wherein the polypeptide is selected from the group consisting of:
[0484] (a) A polypeptide having at least 81%, such as at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity with SEQ ID NO:4;
[0485] (b) A variant of SEQ ID NO:4, wherein the variant has mannanase activity and contains one or more substitutions, and / or one or more deletions, and / or one or more insertions or any combination thereof at positions 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49 or 50;
[0486] (c) A polypeptide comprising the polypeptide of (a) or (b) and an N-terminal and / or C-terminal His-tag and / or HQ-tag;
[0487] (d) A polypeptide comprising the polypeptide of (a) or (b) and an N-terminus and / or C-terminus extension of up to 10 amino acids, such as 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10 amino acids; and
[0488] A fragment of the polypeptide of (e), (a), or (b), which has mannanase activity and has at least 90% of the length of the mature polypeptide.
[0489] 33. The liquid composition as described in item 32, wherein the polypeptide further comprises a carbohydrate binding module (CBM).
[0490] 34. The liquid composition as described in item 33, wherein the carbohydrate binding module is family 35CBM.
[0491] 35. The liquid composition of any one of items 33 to 34, wherein the polypeptide has at least 81%, such as at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity with SEQ ID NO:3 or SEQ ID NO:11.
[0492] 36. The liquid composition of item 32, wherein the liquid composition comprises or consists of amino acids 1 to 330 of SEQ ID NO:4, a mature polypeptide of SEQ ID NO:2 or amino acids 1 to 498 of SEQ ID NO:3, a mature polypeptide of SEQ ID NO:10 or amino acids 1 to 527 of SEQ ID NO:11.
[0493] 37. A liquid composition comprising a polyol and a polypeptide having mannanase activity, wherein the polypeptide is selected from the group consisting of:
[0494] (a) A polypeptide having at least 81%, such as at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity with SEQ ID NO:3 or SEQ ID NO:11;
[0495] (b) A polypeptide encoded by a polynucleotide having at least 81%, for example at least 85%, at least 90%, at least 91%, at least 92%, at least 93%, at least 94%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100% sequence identity with the mature polypeptide encoding sequence of SEQ ID NO:1 or SEQ ID NO:9;
[0496] (c) A variant of SEQ ID NO:3 or SEQ ID NO:11, wherein the variant has mannanase activity and contains one or more substitutions, and / or one or more deletions, and / or one or more insertions or any combination thereof at positions 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49 or 50;
[0497] (d) A polypeptide comprising the polypeptide of (a), (b) or (c) and an N-terminal and / or C-terminal His-tag and / or HQ-tag;
[0498] (e) a polypeptide comprising the polypeptide of (a), (b), or (c) and an N-terminus and / or C-terminus extension of up to 10 amino acids, such as 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10 amino acids; and
[0499] (f) A fragment of the polypeptide of (a), (b) or (c) having mannanase activity and having at least 90% of the length of a mature polypeptide.
[0500] 38. The liquid composition of item 37, wherein the liquid composition comprises or consists of the mature polypeptide of SEQ ID NO:2 or amino acids 1 to 498 of SEQ ID NO:3, the mature polypeptide of SEQ ID NO:10 or amino acids 1 to 527 of SEQ ID NO:11.
[0501] 39. The liquid formulation as described in any one of items 32 to 38, wherein the dose of the polypeptide is between 0.0001% and 10% w / w in the liquid formulation.
[0502] 40. The liquid formulation as described in any one of items 32 to 39, wherein the dosage of the polyol is between 5% and 80% w / w in the liquid formulation.
[0503] 41. The liquid formulation of any one of items 32 to 40, wherein the polyol is selected from the group consisting of: glycerol, sorbitol, propylene glycol (MPG), ethylene glycol, diethylene glycol, triethylene glycol, 1,2-propanediol or 1,3-propanediol, dipropylene glycol, polyethylene glycol (PEG) with an average molecular weight of less than about 600, and polypropylene glycol (PPG) with an average molecular weight of less than about 600, or any combination thereof.
[0504] 42. The liquid formulation as described in any one of items 32 to 41, wherein the formulation further comprises 0.001% to 2.0% w / w of a preservative.
[0505] 43. The liquid formulation as described in item 42, wherein the preservative is selected from the group consisting of: phenoxyethanol, 1,2-benzisothiazolin-3(2H)-one, sodium sorbate, potassium sorbate, sodium benzoate, potassium benzoate, methylisothiazolinone, chloromethylisothiazolinone, methylparaben, ethylparaben, propylparaben, butylparaben, quaternary ammonium salts (such as BAC / ADBAC; alkylbenzylammonium chloride, dioctyldimethylammonium chloride, didecyldimethylammonium chloride, cetrimonium chloride), essential oils and organic acids or any combination thereof.
[0506] 44. The liquid composition of any one of items 32 to 43, wherein the liquid composition further comprises one or more additional enzymes.
[0507] 45. The liquid composition as described in item 44, wherein the additional enzyme is selected from the group consisting of: amylase, protease, protease, peroxidase, cellulase, β-glucanase, xyloglucanase, hemicellulase, xanthan gumase, xanthan gum lyase, lipase, acyltransferase, phospholipase, esterase, laccase, catalase, aryl esterase, amylase, α-amylase, glucosylamylase, cutinase, pectinase, pectin lyase. Enzymes, keratinases, reductases, oxidases, phenol oxidases, lipoxygenases, ligninases, carrageenanases, amylopectinases, tanninases, arabinosidases, hyaluronidases, chondroitinases, xylanases, xylanases, pectin acetylesterases, polygalacturonases, rhamnogalacturonases, other endo-β-mannanases, exo-β-mannanases, pectin methylesterases, cellobiases and transglutaminases, or any combination thereof.
[0508] 46. An animal feed or animal feed additive comprising a polypeptide as described in any one of items 1 to 7, a composition as described in any one of items 8 to 11, granules as described in any one of items 22 to 31, or a liquid composition as described in any one of items 32 to 45, and one or more components selected from the following list, which comprises:
[0509] One or more vitamins;
[0510] One or more minerals; and
[0511] One or more amino acids.
[0512] 47. The animal feed or animal feed additive as described in item 46, wherein the animal feed or animal feed additive further comprises one or more additional enzymes selected from the group consisting of: acetylxylan esterase, acylglycerol lipase, amylase, α-amylase, β-amylase, arabinofuranosylase, cellobiase, cellulase, ferulic acid esterase, galactanase, α-galactosidase, β-galactosidase, β-glucanase, β-glucosidase, lysophospholipase, lysozyme, α-mannosylase, β-mannosylase (mannanase), phytase, phospholipase A1, phospholipase A2, phospholipase D, protease, amylopectinase, pectin esterase, triacylglycerol lipase, xylanase, β-xylosidase, or any combination thereof.
[0513] 48. The animal feed or animal feed additive as described in any one of items 46 to 47, wherein the animal feed or animal feed additive comprises one or more microorganisms selected from the group consisting of: Bacillus subtilis, Bacillus licheniformis, Bacillus amyloliquefaciens, Bacillus cereus, Bacillus pumilus, Bacillus polymyxa, Bacillus megaterium, Bacillus coagulans, Bacillus circumflex, Bifidobacterium bifidum, Bifidobacterium animalis, species of Bifidobacterium, species of Carnivora, Clostridium butyricum, species of Clostridium, Enterococcus faecalis, species of Enterococcus, species of Lactobacillus, Lactobacillus acidophilus, Lactobacillus sausageii, Lactobacillus rhamnosus, Lactobacillus reuteri, Lactobacillus salivarius, Lactococcus lactis, species of Lactococcus, species of Leuconostoc, Giant cellulococcus ehrlich, species of Giant cellulococcus, Pediococcus lactis, species of Pediococcus, Propionibacterium tergenti, species of Propionibacterium, and species of Streptococcus, or any combination thereof.
[0514] 49. Use of the polypeptides as described in any one of items 1 to 7, the compositions as described in any one of items 8 to 11, the detergent compositions as described in any one of items 12 to 21, the particles as described in any one of items 22 to 31, or the liquid formulations as described in any one of items 32 to 45 for the degradation of mannans, such as linear mannans, galactomannans, glucomannans, and galactoglucomannans.
[0515] 50. Use of the polypeptide as described in any one of items 1 to 7, the composition as described in any one of items 8 to 11, the detergent composition as described in any one of items 12 to 21, the particles as described in any one of items 22 to 31, or the liquid formulation as described in any one of items 32 to 45 for controlling the viscosity of drilling fluids.
[0516] 51. Use of any polypeptide as described in any one of items 1 to 7, any composition as described in any one of items 8 to 11, any detergent composition as described in any one of items 12 to 21, any granules as described in any one of items 22 to 31, or any liquid formulation as described in any one of items 32 to 45 for the washing, cleaning, or cleaning of textiles and / or hard surfaces (such as dishwashing).
[0517] 52. The use as described in any one of items 49 to 51, wherein the polypeptide has the benefit of enzymatic washing.
[0518] 53. A method for preparing a food or feed composition and / or a food or feed additive, the method comprising mixing a polypeptide as described in any one of items 1 to 7, a composition as described in any one of items 8 to 11, a granule as described in any one of items 22 to 31, or a liquid formulation as described in any one of items 32 to 45 with one or more food or feed and / or food or feed additive ingredients.
[0519] 54. Use of any polypeptide as described in any one of items 1 to 7, any composition as described in any one of items 8 to 11, any particle as described in any one of items 22 to 31, or any liquid formulation as described in any one of items 32 to 45 in the preparation of food or feed compositions and / or food or feed additives and / or food or feed.
[0520] 55. A method for degrading mannan, such as linear mannan, galactomannan, glucomannan, and galactoglucomannan, the method comprising applying to the mannan a composition comprising any one of items 1 to 7, a composition comprising any one of items 8 to 11, a detergent composition comprising any one of items 12 to 21, particles comprising any one of items 22 to 31, or a liquid formulation comprising any one of items 32 to 45.
[0521] 56. The method of claim 55, wherein the mannan is on the surface of a textile or a hard surface, such as in dishwashing.
[0522] 57. The method of item 55, wherein the mannan is used in the fracturing of underground formations created by a borehole.
[0523] 58. The method as described in item 55, wherein the mannan is a component in the perforated filter cake.
[0524] 59. A method for producing coffee extract, the method comprising the following steps:
[0525] (a) Providing roasted and ground coffee beans;
[0526] (b) Add the coffee bean water and a polypeptide as described in any one of items 1 to 7, a composition as described in any one of items 8 to 11, a particle as described in any one of items 22 to 31, or a liquid preparation as described in any one of items 32 to 45;
[0527] (c) Incubation to produce an aqueous coffee extract; and
[0528] (d) Separate the coffee extract from the extracted coffee beans.
[0529] 60. A method for degrading a cellulose material, the method comprising: treating the cellulose material with an enzyme composition in the presence of a polypeptide having mannanase activity as described in any one of items 1 to 7.
[0530] 61. A method for producing fermentation products, the method comprising:
[0531] (a) Saccharifying cellulose material with an enzyme composition, wherein the enzyme composition comprises a polypeptide as described in any one of items 1 to 7, a composition as described in any one of items 8 to 11, particles as described in any one of items 22 to 31, or a liquid formulation as described in any one of items 32 to 45.
[0532] (b) Fermenting saccharified cellulose material with one or more fermenting microorganisms to produce fermentation products; and
[0533] (c) Recover the fermentation product from the fermentation.
[0534] 62. The method of any one of items 60 or 61, wherein the cellulose material is pretreated.
[0535] 63. The method of any one of items 60 to 62, wherein the enzyme composition comprises one or more enzymes selected from the group consisting of: cellulase, AA9 polypeptide, hemicellulase, esterase, patulin, lignin-degrading enzyme, oxidoreductase, pectinase, protease, and swelling agent.
[0536] 64. A method for fermenting a cellulose material, the method comprising: fermenting the cellulose material with one or more fermenting microorganisms, wherein the cellulose material is saccharified with an enzyme composition, wherein the enzyme composition comprises a polypeptide as described in any one of items 1 to 7, a composition as described in any one of items 8 to 11, particles as described in any one of items 22 to 31, or a liquid formulation as described in any one of items 32 to 45.
[0537] 65. The method of item 64, wherein the cellulose material is pretreated prior to saccharification.
[0538] 66. The method of any one of items 64 to 65, wherein the enzyme composition comprises one or more enzymes selected from the group consisting of: cellulase, AA9 polypeptide, hemicellulase, esterase, patulin, lignin-degrading enzyme, oxidoreductase, pectinase, protease, and swelling agent.
[0539] 67. A polynucleotide encoding a polypeptide as described in any one of items 1 to 7.
[0540] 68. A nucleic acid construct or expression vector comprising a polynucleotide as described in item 67, the polynucleotide being operatively linked to one or more control sequences that direct the production of the polypeptide in an expression host.
[0541] 69. A recombinant host cell comprising a polynucleotide as described in item 67, the polynucleotide being operatively linked to one or more control sequences that direct the production of the polypeptide.
[0542] 70. A method for producing a polypeptide as described in any one of items 1 to 7, the method comprising:
[0543] (a) Cells are cultured under conditions conducive to the production of the polypeptide, and the cells produce the polypeptide in its wild-type form; and
[0544] (b) The polypeptide was recovered.
[0545] 71. A method for producing a polypeptide as described in any one of items 1 to 7, the method comprising:
[0546] (a) Culture host cells as described in item 46 under conditions conducive to the production of the polypeptide; and
[0547] (b) The polypeptide was recovered.
[0548] 72. A transgenic plant, plant part or plant cell transformed with a polynucleotide encoding a polypeptide as described in any one of items 1 to 7.
[0549] 73. A whole culture medium formulation or cell culture composition comprising a polypeptide as described in any one of items 1 to 7.
[0550] 74. Use of any polypeptide as described in any one of items 1 to 7, any composition as described in any one of items 8 to 11, any detergent composition as described in any one of items 12 to 21, any granules as described in any one of items 22 to 31, or any liquid formulation as described in any one of items 32 to 45 for preventing, reducing, or removing biofilms from articles.
[0551] 75. The polypeptide of any one of items 1 to 7, the composition of any one of items 8 to 11, the detergent composition of any one of items 12 to 21, the granules of any one of items 22 to 31, or the liquid formulation of any one of items 32 to 45 for preventing, reducing or removing odor from articles.
[0552] 76. A method for preparing a fermented beverage, the method comprising mixing a polypeptide as described in any one of items 1 to 7, a composition as described in any one of items 8 to 11, particles as described in any one of items 22 to 31, or a liquid preparation as described in any one of items 32 to 45 with malt and / or excipients.
[0553] 77. A method for preparing a fermented beverage, the method comprising contacting mash and / or wort with a polypeptide as described in any one of items 1 to 7, a composition as described in any one of items 8 to 11, particles as described in any one of items 22 to 31, or a liquid preparation as described in any one of items 32 to 45.
[0554] 78. The method of any one of items 76 to 77, wherein the fermented beverage is wine or beer.
[0555] 79. A method for preparing a baked product, the method comprising mixing a polypeptide as described in any one of items 1 to 7, a composition as described in any one of items 8 to 11, particles as described in any one of items 22 to 31, or a liquid formulation as described in any one of items 32 to 45 with dough, and then baking the dough.
[0556] 80. A method for improving the tolerance, flexibility and / or stickiness of dough, the method comprising mixing a polypeptide as described in any one of items 1 to 7, a composition as described in any one of items 8 to 11, particles as described in any one of items 22 to 31, or a liquid formulation as described in any one of items 32 to 45 with the dough.
[0557] 81. A method for improving the pulp structure and delaying the aging of the final baked product, the method comprising mixing a polypeptide as described in any one of items 1 to 7, a composition as described in any one of items 8 to 11, particles as described in any one of items 22 to 31, or a liquid preparation as described in any one of items 32 to 45 with the dough, and then baking the dough.
[0558] 82. A method for preparing milk or dairy products, the method comprising adding to the milk or dairy products
[0559] (a) glucomannan, galactomannan and / or galactoglucomannan; and
[0560] (b) A polypeptide as described in any one of items 1 to 7, a composition as described in any one of items 8 to 11, a particle as described in any one of items 22 to 31, or a liquid formulation as described in any one of items 32 to 45.
[0561] 83. A method for bleaching pulp, the method comprising incubating the pulp with a polypeptide as described in any one of items 1 to 7, a composition as described in any one of items 8 to 11, a detergent composition as described in any one of items 12 to 21, granules as described in any one of items 22 to 31, or a liquid formulation as described in any one of items 32 to 45, until dough is formed.
[0562] The invention is further described through the following examples, but should not be construed as limiting the scope of the invention.
[0563] Example
[0564] strains
[0565] The DNA encoding the GH26 mannanase gene was isolated from Bacillus pineneus, which was isolated from soil samples collected in Denmark in 2007 or earlier.
[0566] The chromosomal DNA from this strain was sequenced using Illumina technology to form a whole genome. Protein sequences containing the glycosyl hydrolase family 26 domain (as defined by CAZY) were analyzed in the genome, and the GH26 mannanase gene was identified in this genome.
[0567] Material
[0568] The chemicals used as buffers and substrates are at least reagent-grade commercial products.
[0569] Example 1: Measurement of the reducing end
[0570] To estimate the mannose yield after substrate hydrolysis, a reducing end assay developed by Lever (1972), Anal. Biochem. [Analytical Biochemistry] 47:273-279, was used. This assay is based on 4-hydroxybenzoic acid hydrazide, which reacts with the reducing end of the sugar under alkaline conditions. The product is a strong yellow anion with absorption at 410 nm.
[0571] method
[0572] 4-Hydroxybenzoyl hydrazide (PAHBAH) (Sigma, H9882) was diluted to a concentration of 15 mg / mL in PAHBAH buffer. The PAHBAH buffer contained 50 g / L K-Na-tartrate (Merck, 1.08087) and 20 g / L sodium hydroxide (Sigma, S8045). This PAHBAH mixture was prepared just before use.
[0573] Mix 70 μl of PAHBAH mixture and MiliQ water in a 96-well PCR plate (Thermo Scientific). Add the sample from the hydrolysis experiment. The total volume of sample and MiliQ is always 150 μl, but the sample dilution varies. Seal the plate with adhesive PCR sealing foil (Thermo Scientific). Incubate the plate at 95°C for 10 min in a PTC-200 thermal cycler (MJ Research), cool, and hold at 10°C for 1 min. Transfer 100 μl of sample to a flat-bottomed 96-well microtiter plate (Nunc™) and measure the color at 405 nm using a SpectraMax 190 absorbance microplate reader (Molecular Devices). Compare the results with mannose standards that have undergone the same treatment and dilution as the samples being compared.
[0574] Example 2: Cloning and expression of GH26β-1,4-mannanase from Bacillus subtilis.
[0575] The gene encoding GH26 mannanase from Bacillus subtilis (SEQ ID NO:1) was expressed as a full-length version including the GH26 and CBM35 domains, and a truncated version without the CBM35 domain. Both forms were represented as an intracellular enzyme with a 6xHis tag (added directly to the C-terminus of the protein). These constructs were prepared as linear integration constructs in which these genes were fused between two Bacillus subtilis homologous chromosomal regions by PCR with a strong promoter and a chloramphenicol resistance marker. Fusion was performed by SOE PCR (Horton, RM, Hunt, HD, Ho, SN, Pullen, JK and Pease, LR (1989) Engineering hybrid genes without the use of restriction enzymes, gene splicing by overlap extension Gene [Gene 77:61-68]). The SOE PCR method is also described in patent application WO 2003095658. These genes were expressed under the control of a triple promoter system (as described in WO 99 / 43835), consisting of a promoter for the Bacillus licheniformis α-amylase gene (amyL) containing a stable sequence, a promoter for the Bacillus amyloliquefaciens α-amylase gene (amyQ), and a Bacillus thuringiensis cryIIIA promoter. Linear PCR constructs were transformed into Bacillus subtilis. Transformants were selected on LB plates supplemented with 6 μg chloramphenicol per ml. Recombinant Bacillus subtilis clones containing each construct with integrated expression were cultured for 3 days in 3L flasks containing 500 ml of yeast extract-based medium at 250 rpm and 30°C. Each culture was centrifuged at 20,000 x g for 20 min, and the supernatant was carefully decanted from the pelleted material. Each supernatant was filtered using a filtration device equipped with a 0.2 μm filter (Nalgene) to remove any cell debris. The enzyme was purified from the filtered supernatant as described in Example 3.
[0576] The gene encoding GH26 mannanase from *Bacillus thymosa* (SEQ ID NO: 9) was expressed by replacing the native secretion signal with a *Bacillus thymosa* secretion signal (with the following amino acid sequence: MKKPLGKIVASTALLISVAFSSSIASA, SEQ ID NO: 14), and an HPHPHPHP (SEQ ID NO: 15) tag was directly added to the C-terminus of the protein. The enzyme-containing supernatant was constructed, transformed, cultured, and harvested as described above for GH26 mannanase from *Bacillus thymosa*.
[0577] Example 3: Purification of GH26 mannanase
[0578] The two recombinant strains expressing GH26 mannanase were purified as follows: the pH of the supernatant was adjusted to pH 8 with 3M Tris, allowed to stand for 1 hour, and then filtered using a filter device (LeGene Technology Co., Ltd.) equipped with a 0.2 μm filter. The filtered supernatant was applied to 5 ml of HisTrap. TM On an Excel column (GE Healthcare Life Sciences), the column was pre-equilibrated with 5 column volumes (CV) of 50 mM Tris / HCl at pH 8. Unbound proteins were eluted by washing the column with 8 CV of 50 mM Tris / HCl at pH 8. Mannanase was eluted with 50 mM HEPES at pH 7–10 mM imidazole, and the elution was monitored by absorbance at 280 nm. The eluted mannanase was then transferred to HiPrep... TM Desalting was performed on a 26 / 10 desalting column (GE Healthcare Life Sciences), which was pre-equilibrated with 3CV of 50mM HEPES pH 7–100mM NaCl. Mannanase was eluted from the column using the same buffer at a flow rate of 10 ml / min. Relevant fractions were selected and pooled based on chromatograms and SDS-PAGE analysis using 4%–12% Bis-Tris gel (Invitrogen) and 2-(N-morpholino)ethanesulfonic acid (MES) SDS-PAGE run buffer (Invitrogen). The gels were stained with Instant Blue (Novexin) and destained with miliQ water. The concentrations of the purified enzymes were determined by absorbance at 280 nm to give the concentrations of full-length mannanase from Bacillus oryzae (SEQ ID NO: 6), truncated mannanase from Bacillus oryzae (SEQ ID NO: 8), and mannanase from Bacillus erythrophyll (SEQ ID NO: 13).
[0579] Characteristics of GH26 mannanase (amino acid SEQ ID NO: 6)
[0580] The N-terminal sequence determined by EDMAN degradation is: MMNMEGTP (SEQ ID NO: 16). This sample is heterologous to two other sequences being investigated, NMEGTPS (SEQ ID NO: 17) and MEGTPSV (SEQ ID NO: 18).
[0581] The molecular weight determined by complete molecular weight analysis is 56577.0 Da.
[0582] Mature sequences (from EDMAN N-terminal sequencing data and complete MS data):
[0583]
[0584] (Amino acid 1-504 of SEQ ID NO: 6)
[0585] The calculated molecular weight from this mature sequence is 56579.6 Da.
[0586] Example 4: Preparation of fenugreek gum
[0587] Fenugreek gum was extracted according to the modified procedure (Brummer, Y. et al. Food Hydrocolloids 2003, 17, 229-236).
[0588] 124 g of ground fenugreek seeds (purchased from a local supermarket, but also available online) were extracted with 880 mL of heptane at 70 °C for 60 min to remove nonpolar lipids. After filtration, the residue was extracted with 76% ethanol (760 mL) at 60 °C for 150 min to remove polar lipids. After filtration, the residue was suspended in 1,200 g of a 60:40 (w / w: 720:480 g) ethanol:water mixture and stirred at ambient temperature for 60 min to remove sugars and salts. After filtration, the residue was dried at ambient temperature overnight.
[0589] Fenugreek galactomannan was extracted from 50.0 g of defatted fenugreek seeds in 1,700 g of ion-exchanged water at 5-10 °C for 120 min. The resulting slurry was centrifuged (14,000 g, for 20 min). The supernatant was precipitated in 96% ethanol to a final concentration of 50% (w / w). The resulting condensate was pressed into a suspension in 96% ethanol to facilitate water removal. Subsequently, the resulting fibers were dried overnight at ambient temperature. The overall yield was 18%.
[0590] Example 5: Substrate specificity of GH26 mannanase
[0591] Fenugreek gum and guar gum are both galactomannans. Fenugreek gum is the most common substitute for galactomannans and was prepared as described in Example 4. Guar gum was used less frequently and was purchased from Megazyme, Inc., USA.
[0592] Prepare a 2.5 mg / mL galactomannan solution in phosphate buffer at pH 7.5 and incubate at 30°C for 30 min with either 0.25 mg / L mannanase or no enzyme (blank). Mannaway is available from Novozymes (Beggswede). Mannanase, commercially available in Denmark, was then used. The reduced end was then measured as described in Example 1.
[0593] The optical density difference (ΔOD) at 405 nm was calculated by subtracting the blank sample (without enzyme, i.e., pure galactomannan solution, incubated at 30°C for 30 min). The data are shown in Table 1 below.
[0594] Table 1. Reduction ends released from different substrates
[0595]
[0596] GH26 mannanase (SEQ ID NO:6) from Bacillus subtilis is superior to the commercial product Mannaway in hydrolyzing fenugreek gum and guar gum.
[0597] Example 6: Detergent performance using AMSA's GH26 mannanase
[0598] Automated Mechanical Stress Measurement (AMSA) is used to evaluate the washing performance of garments during the washing process. AMSA allows for the examination of the washing performance of large quantities of small-volume enzyme detergent solutions. An AMSA plate has numerous tanks and lids for the test solution, with the lids forcefully pressing against the garment sample (the textile to be washed) through all tank openings. During the washing cycle, the plate, test solution, textile, and lids are vigorously shaken to bring the test solution into contact with the textile and apply mechanical stress in a regular, periodic oscillating manner.
[0599] Washing performance is measured by the color brightness of the washed textiles. Brightness can also be expressed as the intensity of light reflected from the sample when it is illuminated with white light. When a sample is contaminated, the intensity of the reflected light is lower than that of a clean sample. Therefore, the intensity of reflected light can be used to measure washing performance.
[0600] Using a professional flatbed scanner (Kodak iQsmart, Kodak Corporation, Midtager 29, DK-2605 Brøndby) (In Denmark) Color measurements are performed using a scanner that captures images of the textiles being washed.
[0601] To extract light intensity values from a scanned image, the 24-bit pixel values from the image are converted into red, green, and blue (RGB) values. The intensity value (Int) is calculated by summing the RGB values as a vector and then taking the length of the resulting vector.
[0602]
[0603] These experiments were conducted using the Automated Mechanical Stress Measurement (AMSA) method described in the instructions for use in garment washing, with one cycle of washing and the experimental conditions specified in Table 2.
[0604] Table 2: Conditions for AMSA Washing Test
[0605]
[0606] Table 3 shows the composition of detergent for model T, and Table 4 shows the composition of detergent for model B.
[0607] Table 3: Composition of model T detergent
[0608]
[0609]
[0610] Table 4: Composition of Detergent in Model B
[0611] Ingredients (abbreviations) illustrate weight% LAS (C10-C13)alkylbenzenesulfonic acid 7.20 SLES Sodium lauryl ether sulfate 10.58 Soy soap 2.75 Coconut oil soap 2.75 AEO alcohol ethoxylates 6.60 NaOH Sodium hydroxide 1.05 ethanol 2.70 Isopropanol 0.30 MPG Monopropylene glycol 6.00 glycerin 1.71 TEA Triethanolamine 3.33 Sodium formate 1.00 Sodium citrate 2.00 DTMPA Diethylenetriaminepenta(methylene)penta(phosphonic acid), heptasodium salt 0.48 PCA Polycarboxylate polymers, sodium salt 0.46 Phenoxyethanol 0.50 Ion-exchanged water 50.59
[0612] Water hardness was adjusted by adding CaCl2, MgCl2, and NaHCO3 to the testing system. After washing, the textiles were rinsed in tap water and air-dried. Two types of small fabric samples were used; these were commercial test materials CS-43 (guar gum and carbon black on cotton) and CS-73 (locust bean gum and carbon black on cotton), which were obtained from the Center for Testmaterials BV (Stoomloggerweg 11, 3133KT Vlaardingen) in the Netherlands.
[0613] Tables 5 through 8 present the results for two dosages of each enzyme at two different temperatures and two different detergent compositions. Each figure is a Δ intensity (ΔInt) calculated by subtracting the detergent blank. Each measurement is the average of at least two independent wells in an AMSA setup.
[0614] Table 5: AMSA washing results of model detergent B on guar gum patch fabric sample CS-43 at 20℃
[0615]
[0616] Table 6: AMSA washing results of guar gum patch fabric sample CS-43 by model detergent B at 40℃
[0617]
[0618] Table 7: AMSA washing results of guar gum small piece fabric sample CS-43 with model detergent T at 20℃
[0619]
[0620] Table 8: Results of AMSA washing on guar gum patch fabric sample CS-43 by model detergent T at 40℃
[0621]
[0622] At 20°C and 40°C, the full-length GH26 mannanase (SEQ ID NO:6) from Bacillus subtilis exhibited excellent performance in removing guar gum, and its performance in model detergents B and T was twice that of the commercial enzyme Mannaway.
[0623] Example 7: Washing performance of GH26 mannanase using the Terg-O-tometer washing test
[0624] The terg-o-tometer is an industry standard. 1 L of washing solution was incubated in a temperature-controlled water bath. The solution was mixed for 5 min before adding 1 L to each beaker. The temperature in the beakers was measured to be 20.0 °C. Small samples of washed and rinsed fabric were dried overnight in a drying oven and measured as shown in Table 9 below.
[0625] Table 9: Conditions for the Terg-O-tometer Washing Test
[0626] Test solution Model B detergent 1g / L Test solution volume 1L pH Model B, unadjusted Washing time 30 minutes temperature 20℃ water hardness 15°dH <![CDATA[Ca 2+ :Mg 2+ CO3 2- Ratio]]> 4:1:7.5 mechanical action 120rpm Enzyme dosage 0.05 mg / L
[0627] The stains used here are a combination of food stains and technical stains provided by the BV Centre for Testing Materials in the Netherlands (Stoomloggerweg 11, 3133 KT Vlardingen) (see Table 10).
[0628] Table 10: Stains used in the Terg-o-tometer washing test
[0629] Material source KC-H033 Chocolate Ice Cream with Guar Gum CFT CS-43 Guar Gum CFT CS-73 Locust Bean Gum CFT
[0630] Washing performance is expressed as a Δreflectance value (ΔRem). After washing and rinsing, small fabric samples were laid flat and allowed to air dry overnight at room temperature. The light reflectance of the small fabric samples was evaluated using a Macbeth Color Eye 7000 reflectance spectrophotometer with a large aperture. Measurements were taken in the absence of UV in the incident light, and the reflectance at 460 nm was extracted. Dry fabric samples were measured using a ColorEye 2. Aperture measurements were performed using three layers (three fabric samples of the same type from the same beaker), with two measurements taken on each fabric sample on the front side labeled with the beaker number and fabric sample number. The reflectance value of a single fabric sample was calculated by subtracting the reflectance value of a control fabric sample from the reflectance value of the washed fabric sample. For each stain, the enzyme effect was calculated by taking the measurement from the enzyme-washed fabric sample and subtracting it from the measurement from the un-enzyme-washed fabric sample. Total enzyme performance is expressed as a single ΔRem. 酶 The average value is calculated and shown in Table 11 below.
[0631] Table 11: Washing Results of Terg-o-tometer
[0632] stains Mannaway SEQ ID NO:6 KC-H033 Vienetta 9 9 CS-43 Guar Gum 4 8 CS-73 Locust Bean Gum 9 9
[0633] The full-length GH26 mannanase (SEQ ID NO:6) from Bacillus subtilis exhibits similar performance to the commercial enzyme Mannaway in removing Vienetta and locust bean gum stains, and demonstrates superior performance in removing guar gum stains, being twice as effective as Mannaway.
[0634] Example 8: Washing performance using AMSA's GH26 mannanase
[0635] The experiment was conducted as described in Example 6 and under the experimental conditions specified in Table 12.
[0636] Table 12: Conditions for AMSA Washing Test
[0637] Test solution Model O detergent 2g / L Test solution volume 160μL pH Model O, unadjusted pH enzyme concentration 0.25 mg / L Washing time 20 minutes temperature 20℃ water hardness 15°dH <![CDATA[Ca 2+ :Mg 2+ CO3 2- Ratio]]> 4:1:7.5
[0638] Table 13 shows the composition of detergent for model O. The results are shown in Table 14.
[0639] Table 13: Composition of Model O Detergent
[0640] Ingredients (abbreviations) illustrate weight% LAS (C10-C13)alkylbenzenesulfonate sodium salt 4.00 SLES Sodium lauryl ether sulfate 8.00 Soy soap 1.00 AEO alcohol ethoxylates 4.00 TEA Triethanolamine 0.40 Sodium citrate Trisodium citrate dihydrate 2.00 Calcium chloride Calcium chloride dihydrate 0.02 Ion-exchanged water 80.58
[0641] Table 14: AMSA washing results of model O detergent on guar gum small piece fabric sample CS-43
[0642]
[0643] The full-length GH26 mannanase (SEQ ID NO:13) from Bacillus ylangis showed excellent performance in removing guar gum, with performance almost twice that of the commercial enzyme Mannaway.
[0644] Example 9: Washing performance of GH26 mannanase using the Terg-O-tometer washing test
[0645] As described in Example 7 and the experiments were conducted under the experimental conditions specified in Table 15.
[0646] Table 15: Conditions for the Terg-O-tometer Washing Test
[0647] Test solution Model A detergent 3.3g / L Test solution volume 1L pH Model A, unadjusted Washing time 30 minutes temperature 20℃ water hardness 15°dH <![CDATA[Ca 2+ :Mg 2+ CO3 2- Ratio]]> 4:1:7.5 mechanical action 120rpm Enzyme dosage 0.6 mg / L
[0648] Table 16 shows the composition of detergent for Model A. The results are shown in Table 17.
[0649] Table 16: Composition of Detergent in Model A
[0650]
[0651] Table 17: Terg-o-tometer washing results of guar gum small cloth sample CS-43 with model O detergent
[0652]
[0653] Compared to the commercial enzyme Mannaway, the full-length (SEQ ID NO:6) and truncated (SEQ ID NO:8) GH26 mannanase from Bacillus subtilis showed superior performance in removing guar gum.
[0654] The invention described and claimed herein is not limited to the specific aspects disclosed herein, as these aspects are intended to illustrate several aspects of the invention. Any equivalent aspects are intended to be within the scope of the invention. In fact, various modifications to the invention, in addition to those shown and described herein, will become apparent to those skilled in the art from the foregoing description. Such modifications are also intended to fall within the scope of the appended claims. In case of conflict, the disclosure including the definition shall prevail. sequence list <110> Novozymes A / S <120> Polypeptides with mannanase activity and polynucleotides encoding them <130> 14623-WO-PCT <160> 18 <170> PatentIn version 3.5 <210> 1 <211> 1587 <212> DNA <213> Pine-like Bacillus <220> <221> CDS <222> (1)..(1584) <220> <221> signal peptide <222> (1)..(90) <220> <221> Mature peptides <222> (91)..(1584) <400> 1 atg gtt ttg tta tgc atg ata att ctg atg gga atg tct ggt tca gct 48 Met Val Leu Leu Cys Met Ile Ile Leu Met Gly Met Ser Gly Ser Ala -30 -25 -20 -15 gct tca ata gcc gat gct tct tca acc gga caa gtt gct ctc atg aat 96 Ala Ser Ile Ala Asp Ala Ser Ser Thr Gly Gln Val Ala Leu Met Asn -10 -5 -1 1 atg gaa ggc acg cca tct gtc agt ccg act aac agc ata acg gtt act 144 Met Glu Gly Thr Pro Ser Val Ser Pro Thr Asn Ser Ile Thr Val Thr 5 10 15 ttt gct aat gcg gtg tta gaa ggt tac ggt atc gag aaa cgc ggt tct 192 Phe Ala Asn Ala Val Leu Glu Gly Tyr Gly Ile Glu Lys Arg Gly Ser 20 25 30 gtc aaa gaa gac gat gat act ttg tat gac ggt gaa ggc tat atc tct 240 Val Lys Glu Asp Asp Asp Thr Leu Tyr Asp Gly Glu Gly Tyr Ile Ser 35 40 45 50 tac ttt ttt gat gaa att gga ggc gct gca gaa ccc gtc ggc agt gca 288 Tyr Phe Phe Asp Glu Ile Gly Gly Ala Ala Glu Pro Val Gly Ser Ala 55 60 65 gct ttt act gtg gac gct gcg aaa gct ggg ctg tat gag ctg agt tta 336 Ala Phe Thr Val Asp Ala Ala Lys Ala Gly Leu Tyr Glu Leu Ser Leu 70 75 80 ggc tac tac atc ccc gaa ggc tac ggg gat aaa gtg acc cgt ata cag 384 Gly Tyr Tyr Ile Pro Glu Gly Tyr Gly Asp Lys Val Thr Arg Ile Gln 85 90 95 att aat ggt gaa ggc acc gga gag ctg aca ttg gat gcg ccg gca gca 432 Ile Asn Gly Glu Gly Thr Gly Glu Leu Thr Leu Asp Ala Pro Ala Ala 100 105 110 ggt acg gtt cgt gct gag aaa atg gtc agt aag gtg ctg ctg aac gca 480 Gly Thr Val Arg Ala Glu Lys Met Val Ser Lys Val Leu Leu Asn Ala 115 120 125 130 ggc agc aat aca atc caa att atg cgc gga tgg ggt tac tac ggc att 528 Gly Ser Asn Thr Ile Gln Ile Met Arg Gly Trp Gly Tyr Tyr Gly Ile 135 140 145 gag cat atc aag ctt gca ccc gcg aat gaa gca cca ccc agt aac aag 576 Glu His Ile Lys Leu Ala Pro Ala Asn Glu Ala Pro Pro Ser Asn Lys 150 155 160 ctg aat gca gag gac agc atc agg act ggc aca ttg aac aat ccc gaa 624 Leu Asn Ala Glu Asp Ser Ile Arg Thr Gly Thr Leu Asn Asn Pro Glu 165 170 175 gcg aca gct gag gcc aga gcg cta atg aac tac ttg ctc agc cag tat 672 Ala Thr Ala Glu Ala Arg Ala Leu Met Asn Tyr Leu Leu Ser Gln Tyr 180 185 190 gga caa aaa att atc tct gga cag cag acg ctt gaa gat gtg gag tgg 720 Gly Gln Lys Ile Ile Ser Gly Gln Gln Thr Leu Glu Asp Val Glu Trp 195 200 205 210 atc aag cag cag aca ggc aaa tat cca gcg att ttc tct aca gac ttg 768 Ile Lys Gln Gln Thr Gly Lys Tyr Pro Ala Ile Phe Ser Thr Asp Leu 215 220 225 atg gat tac tcc cct tcc cgc gtg gat cat gga gcc tcc tcc act gag 816 Met Asp Tyr Ser Pro Ser Arg Val Asp His Gly Ala Ser Ser Thr Glu 230 235 240 gtc gag aag atg atc gaa tgg tac aaa cgc ggt ggt att gtg tct tta 864 Val Glu Lys Met Ile Glu Trp Tyr Lys Arg Gly Gly Ile Val Ser Leu 245 250 255 tgc tgg cac tgg aat gcc ccg aag gga atc ggc ggc aat gag cct ggc 912 Cys Trp His Trp Asn Ala Pro Lys Gly Ile Gly Gly Asn Glu Pro Gly 260 265 270 aac gag tgg tgg cga ggc ttc tac act gaa ttt aca acc ttt gat gtg 960 Asn Glu Trp Trp Arg Gly Phe Tyr Thr Glu Phe Thr Thr Phe Asp Val 275 280 285 290 gaa tat gct ctt aat cat ccg gat tct gag gac tac cag ctc ctg atc 1008 Glu Tyr Ala Leu Asn His Pro Asp Ser Glu Asp Tyr Gln Leu Leu Ile 295 300 305 cgg gac att gac gcc atc gca gtt cag ttg aag cga ttg cag gag gcg 1056 Arg Asp Ile Asp Ala Ile Ala Val Gln Leu Lys Arg Leu Gln Glu Ala 310 315 320 aac gtg cct gtg tta tgg cga ccc ctg cac gag gca gag ggc acc tgg 1104 Asn Val Pro Val Leu Trp Arg Pro Leu His Glu Ala Glu Gly Thr Trp 325 330 335 ttt tgg tgg gga gca aaa ggg ccc gag ccg gcg aaa cag ctc tat cgt 1152 Phe Trp Trp Gly Ala Lys Gly Pro Glu Pro Ala Lys Gln Leu Tyr Arg 340 345 350 tta atg tat gat cgg tta acc aat gat cat aag ctg aac aat ctg att 1200 Leu Met Tyr Asp Arg Leu Thr Asn Asp His Lys Leu Asn Asn Leu Ile 355 360 365 370 tgg gtg tgg aac tcc gag aaa aag gat tgg tat ccg gga gat gat gtc 1248 Trp Val Trp Asn Ser Glu Lys Lys Asp Trp Tyr Pro Gly Asp Asp Val 375 380 385 gta gat atg gta agc gtt gatt atc tac aac cct gca ggc gac tat aat 1296 Val Asp Met Val Ser Val Asp Ile Tyr Asn Pro Ala Gly Asp Tyr Asn 390,395,400 ccg agc atc gca aaa tat gaa gcg ctt gta tct ttg gcg gac aac aag 1344 Pro Being Ile Wing Lys Tyr Glu Wing Lew Val Being Wing Asp Asn Lys 405 410 415 aag atg gct gca cta gcg gag aat ggg cct at ccg gat ccg gat gct 1392 Lys Met Ala Ala Leu Ala Glu Asn Gly Pro Ile Pro Asp Pro Asp Ala 420 425 430 ctt cag gag tac gcc gcc gac tgg agc ttc ttt agt acc tgg acc gc 1440 Leu Gln Glu Tyr Gly Ala Asp Trp Ser Phe Phe Ser Thr Trp Thr Gly 435 440 445 450 gac tac atc agg gat ggc aag aca aat acg ata gaa cat ttg aag aag 1488 Asp Tyr With Arg Asp Gly Lys Thr Asn Thr With Glu His Leu Lys Lys 455 460 465 gta tat caa cac gat tc gtc att act ctc gac gaa ctc ccg gca gac 1536 Val Tyr Gln His Asp Tyr Val Ile Thr Leu Asp Glu Leu Pro Ala Asp 470 475 480 tgt act cca atc ttg atg ata agg caa aga atg gtg aat cag cag gga 1584 Cys Thr Pro Ile Leu Met Ile Arg Gln Arg Met Val Asn Gln Gln Gly 485 490 495 tga 1587 <210> 2 <211> 528 <212> PRT <213> Paenibacillus alvei <400> 2 Met Val Leu Leu Cys Met Ile Ile Leu Met Gly Met Ser Gly Ser Ala -30 -25 -20 -15 Ala Ser Ile Ala Asp Ala Ser Ser Thr Gly Gln Val Ala Leu Met Asn -10 -5 -1 1 Met Glu Gly Thr Pro Ser Val Ser Pro Thr Asn Ser Ile Thr Val Thr 5 10 15 Phe Ala Asn Ala Val Leu Glu Gly Tyr Gly Ile Glu Lys Arg Gly Ser 20 25 30 Val Lys Glu Asp Asp Asp Thr Leu Tyr Asp Gly Glu Gly Tyr Ile Ser 35 40 45 50 Tyr Phe Phe Asp Glu Ile Gly Gly Ala Ala Glu Pro Val Gly Ser Ala 55 60 65 Ala Phe Thr Val Asp Ala Ala Lys Ala Gly Leu Tyr Glu Leu Ser Leu 70 75 80 Gly Tyr Tyr Ile Pro Glu Gly Tyr Gly Asp Lys Val Thr Arg Ile Gln 85 90 95 Ile Asn Gly Glu Gly Thr Gly Glu Leu Thr Leu Asp Ala Pro Ala Ala 100 105 110 Gly Thr Val Arg Ala Glu Lys Met Val Ser Lys Val Leu Leu Asn Ala 115 120 125 130 Gly Ser Asn Thr Ile Gln Ile Met Arg Gly Trp Gly Tyr Tyr Gly Ile 135 140 145 Glu His Ile Lys Leu Ala Pro Ala Asn Glu Ala Pro Pro Ser Asn Lys 150 155 160 Leu Asn Ala Glu Asp Ser Ile Arg Thr Gly Thr Leu Asn Asn Pro Glu 165 170 175 Ala Thr Ala Glu Ala Arg Ala Leu Met Asn Tyr Leu Leu Ser Gln Tyr 180 185 190 Gly Gln Lys Ile Ile Ser Gly Gln Gln Thr Leu Glu Asp Val Glu Trp 195 200 205 210 Ile Lys Gln Gln Thr Gly Lys Tyr Pro Ala Ile Phe Ser Thr Asp Leu 215 220 225 Met Asp Tyr Ser Pro Ser Arg Val Asp His Gly Ala Ser Ser Thr Glu 230 235 240 Val Glu Lys Met Ile Glu Trp Tyr Lys Arg Gly Gly Ile Val Ser Leu 245 250 255 Cys Trp His Trp Asn Ala Pro Lys Gly Ile Gly Gly Asn Glu Pro Gly 260 265 270 Asn Glu Trp Trp Arg Gly Phe Tyr Thr Glu Phe Thr Thr Phe Asp Val 275 280 285 290 Glu Tyr Ala Leu Asn His Pro Asp Ser Glu Asp Tyr Gln Leu Leu Ile 295 300 305 Arg Asp Ile Asp Ala Ile Ala Val Gln Leu Lys Arg Leu Gln Glu Ala 310 315 320 Asn Val Pro Val Leu Trp Arg Pro Leu His Glu Ala Glu Gly Thr Trp 325 330 335 Phe Trp Trp Gly Ala Lys Gly Pro Glu Pro Ala Lys Gln Leu Tyr Arg 340 345 350 Leu Met Tyr Asp Arg Leu Thr Asn Asp His Lys Leu Asn Asn Leu Ile 355 360 365 370 Trp Val Trp Asn Ser Glu Lys Lys Asp Trp Tyr Pro Gly Asp Asp Val 375 380 385 Val Asp Met Val Ser Val Asp Ile Tyr Asn Pro Ala Gly Asp Tyr Asn 390 395 400 Pro Ser Ile Ala Lys Tyr Glu Ala Leu Val Ser Leu Ala Asp Asn Lys 405 410 415 Lys Met Ala Ala Leu Ala Glu Asn Gly Pro Ile Pro Asp Pro Asp Ala 420 425 430 Leu Gln Glu Tyr Gly Ala Asp Trp Ser Phe Phe Ser Thr Trp Thr Gly 435 440 445 450 Asp Tyr Ile Arg Asp Gly Lys Thr Asn Thr Ile Glu His Leu Lys Lys 455 460 465 Val Tyr Gln His Asp Tyr Val Ile Thr Leu Asp Glu Leu Pro Ala Asp 470 475 480 Cys Thr Pro Ile Leu Met Ile Arg Gln Arg Met Val Asn Gln Gln Gly 485 490 495 <210> 3 <211> 498 <212> PRT <213> Pine-like Bacillus <220> <221> Mature peptides <222> (1)..(498) <400> 3 Met Asn Met Glu Gly Thr Pro Ser Val Ser Pro Thr Asn Ser Ile Thr 1 5 10 15 Val Thr Phe Ala Asn Ala Val Leu Glu Gly Tyr Gly Ile Glu Lys Arg 20 25 30 Gly Ser Val Lys Glu Asp Asp Asp Thr Leu Tyr Asp Gly Glu Gly Tyr 35 40 45 Ile Ser Tyr Phe Phe Asp Glu Ile Gly Gly Ala Ala Glu Pro Val Gly 50 55 60 Ser Ala Ala Phe Thr Val Asp Ala Ala Lys Ala Gly Leu Tyr Glu Leu 65 70 75 80 Ser Leu Gly Tyr Tyr Ile Pro Glu Gly Tyr Gly Asp Lys Val Thr Arg 85 90 95 Ile Gln Ile Asn Gly Glu Gly Thr Gly Glu Leu Thr Leu Asp Ala Pro 100 105 110 Ala Ala Gly Thr Val Arg Ala Glu Lys Met Val Ser Lys Val Leu Leu 115 120 125 Asn Ala Gly Ser Asn Thr Ile Gln Ile Met Arg Gly Trp Gly Tyr Tyr 130 135 140 Gly Ile Glu His Ile Lys Leu Ala Pro Ala Asn Glu Ala Pro Pro Ser 145 150 155 160 Asn Lys Leu Asn Ala Glu Asp Ser Ile Arg Thr Gly Thr Leu Asn Asn 165 170 175 Pro Glu Ala Thr Ala Glu Ala Arg Ala Leu Met Asn Tyr Leu Leu Ser 180 185 190 Gln Tyr Gly Gln Lys Ile Ile Ser Gly Gln Gln Thr Leu Glu Asp Val 195 200 205 Glu Trp Ile Lys Gln Gln Thr Gly Lys Tyr Pro Ala Ile Phe Ser Thr 210 215 220 Asp Leu Met Asp Tyr Ser Pro Ser Arg Val Asp His Gly Ala Ser Ser 225 230 235 240 Thr Glu Val Glu Lys Met Ile Glu Trp Tyr Lys Arg Gly Gly Ile Val 245 250 255 Ser Leu Cys Trp His Trp Asn Ala Pro Lys Gly Ile Gly Gly Asn Glu 260 265 270 Pro Gly Asn Glu Trp Trp Arg Gly Phe Tyr Thr Glu Phe Thr Thr Phe 275 280 285 Asp Val Glu Tyr Ala Leu Asn His Pro Asp Ser Glu Asp Tyr Gln Leu 290 295 300 Leu Ile Arg Asp Ile Asp Ala Ile Ala Val Gln Leu Lys Arg Leu Gln 305 310 315 320 Glu Ala Asn Val Pro Val Leu Trp Arg Pro Leu His Glu Ala Glu Gly 325 330 335 Thr Trp Phe Trp Trp Gly Ala Lys Gly Pro Glu Pro Ala Lys Gln Leu 340 345 350 Tyr Arg Leu Met Tyr Asp Arg Leu Thr Asn Asp His Lys Leu Asn Asn 355 360 365 Leu Ile Trp Val Trp Asn Ser Glu Lys Lys Asp Trp Tyr Pro Gly Asp 370 375 380 Asp Val Val Asp Met Val Ser Val Asp Ile Tyr Asn Pro Ala Gly Asp 385 390 395 400 Tyr Asn Pro Ser Ile Ala Lys Tyr Glu Ala Leu Val Ser Leu Ala Asp 405 410 415 Asn Lys Lys Met Ala Ala Leu Ala Glu Asn Gly Pro Ile Pro Asp Pro 420 425 430 Asp Ala Leu Gln Glu Tyr Gly Ala Asp Trp Ser Phe Phe Ser Thr Trp 435 440 445 Thr Gly Asp Tyr Ile Arg Asp Gly Lys Thr Asn Thr Ile Glu His Leu 450 455 460 Lys Lys Val Tyr Gln His Asp Tyr Val Ile Thr Leu Asp Glu Leu Pro 465 470 475 480 Ala Asp Cys Thr Pro Ile Leu Met Ile Arg Gln Arg Met Val Asn Gln 485 490 495 Gln Gly <210> 4 <211> 330 <212> PRT <213> Artificial sequence <220> <223> A truncated GH26 mannanase lacking the CBM35 domain, isolated from wild-type Bacillus subtilis. <220> <221> Mature peptides <222> (1)..(330) <400> 4 Ile Arg Thr Gly Thr Leu Asn Asn Pro Glu Ala Thr Ala Glu Ala Arg 1 5 10 15 Ala Leu Met Asn Tyr Leu Leu Ser Gln Tyr Gly Gln Lys Ile Ile Ser 20 25 30 Gly Gln Gln Thr Leu Glu Asp Val Glu Trp Ile Lys Gln Gln Thr Gly 35 40 45 Lys Tyr Pro Ala Ile Phe Ser Thr Asp Leu Met Asp Tyr Ser Pro Ser 50 55 60 Arg Val Asp His Gly Ala Ser Ser Thr Glu Val Glu Lys Met Ile Glu 65 70 75 80 Trp Tyr Lys Arg Gly Gly Ile Val Ser Leu Cys Trp His Trp Asn Ala 85 90 95 Pro Lys Gly Ile Gly Gly Asn Glu Pro Gly Asn Glu Trp Trp Arg Gly 100 105 110 Phe Tyr Thr Glu Phe Thr Thr Phe Asp Val Glu Tyr Ala Leu Asn His 115 120 125 Pro Asp Ser Glu Asp Tyr Gln Leu Leu Ile Arg Asp Ile Asp Ala Ile 130 135 140 Ala Val Gln Leu Lys Arg Leu Gln Glu Ala Asn Val Pro Val Leu Trp 145 150 155 160 Arg Pro Leu His Glu Ala Glu Gly Thr Trp Phe Trp Trp Gly Ala Lys 165 170 175 Gly Pro Glu Pro Ala Lys Gln Leu Tyr Arg Leu Met Tyr Asp Arg Leu 180 185 190 Thr Asn Asp His Lys Leu Asn Asn Leu Ile Trp Val Trp Asn Ser Glu 195 200 205 Lys Lys Asp Trp Tyr Pro Gly Asp Asp Val Val Asp Met Val Ser Val 210 215 220 Asp Ile Tyr Asn Pro Ala Gly Asp Tyr Asn Pro Ser Ile Ala Lys Tyr 225 230 235 240 Glu Ala Leu Val Ser Leu Ala Asp Asn Lys Lys Met Ala Ala Leu Ala 245 250 255 Glu Asn Gly Pro Ile Pro Asp Pro Asp Ala Leu Gln Glu Tyr Gly Ala 260 265 270 Asp Trp Ser Phe Phe Ser Thr Trp Thr Gly Asp Tyr Ile Arg Asp Gly 275 280 285 Lys Thr Asn Thr Ile Glu His Leu Lys Lys Val Tyr Gln His Asp Tyr 290 295 300 Val Ile Thr Leu Asp Glu Leu Pro Ala Asp Cys Thr Pro Ile Leu Met 305 310 315 320 Ile Arg Gln Arg Met Val Asn Gln Gln Gly 325 330 <210> 5 <211> 1515 <212> DNA <213> Artificial sequence <220> <223> The construct DNA sequence of GH26 mannanase containing CBM35, in which the native secretion signal is removed and a 6xHis tag is directly added to the C-terminus of the protein. <220> <221> CDS <222> (1)..(1512) <220> <221> Mature peptides <222> (1)..(1512) <400> 5 atg aat atg gaa ggc acg cca tct gtc agt ccg act aac agc ata acg 48 Met Asn Met Glu Gly Thr Pro Ser Val Ser Pro Thr Asn Ser Ile Thr 1 5 10 15 gtt act ttt gct aat gcg gtg tta gaa ggt tac ggt atc gag aaa cgc 96 Val Thr Phe Ala Asn Ala Val Leu Glu Gly Tyr Gly Ile Glu Lys Arg 20 25 30 ggt tct gtc aaa gaa gac gat gat act ttg tat gac ggt gaa ggc tat 144 Gly Ser Val Lys Glu Asp Asp Asp Thr Leu Tyr Asp Gly Glu Gly Tyr 35 40 45 atc tct tac ttt ttt gat gaa att gga ggc gct gca gaa ccc gtc ggc 192 Ile Ser Tyr Phe Phe Asp Glu Ile Gly Gly Ala Ala Glu Pro Val Gly 50 55 60 agt gca gct ttt act gtg gac gct gcg aaa gct ggg ctg tat gag ctg 240 Ser Ala Ala Phe Thr Val Asp Ala Ala Lys Ala Gly Leu Tyr Glu Leu 65 70 75 80 agt tta ggc tac tac atc ccc gaa ggc tac ggg gat aaa gtg acc cgt 288 Ser Leu Gly Tyr Tyr Ile Pro Glu Gly Tyr Gly Asp Lys Val Thr Arg 85 90 95 ata cag att aat ggt gaa ggc acc gga gag ctg aca ttg gat gcg ccg 336 Ile Gln Ile Asn Gly Glu Gly Thr Gly Glu Leu Thr Leu Asp Ala Pro 100 105 110 gca gca ggt acg gtt cgt gct gag aaa atg gtc agt aag gtg ctg ctg 384 Ala Ala Gly Thr Val Arg Ala Glu Lys Met Val Ser Lys Val Leu Leu 115 120 125 aac gca ggc agc aat aca atc caa att atg cgc gga tgg ggt tac tac 432 Asn Ala Gly Ser Asn Thr Ile Gln Ile Met Arg Gly Trp Gly Tyr Tyr 130 135 140 ggc att gag cat atc aag ctt gca ccc gcg aat gaa gca cca ccc agt 480 Gly Ile Glu His Ile Lys Leu Ala Pro Ala Asn Glu Ala Pro Pro Ser 145 150 155 160 aac aag ctg aat gca gag gac agc atc agg act ggc aca ttg aac aat 528 Asn Lys Leu Asn Ala Glu Asp Ser Ile Arg Thr Gly Thr Leu Asn Asn 165 170 175 ccc gaa gcg aca gct gag gcc aga gcg cta atg aac tac ttg ctc agc 576 Pro Glu Ala Thr Ala Glu Ala Arg Ala Leu Met Asn Tyr Leu Leu Ser 180 185 190 cag tat gga caa aaa att atc tct gga cag cag acg ctt gaa gat gtg 624 Gln Tyr Gly Gln Lys Ile Ile Ser Gly Gln Gln Thr Leu Glu Asp Val 195 200 205 gag tgg atc aag cag cag aca ggc aaa tat cca gcg att ttc tct aca 672 Glu Trp Ile Lys Gln Gln Thr Gly Lys Tyr Pro Ala Ile Phe Ser Thr 210 215 220 gac ttg atg gat tac tcc cct tcc cgc gtg gat cat gga gcc tcc tcc 720 Asp Leu Met Asp Tyr Ser Pro Ser Arg Val Asp His Gly Ala Ser Ser 225 230 235 240 act gag gtc gag aag atg atc gaa tgg tac aaa cgc ggt ggt att gtg 768 Thr Glu Val Glu Lys Met Ile Glu Trp Tyr Lys Arg Gly Gly Ile Val 245 250 255 tct tta tgc tgg cac tgg aat gcc ccg aag gga atc ggc ggc aat gag 816 Ser Leu Cys Trp His Trp Asn Ala Pro Lys Gly Ile Gly Gly Asn Glu 260 265 270 cct ggc aac gag tgg tgg cga ggc ttc tac act gaa ttt aca acc ttt 864 Pro Gly Asn Glu Trp Trp Arg Gly Phe Tyr Thr Glu Phe Thr Thr Phe 275 280 285 gat gtg gaa tat gct ctt aat cat ccg gat tct gag gac tac cag ctc 912 Asp Val Glu Tyr Ala Leu Asn His Pro Asp Ser Glu Asp Tyr Gln Leu 290 295 300 ctg atc cgg gac att gac gcc atc gca gtt cag ttg aag cga ttg cag 960 Leu Ile Arg Asp Ile Asp Ala Ile Ala Val Gln Leu Lys Arg Leu Gln 305 310 315 320 gag gcg aac gtg cct gtg tta tgg cga ccc ctg cac gag gca gag ggc 1008 Glu Ala Asn Val Pro Val Leu Trp Arg Pro Leu His Glu Ala Glu Gly 325 330 335 acc tgg ttt tgg tgg gga gca aaa ggg ccc gag ccg gcg aaa cag ctc 1056 Thr Trp Phe Trp Trp Gly Ala Lys Gly Pro Glu Pro Ala Lys Gln Leu 340 345 350 tat cgt tta atg tat gat cgg tta acc aat gat cat aag ctg aac aat 1104 Tyr Arg Leu Met Tyr Asp Arg Leu Thr Asn Asp His Lys Leu Asn Asn 355 360 365 ctg att tgg gtg tgg aac tcc gag aaa aag gat tgg tat ccg gga gat 1152 Leu Ile Trp Val Trp Asn Ser Glu Lys Lys Asp Trp Tyr Pro Gly Asp 370 375 380 gat gtc gta gat atg gta agc gtt gat atc tac aac cct gca ggc gac 1200 Asp Val Val Asp Met Val Ser Val Asp Ile Tyr Asn Pro Ala Gly Asp 385 390 395 400 tat aat ccg agc atc gca aaa tat gaa gcg ctt gta tct ttg gcg gac 1248 Tyr Asn Pro Ser Ile Ala Lys Tyr Glu Ala Leu Val Ser Leu Ala Asp 405 410 415 aac aag aag atg gct gca cta gcg gag aat ggg cct att ccg gat ccg 1296 Asn Lys Lys Met Ala Ala Leu Ala Glu Asn Gly Pro Ile Pro Asp Pro 420 425 430 gat gct ctt cag gag tac ggc gcc gac tgg agc ttc ttt agt acc tgg 1344 Asp Ala Leu Gln Glu Tyr Gly Ala Asp Trp Ser Phe Phe Ser Thr Trp 435 440 445 acc ggc gac tac atc agg gat ggc aag aca aat acg ata gaa cat ttg 1392 Thr Gly Asp Tyr Ile Arg Asp Gly Lys Thr Asn Thr Ile Glu His Leu 450 455 460 aag aag gta tat caa cac gat tac gtc att act ctc gac gaa ctc ccg 1440 Lys Lys Val Tyr Gln His Asp Tyr Val Ile Thr Leu Asp Glu Leu Pro 465 470 475 480 gca gac tgt act cca atc ttg atg ata agg caa aga atg gtg aat cag 1488 Ala Asp Cys Thr Pro Ile Leu Met Ile Arg Gln Arg Met Val Asn Gln 485 490 495 cag gga cat cat cac cat cac cac taa 1515 Gln Gly His His His His His His 500 <210> 6 <211> 504 <212> PRT <213> Artificial sequence <220> <223> Synthetic construct <400> 6 Met Asn Met Glu Gly Thr Pro Ser Val Ser Pro Thr Asn Ser Ile Thr 1 5 10 15 Val Thr Phe Ala Asn Ala Val Leu Glu Gly Tyr Gly Ile Glu Lys Arg 20 25 30 Gly Ser Val Lys Glu Asp Asp Asp Thr Leu Tyr Asp Gly Glu Gly Tyr 35 40 45 Ile Ser Tyr Phe Phe Asp Glu Ile Gly Gly Ala Ala Glu Pro Val Gly 50 55 60 Ser Ala Ala Phe Thr Val Asp Ala Ala Lys Ala Gly Leu Tyr Glu Leu 65 70 75 80 Ser Leu Gly Tyr Tyr Ile Pro Glu Gly Tyr Gly Asp Lys Val Thr Arg 85 90 95 Ile Gln Ile Asn Gly Glu Gly Thr Gly Glu Leu Thr Leu Asp Ala Pro 100 105 110 Ala Ala Gly Thr Val Arg Ala Glu Lys Met Val Ser Lys Val Leu Leu 115 120 125 Asn Ala Gly Ser Asn Thr Ile Gln Ile Met Arg Gly Trp Gly Tyr Tyr 130 135 140 Gly Ile Glu His Ile Lys Leu Ala Pro Ala Asn Glu Ala Pro Pro Ser 145 150 155 160 Asn Lys Leu Asn Ala Glu Asp Ser Ile Arg Thr Gly Thr Leu Asn Asn 165 170 175 Pro Glu Ala Thr Ala Glu Ala Arg Ala Leu Met Asn Tyr Leu Leu Ser 180 185 190 Gln Tyr Gly Gln Lys Ile Ile Ser Gly Gln Gln Thr Leu Glu Asp Val 195 200 205 Glu Trp Ile Lys Gln Gln Thr Gly Lys Tyr Pro Ala Ile Phe Ser Thr 210 215 220 Asp Leu Met Asp Tyr Ser Pro Ser Arg Val Asp His Gly Ala Ser Ser 225 230 235 240 Thr Glu Val Glu Lys Met Ile Glu Trp Tyr Lys Arg Gly Gly Ile Val 245 250 255 Ser Leu Cys Trp His Trp Asn Ala Pro Lys Gly Ile Gly Gly Asn Glu 260 265 270 Pro Gly Asn Glu Trp Trp Arg Gly Phe Tyr Thr Glu Phe Thr Thr Phe 275 280 285 Asp Val Glu Tyr Ala Leu Asn His Pro Asp Ser Glu Asp Tyr Gln Leu 290 295 300 Leu Ile Arg Asp Ile Asp Ala Ile Ala Val Gln Leu Lys Arg Leu Gln 305 310 315 320 Glu Ala Asn Val Pro Val Leu Trp Arg Pro Leu His Glu Ala Glu Gly 325 330 335 Thr Trp Phe Trp Trp Gly Ala Lys Gly Pro Glu Pro Ala Lys Gln Leu 340 345 350 Tyr Arg Leu Met Tyr Asp Arg Leu Thr Asn Asp His Lys Leu Asn Asn 355 360 365 Leu Ile Trp Val Trp Asn Ser Glu Lys Lys Asp Trp Tyr Pro Gly Asp 370 375 380 Asp Val Val Asp Met Val Ser Val Asp Ile Tyr Asn Pro Ala Gly Asp 385 390 395 400 Tyr Asn Pro Ser Ile Ala Lys Tyr Glu Ala Leu Val Ser Leu Ala Asp 405 410 415 Asn Lys Lys Met Ala Ala Leu Ala Glu Asn Gly Pro Ile Pro Asp Pro 420 425 430 Asp Ala Leu Gln Glu Tyr Gly Ala Asp Trp Ser Phe Phe Ser Thr Trp 435 440 445 Thr Gly Asp Tyr Ile Arg Asp Gly Lys Thr Asn Thr Ile Glu His Leu 450 455 460 Lys Lys Val Tyr Gln His Asp Tyr Val Ile Thr Leu Asp Glu Leu Pro 465 470 475 480 Ala Asp Cys Thr Pro Ile Leu Met Ile Arg Gln Arg Met Val Asn Gln 485 490 495 Gln Gly His His His His His His 500 <210> 7 <211> 1014 <212> DNA <213> Artificial sequence <220> <223> The construct DNA sequence of GH26 mannanase lacking the CBM35 domain and the 6xHis tag. Added directly to the C-terminus of the protein <220> <221> CDS <222> (1)..(1011) <400> 7 atg atc agg act ggc aca ttg aac aat ccc gaa gcg aca gct gag gcc 48 Met Ile Arg Thr Gly Thr Leu Asn Asn Pro Glu Ala Thr Ala Glu Ala 1 5 10 15 aga gcg cta atg aac tac ttg ctc agc cag tat gga caa aaa att atc 96 Arg Ala Leu Met Asn Tyr Leu Leu Ser Gln Tyr Gly Gln Lys Ile Ile 20 25 30 tct gga cag cag acg ctt gaa gat gtg gag tgg atc aag cag cag aca 144 Ser Gly Gln Gln Thr Leu Glu Asp Val Glu Trp Ile Lys Gln Gln Thr 35 40 45 ggc aaa tat cca gcg att ttc tct aca gac ttg atg gat tac tcc cct 192 Gly Lys Tyr Pro Ala Ile Phe Ser Thr Asp Leu Met Asp Tyr Ser Pro 50 55 60 tcc cgc gtg gat cat gga gcc tcc tcc act gag gtc gag aag atg atc 240 Ser Arg Val Asp His Gly Ala Ser Ser Thr Glu Val Glu Lys Met Ile 65 70 75 80 gaa tgg tac aaa cgc ggt ggt att gtg tct tta tgc tgg cac tgg aat 288 Glu Trp Tyr Lys Arg Gly Gly Ile Val Ser Leu Cys Trp His Trp Asn 85 90 95 gcc ccg aag gga atc ggc ggc aat gag cct ggc aac gag tgg tgg cga 336 Ala Pro Lys Gly Ile Gly Gly Asn Glu Pro Gly Asn Glu Trp Trp Arg 100 105 110 ggc ttc tac act gaa ttt aca acc ttt gat gtg gaa tat gct ctt aat 384 Gly Phe Tyr Thr Glu Phe Thr Thr Phe Asp Val Glu Tyr Ala Leu Asn 115 120 125 cat ccg gat tct gag gac tac cag ctc ctg atc cgg gac att gac gcc 432 His Pro Asp Ser Glu Asp Tyr Gln Leu Leu Ile Arg Asp Ile Asp Ala 130 135 140 atc gca gtt cag ttg aag cga ttg cag gag gcg aac gtg cct gtg tta 480 Ile Ala Val Gln Leu Lys Arg Leu Gln Glu Ala Asn Val Pro Val Leu 145 150 155 160 tgg cga ccc ctg cac gag gca gag ggc acc tgg ttt tgg tgg gga gca 528 Trp Arg Pro Leu His Glu Ala Glu Gly Thr Trp Phe Trp Trp Gly Ala 165 170 175 aaa ggg ccc gag ccg gcg aaa cag ctc tat cgt tta atg tat gat cgg 576 Lys Gly Pro Glu Pro Ala Lys Gln Leu Tyr Arg Leu Met Tyr Asp Arg 180 185 190 tta acc aat gat cat aag ctg aac aat ctg att tgg gtg tgg aac tcc 624 Leu Thr Asn Asp His Lys Leu Asn Asn Leu Ile Trp Val Trp Asn Ser 195 200 205 gag aaa aag gat tgg tat ccg gga gat gat gtc gta gat atg gta agc 672 Glu Lys Lys Asp Trp Tyr Pro Gly Asp Asp Val Val Asp Met Val Ser 210 215 220 gtt gat atc tac aac cct gca ggc gac tat aat ccg agc atc gca aaa 720 Val Asp Ile Tyr Asn Pro Ala Gly Asp Tyr Asn Pro Ser Ile Ala Lys 225 230 235 240 tat gaa gcg ctt gta tct ttg gcg gac aac aag aag atg gct gca cta 768 Tyr Glu Ala Leu Val Ser Leu Ala Asp Asn Lys Lys Met Ala Ala Leu 245 250 255 gcg gag aat ggg cct att ccg gat ccg gat gct ctt cag gag tac ggc 816 Ala Glu Asn Gly Pro Ile Pro Asp Pro Asp Ala Leu Gln Glu Tyr Gly 260 265 270 gcc gac tgg agc ttc ttt agt acc tgg acc ggc gac tac atc agg gat 864 Ala Asp Trp Ser Phe Phe Ser Thr Trp Thr Gly Asp Tyr Ile Arg Asp 275 280 285 ggc aag aca aat acg ata gaa cat ttg aag aag gta tat caa cac gat 912 Gly Lys Thr Asn Thr Ile Glu His Leu Lys Lys Val Tyr Gln His Asp 290 295 300 tac gtc att act ctc gac gaa ctc ccg gca gac tgt act cca atc ttg 960 Tyr Val Ile Thr Leu Asp Glu Leu Pro Ala Asp Cys Thr Pro Ile Leu 305 310 315 320 atg ata agg caa aga atg gtg aat cag cag gga cat cat cac cat cac 1008 Met Ile Arg Gln Arg Met Val Asn Gln Gln Gly His His His His His 325 330 335 cac taa 1014 His <210> 8 <211> 337 <212> PRT <213> Artificial sequence <220> <223> Synthetic construct <400> 8 Met Ile Arg Thr Gly Thr Leu Asn Asn Pro Glu Ala Thr Ala Glu Ala 1 5 10 15 Arg Ala Leu Met Asn Tyr Leu Leu Ser Gln Tyr Gly Gln Lys Ile Ile 20 25 30 Ser Gly Gln Gln Thr Leu Glu Asp Val Glu Trp Ile Lys Gln Gln Thr 35 40 45 Gly Lys Tyr Pro Ala Ile Phe Ser Thr Asp Leu Met Asp Tyr Ser Pro 50 55 60 Ser Arg Val Asp His Gly Ala Ser Ser Thr Glu Val Glu Lys Met Ile 65 70 75 80 Glu Trp Tyr Lys Arg Gly Gly Ile Val Ser Leu Cys Trp His Trp Asn 85 90 95 Ala Pro Lys Gly Ile Gly Gly Asn Glu Pro Gly Asn Glu Trp Trp Arg 100 105 110 Gly Phe Tyr Thr Glu Phe Thr Thr Phe Asp Val Glu Tyr Ala Leu Asn 115 120 125 His Pro Asp Ser Glu Asp Tyr Gln Leu Leu Ile Arg Asp Ile Asp Ala 130 135 140 Ile Ala Val Gln Leu Lys Arg Leu Gln Glu Ala Asn Val Pro Val Leu 145 150 155 160 Trp Arg Pro Leu His Glu Ala Glu Gly Thr Trp Phe Trp Trp Gly Ala 165 170 175 Lys Gly Pro Glu Pro Ala Lys Gln Leu Tyr Arg Leu Met Tyr Asp Arg 180 185 190 Leu Thr Asn Asp His Lys Leu Asn Asn Leu Ile Trp Val Trp Asn Ser 195 200 205 Glu Lys Lys Asp Trp Tyr Pro Gly Asp Asp Val Val Asp Met Val Ser 210 215 220 Val Asp Ile Tyr Asn Pro Ala Gly Asp Tyr Asn Pro Ser Ile Ala Lys 225 230 235 240 Tyr Glu Ala Leu Val Ser Leu Ala Asp Asn Lys Lys Met Ala Ala Leu 245 250 255 Ala Glu Asn Gly Pro Ile Pro Asp Pro Asp Ala Leu Gln Glu Tyr Gly 260 265 270 Ala Asp Trp Ser Phe Phe Ser Thr Trp Thr Gly Asp Tyr Ile Arg Asp 275 280 285 Gly Lys Thr Asn Thr Ile Glu His Leu Lys Lys Val Tyr Gln His Asp 290 295 300 Tyr Val Ile Thr Leu Asp Glu Leu Pro Ala Asp Cys Thr Pro Ile Leu 305 310 315 320 Met Ile Arg Gln Arg Met Val Asn Gln Gln Gly His His His His 325 330 335 His <210> 9 <211> 1704 <212> DNA <213> Bacillus ylangis <220> <221> CDS <222> (1)..(1704) <220> <221> signal peptide <222> (1)..(123) <220> <221> Mature peptides <222> (124) (1704) <400> 9 atg aaa gca atg tct aac ctt ctt gta gct gcg gag cag cgc aaa cgt 48 Met Lys Ala Met Ser Asn Leu Leu Val Ala Ala Glu Gln Arg Lys Arg -40 -35 -30 cgc ttc agc atc ttt ctt ttc tgt ttc gta atc ctt gct gga act tac 96 Arg Phe Ser Ile Phe Leu Phe Cys Phe Val Ile Leu Ala Gly Thr Tyr -25 -20 -15 -10 gga tca gcg gca cct atc gcg gac gct agc tct gca ctt cct gac acg 144 Gly Ser Ala Ala Pro Ile Ala Asp Ala Ser Ser Ala Leu Pro Asp Thr -5 -1 1 5 gtt gta aaa gag gct cct tct gct tct cct act aac ggc atc aca gta 192 Val Val Lys Glu Ala Pro Ser Ala Ser Pro Thr Asn Gly Ile Thr Val 10 15 20 aca ttt gct gac gct gtt ctt act gga tac ggc atc gag aaa cgc ggt 240 Thr Phe Ala Asp Ala Val Leu Thr Gly Tyr Gly Ile Glu Lys Arg Gly 25 30 35 tct gta aag gag aac gag gac acg ctt tac gac ggc aaa ggt tac atc 288 Ser Val Lys Glu Asn Glu Asp Thr Leu Tyr Asp Gly Lys Gly Tyr Ile 40 45 50 55 tca tac ttc ttc gac gag gac gct aac gct gct gag cct gtt ggc tct 336 Ser Tyr Phe Phe Asp Glu Asp Ala Asn Ala Ala Glu Pro Val Gly Ser 60 65 70 gct aca ttc act gtt gac gta gcg gaa gct ggc ctt tac aaa ctt tca 384 Ala Thr Phe Thr Val Asp Val Ala Glu Ala Gly Leu Tyr Lys Leu Ser 75 80 85 ctt ggc tac tat ctt cct gag ggc tat ggc gac aaa gtt act tct atc 432 Leu Gly Tyr Tyr Leu Pro Glu Gly Tyr Gly Asp Lys Val Thr Ser Ile 90 95 100 gag atc aat ggc gca ggt aca gga gag ctt aca ctt gac gag cct gct 480 Glu Ile Asn Gly Ala Gly Thr Gly Glu Leu Thr Leu Asp Glu Pro Ala 105 110 115 gcc ggt act gtt cgc gct gag aaa atg gtt tca aaa gtt ctt ctt aac 528 Ala Gly Thr Val Arg Ala Glu Lys Met Val Ser Lys Val Leu Leu Asn 120 125 130 135 gca ggc agc aac aca atc aaa atc atg cgt ggt tgg ggc tat tac ggc 576 Ala Gly Ser Asn Thr Ile Lys Ile Met Arg Gly Trp Gly Tyr Tyr Gly 140 145 150 atc gag cac atc aaa ctt gag cct gct ggc gca gca tca tct tca aac 624 Ile Glu His Ile Lys Leu Glu Pro Ala Gly Ala Ala Ser Ser Ser Asn 155 160 165 aag ctt gct gct gag gac ggt cct atg aca ggc gca ctt aac aac cct 672 Lys Leu Ala Ala Glu Asp Gly Pro Met Thr Gly Ala Leu Asn Asn Pro 170 175 180 gag gct aca cct gag gct cgc gca ctt atg gac tat ctt ctt tct cag 720 Glu Ala Thr Pro Glu Ala Arg Ala Leu Met Asp Tyr Leu Leu Ser Gln 185 190 195 tac ggc cag aaa atc atc tct ggt caa caa act atc gag gac atc gag 768 Tyr Gly Gln Lys Ile Ile Ser Gly Gln Gln Thr Ile Glu Asp Ile Glu 200 205 210 215 tgg atc aaa caa caa aca ggc aag tat cct gct atc ttc agc acg gac 816 Trp Ile Lys Gln Gln Thr Gly Lys Tyr Pro Ala Ile Phe Ser Thr Asp 220 225 230 ctt atg gac tat tca cct tct cgc atc gag aat ggc gca tct tct act 864 Leu Met Asp Tyr Ser Pro Ser Arg Ile Glu Asn Gly Ala Ser Ser Thr 235 240 245 gag gtt gag aaa atg atc gag tgg tac aaa cgc ggt ggc atc gtt tca 912 Glu Val Glu Lys Met Ile Glu Trp Tyr Lys Arg Gly Gly Ile Val Ser 250 255 260 ctt tgt tgg cac tgg aac gct cct aag gga atc ggt ggc aac gag cct 960 Leu Cys Trp His Trp Asn Ala Pro Lys Gly Ile Gly Gly Asn Glu Pro 265 270 275 ggt cat gag tgg tgg cgt ggc ttc tat acg gag ttt acg acg ttc gac 1008 Gly His Glu Trp Trp Arg Gly Phe Tyr Thr Glu Phe Thr Thr Phe Asp 280 285 290 295 gtt gag ttt gca ctt aac cat tta gac agc gag gac tac caa ctt ctt 1056 Val Glu Phe Ala Leu Asn His Leu Asp Ser Glu Asp Tyr Gln Leu Leu 300 305 310 atc cgc gac atc gac gcc atc gct gtt cag ctt aaa cgc ctt caa gac 1104 Ile Arg Asp Ile Asp Ala Ile Ala Val Gln Leu Lys Arg Leu Gln Asp 315 320 325 gct aac gta cct gtt ctt tgg cgt cct ctt cac gag gca gag gga ggc 1152 Ala Asn Val Pro Val Leu Trp Arg Pro Leu His Glu Ala Glu Gly Gly 330 335 340 tgg ttc tgg tgg gga gcg aaa ggt cct gag cct gca aaa caa ctt tat 1200 Trp Phe Trp Trp Gly Ala Lys Gly Pro Glu Pro Ala Lys Gln Leu Tyr 345 350 355 cgc ctt atg tat gac cgc ctt aca cac gac cat aac ctt aac aac ctt 1248 Arg Leu Met Tyr Asp Arg Leu ...
Claims
1. A polypeptide with mannanase activity, wherein the polypeptide has 100% sequence identity with SEQ ID NO: 6, wherein the polypeptide is obtained from Bacillus subtilis.
2. A detergent composition comprising a surfactant and a polypeptide having mannanase activity, wherein the polypeptide has 100% sequence identity with SEQ ID NO: 6, wherein the polypeptide is obtained from Bacillus subtilis.
3. The detergent composition of claim 2, further comprising one or more components selected from the group consisting of: Water-soluble auxiliaries, detergent builders, chelating agents, bleaching components, polymers, fabric colorants, fabric conditioning agents, foaming agents, defoaming agents, dye transfer inhibitors, fluorescent whitening agents, fragrances, optical brighteners, bactericides, fungicides, dirt suspending agents, enzyme inhibitors, enzyme stabilizers, enzyme activators, and antioxidants.
4. The detergent composition of claim 2 or 3, wherein the detergent composition further comprises one or more additional enzymes.
5. The detergent composition of claim 4, wherein the additional enzyme is selected from the group consisting of: Amylase, protease, cellulase, hemicellulase, xanthan gumase, esterase, pectinase, reductase, oxidase, ligninase, carrageenanase, tanninase, hyaluronidase, chondroitinase, and transglutaminase, or any combination thereof.
6. The detergent composition of claim 3, wherein the water-soluble additive comprises a solubilizer.
7. The detergent composition of claim 3, wherein the detergent aid comprises a co-agent.
8. The detergent composition of claim 3, wherein the polymer comprises one or more components selected from the group consisting of: dirt-releasing polymers, anti-redeposition agents, and dispersants.
9. The detergent composition of claim 5, wherein the amylase is selected from the group consisting of: α-Amylase, glucosylamylase, and amylopectin.
10. The detergent composition of claim 5, wherein the protease comprises keratinase.
11. The detergent composition of claim 5, wherein the oxidase is selected from the group consisting of: Peroxidase, catalase, laccase, phenol oxidase, and lipoxygenase.
12. The detergent composition of claim 5, wherein the cellulase comprises cellobiase.
13. The detergent composition of claim 5, wherein the hemicellulase is selected from the group consisting of: β-glucanase, xyloglucanase, xylanase, endo-β-mannanase, exo-β-mannanase, and arabinosidase.
14. The detergent composition of claim 5, wherein the xanthan gumase comprises xanthan gum lyase.
15. The detergent composition of claim 5, wherein the pectinase is selected from the group consisting of: Pectin lyase, pectin acetylesterase, pectin methylesterase, polygalacturonase, and rhamnogalacturonase.
16. The detergent composition of claim 5, wherein the esterase is selected from the group consisting of: Lipase, acyltransferase, phospholipase, aryl esterase, and keratinase.
17. A particle comprising a core particle and one or more coatings, wherein the particle comprises a polypeptide having 100% sequence identity with SEQ ID NO: 6, wherein the polypeptide is obtained from Bacillus subtilis.
18. A liquid formulation comprising a polyol and a polypeptide having mannanase activity, wherein the polypeptide has 100% sequence identity with SEQ ID NO:6, wherein the polypeptide is obtained from Bacillus subtilis.
19. The liquid formulation of claim 18, wherein the amount of the polypeptide added is between 0.0001% and 10% w / w of the liquid formulation.
20. The liquid formulation of claim 18, wherein the amount of the polyol added is between 5% and 80% w / w of the liquid formulation.
21. Use of the polypeptide of claim 1 or the detergent composition of claim 2 for washing clothes, cleaning or cleaning textiles and / or hard surfaces.
22. Use of the polypeptide of claim 1 or the detergent composition of claim 2 for dishwashing.
23. A method for degrading mannan, the method comprising applying to the mannan a composition comprising a polypeptide as claimed in claim 1 or a detergent composition as claimed in claim 2.
24. The method of claim 23, wherein the mannan is on the surface of the textile or on a hard surface.
25. The method of claim 23, wherein the mannan comprises linear mannan, galactomannan, glucomannan, or galactoglucomannan.
Citation Information
Patent Citations
Enzyme containing granulates suitable for use as detergent additives
EP0170360A1
Novel lipolytic enzymes and their use in detergent compositions
EP0218272A1
Process for the production of protein products in Aspergillus oryzae and a promoter for use in Aspergillus
EP0238023A2
Protected enzyme systems
EP0238216A1
Enzymatic detergent additive
EP0258068A2
